Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,1513,38,9.89 [1.70-57.60],0.0108026167824936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AAMDC,Mth938 domain-containing protein,1469,38,0.92 [0.51-1.66],0.7868914980708761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,1733,49,1.42 [0.93-2.16],0.107359322602413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABCA2,ATP-binding cassette sub-family A member 2,1448,37,1.79 [0.94-3.41],0.0741734631990825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABHD14B,Protein ABHD14B,1710,47,1.22 [0.79-1.87],0.366483087644074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABL1,Tyrosine-protein kinase ABL1,1733,49,1.03 [0.71-1.50],0.8744925246885585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABO,Histo-blood group ABO system transferase,1511,38,0.98 [0.79-1.22],0.8637153090970335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABRAXAS2,BRISC complex subunit Abraxas 2,1448,37,0.86 [0.53-1.38],0.5257108785389266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",1682,45,0.97 [0.72-1.30],0.8324954259218837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",1483,38,1.52 [1.06-2.17],0.0223151459065991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",1502,38,0.87 [0.60-1.24],0.4309556558033038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAN,Aggrecan core protein,1715,49,0.66 [0.29-1.51],0.3282656434856795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE,Angiotensin-converting enzyme,1511,38,2.01 [0.64-6.31],0.229361780632663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE2,Angiotensin-converting enzyme 2,1701,48,1.07 [0.75-1.54],0.6960073493969563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACHE,Acetylcholinesterase,1479,37,1.70 [0.81-3.59],0.1641117826884718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOT13,Acyl-coenzyme A thioesterase 13,1487,38,0.83 [0.63-1.10],0.1877554223449009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,1735,50,0.64 [0.38-1.10],0.1048240866984763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,1453,37,1.07 [0.53-2.15],0.8598110569844041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP5,Tartrate-resistant acid phosphatase type 5,1743,50,1.09 [0.50-2.40],0.8300425930483941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP6,Lysophosphatidic acid phosphatase type 6,1746,50,0.93 [0.64-1.36],0.7199518946621222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRBP,Acrosin-binding protein,1498,38,0.62 [0.26-1.48],0.281910310830705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRV1,Acrosomal protein SP-10,1453,37,1.42 [0.59-3.38],0.4326856634854763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,1448,37,0.67 [0.23-1.94],0.465541475357099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",1701,48,1.73 [1.22-2.46],0.0022794563574411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN2,Alpha-actinin-2,1448,37,1.08 [0.62-1.90],0.7817508343584164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN4,Alpha-actinin-4,1687,47,0.86 [0.35-2.12],0.7491679446380743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1715,47,5.69 [2.76-11.75],2.585420170149092e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY1,Aminoacylase-1,1735,50,0.96 [0.68-1.34],0.8030520199045508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,1448,37,1.10 [0.66-1.82],0.7184408754871415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACYP1,Acylphosphatase-1,1474,37,1.12 [0.70-1.78],0.6438719959518681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA,Adenosine deaminase,1751,50,1.31 [0.66-2.61],0.4476523035358187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,1728,48,2.06 [1.24-3.40],0.0050389098072625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1453,37,2.15 [1.10-4.20],0.0251966619923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,1701,48,0.74 [0.33-1.65],0.4639573353391049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,1718,47,2.30 [1.17-4.51],0.0156498889543559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,1751,50,1.63 [0.78-3.40],0.1947018967997201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,1745,49,1.18 [0.47-2.94],0.7298190854807726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1487,38,2.89 [1.37-6.09],0.0053230416746457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1453,37,4.36 [2.04-9.33],0.0001450841477588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,1753,50,0.74 [0.28-1.95],0.5433909854608048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,1733,49,1.25 [0.73-2.13],0.4220114374530918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,1701,48,1.15 [0.53-2.52],0.7193205317249283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,1453,37,1.60 [0.70-3.65],0.2637688707183157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,1741,50,0.97 [0.56-1.66],0.9058404582947266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,1508,38,1.94 [1.04-3.63],0.0371756869795076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL4,ADAMTS-like protein 4,1469,38,1.84 [0.53-6.39],0.3338827528057494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL5,ADAMTS-like protein 5,1502,38,1.47 [0.74-2.92],0.2765383791657805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,1682,45,0.84 [0.39-1.81],0.6610530578002395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADD1,Alpha-adducin,1479,37,0.87 [0.56-1.35],0.5398859691223448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,1715,47,2.62 [1.55-4.44],0.00033847000632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,1479,37,3.06 [1.61-5.81],0.0006536854120295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE1,Adhesion G protein-coupled receptor E1,1487,38,0.85 [0.50-1.45],0.5533281857930229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,1738,49,1.71 [0.76-3.87],0.1973359389578454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,1746,50,1.67 [0.82-3.42],0.1576778669003583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRF5,Adhesion G protein-coupled receptor F5,1502,38,3.63 [1.19-11.08],0.0238968152344174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,1733,49,1.47 [1.19-1.81],0.0003774938711404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,1735,50,0.41 [0.17-0.97],0.043401744879656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRV1,Adhesion G-protein coupled receptor V1,1441,37,0.67 [0.38-1.19],0.168600742924163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH1B,All-trans-retinol dehydrogenase,1479,37,1.04 [0.73-1.48],0.8189200350022428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,1701,48,0.84 [0.63-1.12],0.2381164523419545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADIPOQ,Adiponectin,1513,38,1.12 [0.75-1.66],0.5885656610140535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,1751,50,8.77 [3.34-22.99],1.0164943334106428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADRA2A,Alpha-2A adrenergic receptor,1448,37,1.03 [0.67-1.58],0.8946946825432878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFAP1,Actin filament-associated protein 1,1479,37,0.72 [0.46-1.11],0.1348425367558909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFM,Afamin,1513,38,0.48 [0.13-1.84],0.284080201993604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFP,Alpha-fetoprotein,1711,47,0.90 [0.60-1.36],0.6189815105834722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGBL2,Cytosolic carboxypeptidase 2,1441,37,1.30 [0.98-1.72],0.0667361225932674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGER,Advanced glycosylation end product-specific receptor,1725,49,1.28 [0.73-2.24],0.3917080655911318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,1659,43,1.64 [1.30-2.08],4.069462790485162e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,1680,45,2.22 [1.44-3.43],0.0003386115965743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,1738,49,2.65 [1.58-4.44],0.0002233247090238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,1751,50,1.64 [1.04-2.59],0.0342280374947424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGT,Angiotensinogen,1511,38,1.76 [0.62-4.99],0.2881077052575882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGXT,Serine--pyruvate aminotransferase,1735,50,0.94 [0.70-1.24],0.646784708741564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHCY,Adenosylhomocysteinase,1735,50,1.11 [0.77-1.59],0.5777376251887101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,1469,38,1.18 [0.43-3.28],0.7487445075470138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK2,Protein AHNAK2,1469,38,1.36 [0.52-3.59],0.5322305576873805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,1498,38,0.98 [0.61-1.57],0.9406930006615216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSG,Alpha-2-HS-glycoprotein,1511,38,2.41 [0.77-7.49],0.1298071080201926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSP,Alpha-hemoglobin-stabilizing protein,1739,50,1.14 [0.87-1.50],0.3544374913559617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIDA,"Axin interactor, dorsalization-associated protein",1465,37,0.94 [0.64-1.38],0.7426752693398959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1,Allograft inflammatory factor 1,1682,45,1.10 [0.67-1.81],0.692537406570499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1L,Allograft inflammatory factor 1-like,1469,38,0.98 [0.55-1.73],0.9367124425758088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",1731,49,0.91 [0.72-1.16],0.449147495114033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK1,Adenylate kinase isoenzyme 1,1735,50,1.04 [0.71-1.51],0.8450085056426375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK2,"Adenylate kinase 2, mitochondrial",1497,38,1.01 [0.74-1.37],0.9606141212759064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKAP12,A-kinase anchor protein 12,1479,37,1.38 [0.44-4.38],0.5836414473107786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B1,Aldo-keto reductase family 1 member B1,1682,45,0.97 [0.67-1.39],0.8613319217451925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B10,Aldo-keto reductase family 1 member B10,1465,37,1.05 [0.75-1.47],0.7789768771584433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1C4,Aldo-keto reductase family 1 member C4,1701,48,0.59 [0.33-1.06],0.0762550801665964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,1453,37,1.29 [0.90-1.86],0.162511080737754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT1S1,Proline-rich AKT1 substrate 1,1670,45,1.03 [0.69-1.53],0.8937167394509834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT2,RAC-beta serine/threonine-protein kinase,1506,38,0.90 [0.70-1.15],0.3932440768256366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT3,RAC-gamma serine/threonine-protein kinase,1674,45,0.76 [0.47-1.22],0.2538092029391543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALCAM,CD166 antigen,1753,50,1.55 [0.52-4.59],0.4265216483371713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH1A1,Retinal dehydrogenase 1,1741,50,0.89 [0.61-1.30],0.5521250134206954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",1498,38,1.09 [0.64-1.85],0.7572415712411429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",1721,49,0.99 [0.73-1.33],0.9308161288553484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",1506,38,0.91 [0.47-1.76],0.7752075752105494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALMS1,Alstrom syndrome protein 1,1483,38,0.49 [0.20-1.20],0.1183769543361473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPI,Intestinal-type alkaline phosphatase,1453,37,1.01 [0.78-1.31],0.9294075834617552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPP,"Alkaline phosphatase, placental type",1733,49,0.94 [0.74-1.20],0.628173398244777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBN,Ameloblastin,1687,47,0.93 [0.35-2.48],0.8858280738815832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,1749,50,11.19 [3.95-31.72],5.590195528753174e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,1508,38,0.99 [0.29-3.44],0.9890335640333522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMFR,E3 ubiquitin-protein ligase AMFR,1670,45,1.37 [0.97-1.94],0.0701517302812838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO1,Amphoterin-induced protein 1,1465,37,0.52 [0.24-1.16],0.1086900691242923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO2,Amphoterin-induced protein 2,1733,49,1.18 [0.41-3.37],0.7555933150203568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMN,Protein amnionless,1687,47,1.16 [0.71-1.91],0.5494502491201879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOT,Angiomotin,1479,37,1.36 [0.70-2.67],0.3672705306553198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOTL2,Angiomotin-like protein 2,1492,37,1.09 [0.60-1.99],0.7734053936054975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMPD3,AMP deaminase 3,1497,38,1.29 [0.86-1.93],0.2256741511857459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,1410,37,0.68 [0.35-1.30],0.2396655737096268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2A,Pancreatic alpha-amylase,1650,50,0.66 [0.41-1.06],0.0840675017231765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2B,Alpha-amylase 2B,1598,47,0.61 [0.37-1.00],0.0483300047109783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,1736,48,2.03 [1.08-3.81],0.028135832955376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT1,Angiopoietin-1,1725,49,0.96 [0.71-1.29],0.7834470339886144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,1751,50,3.07 [1.76-5.34],7.295014624514548e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL1,Angiopoietin-related protein 1,1707,48,1.43 [0.63-3.26],0.3927793835860734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL2,Angiopoietin-related protein 2,1734,48,0.75 [0.42-1.36],0.3444303398351764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL3,Angiopoietin-related protein 3,1741,48,0.78 [0.42-1.47],0.4442964169511485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,1733,49,3.14 [1.90-5.20],8.320980083069513e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL7,Angiopoietin-related protein 7,1751,50,1.40 [0.81-2.42],0.2225580983284454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANK2,Ankyrin-2,1448,37,0.97 [0.64-1.46],0.8735775220631837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,1453,37,0.87 [0.59-1.30],0.5026884446811197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRA2,Ankyrin repeat family A protein 2,1449,38,1.03 [0.61-1.73],0.9109432024893946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRD54,Ankyrin repeat domain-containing protein 54,1682,45,1.03 [0.67-1.57],0.9006206524916668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,1469,38,0.96 [0.44-2.12],0.9287781519161652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANPEP,Aminopeptidase N,1740,49,1.06 [0.47-2.40],0.8796557262510133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA1,Annexin A1,1474,36,1.27 [0.67-2.41],0.4605979065708775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA10,Annexin A10,1670,45,1.17 [0.89-1.53],0.2594036954497958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA11,Annexin A11,1725,49,0.87 [0.59-1.27],0.4599586952728833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA2,Annexin A2,1453,36,0.81 [0.49-1.34],0.4153662227688777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA3,Annexin A3,1745,49,1.04 [0.73-1.48],0.8329081787684149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA4,Annexin A4,1727,49,0.92 [0.64-1.32],0.6524114370415052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,1666,45,1.71 [0.76-3.86],0.1957922412807147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],1687,47,1.14 [0.78-1.67],0.4971310598566938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,1743,49,3.08 [1.47-6.44],0.0028223762150658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP1G2,AP-1 complex subunit gamma-like 2,1498,38,0.87 [0.58-1.30],0.5013737865468963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP2B1,AP-2 complex subunit beta,1465,37,1.05 [0.56-1.96],0.8714169869328833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3B1,AP-3 complex subunit beta-1,1487,38,0.87 [0.58-1.31],0.5065577357381554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3S2,AP-3 complex subunit sigma-2,1497,38,0.74 [0.39-1.43],0.3716127825827718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,1733,49,1.62 [1.06-2.47],0.0260944522280698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APCS,Serum amyloid P-component,1497,37,0.85 [0.35-2.09],0.7308579480846227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,1744,50,1.20 [0.79-1.82],0.382149813052677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APLP1,Amyloid-like protein 1,1735,50,0.85 [0.52-1.38],0.5083509146871892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA1,Apolipoprotein A-I,1513,38,0.92 [0.30-2.79],0.8779836255474999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA2,Apolipoprotein A-II,1511,38,1.62 [0.91-2.90],0.1029198098188828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,1513,38,2.91 [1.55-5.47],0.0009312881107664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOB,Apolipoprotein B-100,1511,38,1.30 [0.34-4.92],0.7041234809580836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOBR,Apolipoprotein B receptor,1469,38,0.77 [0.37-1.57],0.4664845092520999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOC1,Apolipoprotein C-I,1508,37,1.11 [0.45-2.73],0.8184424552916009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOD,Apolipoprotein D,1446,33,0.41 [0.15-1.11],0.0801920238539423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOE,Apolipoprotein E,1513,38,1.39 [0.92-2.11],0.1194457996857547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOF,Apolipoprotein F,1511,38,0.41 [0.18-0.91],0.0280085430949101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOH,Beta-2-glycoprotein 1,1741,50,1.97 [1.04-3.72],0.0370211419746067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOL1,Apolipoprotein L1,1511,38,1.18 [0.78-1.79],0.4346066417885853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOM,Apolipoprotein M,1742,49,1.01 [0.43-2.37],0.9757157571154996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APP,Amyloid-beta precursor protein,1737,49,1.03 [0.71-1.50],0.8714356347389149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APPL2,DCC-interacting protein 13-beta,1479,37,0.88 [0.66-1.17],0.3766523811693959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APRT,Adenine phosphoribosyltransferase,1717,47,1.77 [0.97-3.22],0.0642175192364195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARAF,Serine/threonine-protein kinase A-Raf,1483,38,0.73 [0.43-1.23],0.2374103421475898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,1733,49,1.86 [1.21-2.88],0.0050606930791136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARF6,ADP-ribosylation factor 6,1487,38,0.88 [0.66-1.16],0.3631420323518424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARFIP1,Arfaptin-1,1506,38,0.79 [0.50-1.24],0.3096918995462813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG1,Arginase-1,1732,49,1.45 [0.94-2.23],0.0929944010515732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG2,"Arginase-2, mitochondrial",1498,38,1.22 [0.66-2.24],0.5309886004304714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP1,Rho GTPase-activating protein 1,1682,45,0.62 [0.34-1.14],0.124143171646582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP25,Rho GTPase-activating protein 25,1682,45,1.14 [0.73-1.77],0.5724508081288721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP30,Rho GTPase-activating protein 30,1483,38,1.34 [0.69-2.60],0.3864589518616019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP45,Rho GTPase-activating protein 45,1479,37,0.82 [0.55-1.20],0.3028881725816794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP5,Rho GTPase-activating protein 5,1449,38,0.97 [0.65-1.45],0.8938610765810417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,1497,38,0.92 [0.65-1.31],0.6418365332707084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,1506,38,0.84 [0.60-1.19],0.3312775442926522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,1726,49,0.95 [0.74-1.22],0.6873668997136756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,1441,37,1.37 [0.98-1.90],0.0663554319180987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID3A,AT-rich interactive domain-containing protein 3A,1441,37,1.19 [0.56-2.52],0.6466481075912921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID4B,AT-rich interactive domain-containing protein 4B,1670,45,0.89 [0.47-1.69],0.720152374238884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL13B,ADP-ribosylation factor-like protein 13B,1448,37,0.85 [0.53-1.37],0.5120312983036144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,1448,37,0.79 [0.37-1.71],0.5524152811322389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,1441,37,0.66 [0.34-1.29],0.2255342074687059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,1687,47,1.08 [0.53-2.19],0.8323469465712431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,1448,37,0.61 [0.28-1.32],0.2068619863714748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSA,Arylsulfatase A,1741,50,1.12 [0.67-1.87],0.6686197651853248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSB,Arylsulfatase B,1733,49,0.89 [0.56-1.40],0.6112506049083324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART3,Ecto-ADP-ribosyltransferase 3,1743,49,1.73 [0.91-3.27],0.0936525902282448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART5,Ecto-ADP-ribosyltransferase 5,1441,37,0.95 [0.56-1.59],0.8321696261382806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARTN,Artemin,1687,47,0.81 [0.44-1.50],0.5090054540084026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH1,Acid ceramidase,1499,38,0.54 [0.25-1.14],0.1068547408119368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH2,Neutral ceramidase,1718,47,1.24 [0.74-2.10],0.410910028424001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,1718,47,3.40 [1.76-6.56],0.0002697257646216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,1511,38,4.65 [2.00-10.77],0.0003432305168994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPN,Asporin,1502,38,2.25 [1.18-4.29],0.014346901956814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPSCR1,Tether containing UBX domain for GLUT4,1506,38,0.94 [0.58-1.50],0.7837826274873686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,1469,38,0.89 [0.65-1.22],0.4680765727120993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASS1,Argininosuccinate synthase,1448,37,0.99 [0.68-1.44],0.9550279556271946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,1670,45,1.00 [0.69-1.46],0.984639561730601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,1449,38,0.90 [0.34-2.39],0.8321733793656206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG16L1,Autophagy-related protein 16-1,1487,38,0.91 [0.63-1.32],0.614885192347769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG4A,Cysteine protease ATG4A,1682,45,1.11 [0.72-1.70],0.6445364339717028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATOX1,Copper transport protein ATOX1,1741,50,1.13 [0.78-1.64],0.5110430744792405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,1448,37,0.87 [0.42-1.82],0.7150823672365889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,1448,37,0.71 [0.27-1.87],0.4924239465272538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,1448,37,0.77 [0.31-1.91],0.5749062420623309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B4,Protein ATP1B4,1449,38,0.61 [0.26-1.41],0.244411520646507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,1448,37,1.02 [0.62-1.67],0.9338717248500046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",1448,37,1.24 [0.74-2.07],0.4161978833452642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5IF1,"ATPase inhibitor, mitochondrial",1738,49,0.98 [0.78-1.24],0.8662513358715569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5PO,"ATP synthase subunit O, mitochondrial",1670,45,0.73 [0.38-1.42],0.3583923871765196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6AP2,Renin receptor,1682,45,0.87 [0.41-1.81],0.7041823323639496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1D,V-type proton ATPase subunit D,1733,49,1.67 [0.88-3.17],0.1144813512361417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1F,V-type proton ATPase subunit F,1666,45,1.14 [0.76-1.71],0.5116360545530205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G1,V-type proton ATPase subunit G 1,1469,38,0.86 [0.56-1.34],0.5057416151087681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G2,V-type proton ATPase subunit G 2,1448,37,0.93 [0.65-1.33],0.692727695037613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,1487,38,2.15 [1.08-4.27],0.0297353392707282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRN,"Attractin, Isoform 2",1513,38,5.09 [0.89-29.03],0.0668498374928112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN10,Ataxin-10,1670,45,0.90 [0.62-1.30],0.5718805494934962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2,Ataxin-2,1441,37,0.88 [0.62-1.24],0.4511940055707515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2L,Ataxin-2-like protein,1506,38,0.62 [0.30-1.30],0.2064746494567477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN3,Ataxin-3,1497,38,0.98 [0.60-1.58],0.9283119755884368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXIN1,Axin-1,1726,49,0.91 [0.69-1.19],0.4713325969149724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXL,Tyrosine-protein kinase receptor UFO,1743,49,1.44 [0.61-3.40],0.4048741772062639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZI2,5-azacytidine-induced protein 2,1506,38,0.55 [0.29-1.04],0.0652535225812353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZU1,Azurocidin,1686,50,1.16 [0.88-1.54],0.2944369745224286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,1513,38,2.57 [1.23-5.36],0.012183849979103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1448,37,0.31 [0.06-1.72],0.1823092723859471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1469,38,4.00 [1.80-8.91],0.0006836226546176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",1738,49,2.02 [0.88-4.63],0.0961724474405747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",1741,50,1.14 [0.41-3.14],0.8025893801763958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BABAM1,BRISC and BRCA1-A complex member 1,1453,37,0.43 [0.13-1.45],0.1728957909494628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BACH1,Transcription regulator protein BACH1,1726,49,0.86 [0.60-1.23],0.4101565900851036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG3,BAG family molecular chaperone regulator 3,1715,47,0.98 [0.53-1.81],0.9611468791878994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG4,BAG family molecular chaperone regulator 4,1453,37,0.82 [0.42-1.61],0.5702376346811423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG6,Large proline-rich protein BAG6,1701,48,0.55 [0.26-1.14],0.1091991021605168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1682,45,1.60 [1.16-2.22],0.0044868712766554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,1682,45,1.98 [0.95-4.16],0.0698503940737811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BANK1,B-cell scaffold protein with ankyrin repeats,1726,49,0.91 [0.72-1.16],0.4523631970075167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAP18,Chromatin complexes subunit BAP18,1497,38,0.88 [0.55-1.41],0.6017164335911898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BATF,Basic leucine zipper transcriptional factor ATF-like,1465,37,0.97 [0.65-1.45],0.8825799250201156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAX,Apoptosis regulator BAX,1669,45,0.96 [0.71-1.31],0.8017745290833375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,1741,50,2.88 [1.13-7.33],0.0261124708126068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAN,Brevican core protein,1718,47,0.85 [0.42-1.71],0.6509734897033163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",1502,38,1.13 [0.43-2.94],0.8009528268756698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",1441,37,0.89 [0.47-1.68],0.7154147310352348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCHE,Cholinesterase,1488,37,1.58 [0.47-5.31],0.45530428655321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2,Apoptosis regulator Bcl-2,1487,38,1.21 [0.76-1.93],0.4245014666096689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L1,Bcl-2-like protein 1,1497,38,0.90 [0.66-1.24],0.5292569355168943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",1726,49,1.73 [0.89-3.35],0.1051661918297819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L15,Bcl-2-like protein 15,1453,37,1.36 [0.87-2.13],0.1799814044941967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,1449,38,0.99 [0.60-1.65],0.976777693778713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,1498,38,1.21 [0.64-2.29],0.5520907190223714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCR,Breakpoint cluster region protein,1726,49,0.93 [0.70-1.23],0.5885286636805385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BDNF,Brain-derived neurotrophic factor,1508,38,1.09 [0.75-1.60],0.6481198796998155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BECN1,Beclin-1,1469,38,0.83 [0.50-1.40],0.4883457689635616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BEX3,Protein BEX3,1449,38,0.84 [0.38-1.89],0.6788630292669979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGLAP,Osteocalcin,1508,38,0.99 [0.72-1.37],0.9556654840625772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGN,Biglycan,1680,45,1.06 [0.85-1.33],0.5894428679748909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHLHE40,Class E basic helix-loop-helix protein 40,1441,37,0.82 [0.50-1.35],0.4364884291837652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,1448,37,1.08 [0.31-3.78],0.9070514878748585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BID,BH3-interacting domain death agonist,1726,49,0.99 [0.69-1.42],0.95191300631122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIN2,Bridging integrator 2,1741,50,0.84 [0.63-1.12],0.2364173341977925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIRC2,Baculoviral IAP repeat-containing protein 2,1682,45,0.86 [0.56-1.32],0.4949709320070719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLMH,Bleomycin hydrolase,1753,50,0.59 [0.32-1.09],0.0907326936814215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLNK,B-cell linker protein,1453,37,0.99 [0.41-2.41],0.9892357913760544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,1441,37,1.02 [0.65-1.58],0.9372943225988244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,1497,38,0.82 [0.37-1.80],0.6240844366727709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLVRB,Flavin reductase,1741,50,1.08 [0.77-1.52],0.6483313322898243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,1479,37,7.84 [2.75-22.34],0.0001178580265819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP4,Bone morphogenetic protein 4,1715,47,1.35 [0.83-2.20],0.2241655520495838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP6,Bone morphogenetic protein 6,1698,48,1.22 [0.65-2.30],0.5336285799684531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,1479,37,4.99 [1.48-16.91],0.0097458230631279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,1502,38,0.94 [0.38-2.35],0.8983906910181222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,1453,37,1.30 [0.67-2.51],0.4404516532872974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,1701,48,2.95 [1.02-8.50],0.0452381034180111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA1,BolA-like protein 1,1441,37,1.36 [0.81-2.29],0.2400155258723437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA2_BOLA2B,BolA-like protein 2,1469,38,0.95 [0.54-1.67],0.8609780811036319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFA2,BPI fold-containing family A member 2,1426,37,0.95 [0.71-1.26],0.7068346716715158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB1,BPI fold-containing family B member 1,1722,50,0.77 [0.54-1.11],0.1607373281981997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB2,BPI fold-containing family B member 2,1500,38,0.95 [0.66-1.38],0.7954542304339103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRAP,BRCA1-associated protein,1469,38,0.98 [0.74-1.31],0.9138068774268072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD1,Bromodomain-containing protein 1,1483,38,1.21 [0.53-2.79],0.6481215930715265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD2,Bromodomain-containing protein 2,1441,37,0.81 [0.29-2.28],0.6920526585719544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD3,Bromodomain-containing protein 3,1448,37,0.52 [0.22-1.22],0.1346110604590301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRDT,Bromodomain testis-specific protein,1448,37,0.88 [0.36-2.17],0.7880962705383121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRK1,Protein BRICK1,1670,45,0.90 [0.51-1.59],0.7258962981432076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRME1,Break repair meiotic recombinase recruitment factor 1,1441,37,0.78 [0.33-1.85],0.5719038977309945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRSK2,Serine/threonine-protein kinase BRSK2,1506,38,0.70 [0.32-1.58],0.3935421057320964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,1749,50,3.70 [1.35-10.17],0.011058410263675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSND,Barttin,1449,38,1.92 [0.97-3.81],0.0616008249646586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,1748,49,1.40 [0.68-2.88],0.356087342137711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST2,Bone marrow stromal antigen 2,1748,49,0.95 [0.63-1.43],0.8152565470570288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTC,Probetacellulin,1682,45,0.83 [0.55-1.25],0.3724605756023853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTD,Biotinidase,1513,38,2.22 [0.51-9.72],0.2901012507299029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTLA,B- and T-lymphocyte attenuator,1449,38,0.99 [0.71-1.38],0.9453219826630956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN1A1,Butyrophilin subfamily 1 member A1,1495,38,1.10 [0.53-2.30],0.794167308844678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,1738,49,3.67 [2.00-6.71],2.4611294251847167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,1726,49,2.14 [1.14-4.02],0.0177143218579797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTNL10,Butyrophilin-like protein 10,1449,38,1.03 [0.54-1.96],0.9239228290438168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C19orf12,Protein C19orf12,1670,45,0.74 [0.51-1.08],0.1204376747868315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,1448,37,3.58 [1.56-8.22],0.0026315865260561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QA,Complement C1q subcomponent subunit A,1743,50,1.71 [0.66-4.39],0.267968370665771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",1506,38,0.58 [0.29-1.17],0.125243505699723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QL2,Complement C1q-like protein 2,1453,37,0.80 [0.38-1.68],0.5488939656180303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1743,49,1.67 [1.01-2.75],0.0446575214466123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,1479,37,0.66 [0.30-1.46],0.2996823628792791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,1506,38,1.78 [1.03-3.10],0.0392561815777699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,1476,37,0.70 [0.39-1.25],0.2237518637020907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1R,Complement C1r subcomponent,1513,38,0.68 [0.10-4.58],0.6926994044778912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1RL,Complement C1r subcomponent-like protein,1511,38,1.96 [0.43-8.87],0.3805897447030231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1S,Complement C1s subcomponent,1513,38,0.91 [0.25-3.30],0.8903758412725199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2,Complement C2,1742,49,2.12 [0.59-7.57],0.2464723750555003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2CD2L,Phospholipid transfer protein C2CD2L,1666,45,0.86 [0.45-1.65],0.6536037330075302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2orf69,UPF0565 protein C2orf69,1465,37,0.70 [0.36-1.38],0.3038594938231916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C3,Complement C3,1423,32,1.46 [0.77-2.76],0.2503707224380017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C4BPB,C4b-binding protein beta chain,1741,50,0.67 [0.37-1.22],0.1902496251331757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C5,Complement C5,1513,38,0.57 [0.08-3.90],0.5680657394883284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,1467,37,2.16 [0.97-4.82],0.059075429906399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7orf50,Uncharacterized protein C7orf50,1497,38,1.24 [0.32-4.77],0.756659411622232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C8B,Complement component C8 beta chain,1513,38,1.45 [0.55-3.81],0.4522803342953482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9,Complement component C9,1511,38,0.71 [0.43-1.17],0.1780490368232444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9orf40,Uncharacterized protein C9orf40,1487,38,1.12 [0.79-1.59],0.5348749348284818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA1,Carbonic anhydrase 1,1705,47,1.16 [0.79-1.70],0.4629048413998704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA11,Carbonic anhydrase-related protein 11,1682,45,1.08 [0.57-2.05],0.8062291284766029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,1733,49,3.03 [2.13-4.31],7.288860695101504e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA13,Carbonic anhydrase 13,1715,48,0.91 [0.71-1.16],0.4512636612128771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA14,Carbonic anhydrase 14,1751,50,1.69 [0.91-3.13],0.0964826135670494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA2,Carbonic anhydrase 2,1738,50,1.13 [0.82-1.57],0.4492303120402739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA3,Carbonic anhydrase 3,1751,50,1.35 [0.94-1.93],0.1060348911258727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,1753,50,2.60 [1.10-6.17],0.0302239351830086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",1701,48,0.92 [0.71-1.19],0.5215738879475147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA6,Carbonic anhydrase 6,1733,50,0.76 [0.52-1.11],0.1568970626794192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA7,Carbonic anhydrase 7,1483,38,0.59 [0.20-1.69],0.3213778642614673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA8,Carbonic anhydrase-related protein,1453,37,0.64 [0.15-2.68],0.543166497928161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA9,Carbonic anhydrase 9,1751,50,1.43 [0.94-2.17],0.092475138028173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CABP2,Calcium-binding protein 2,1465,37,0.63 [0.35-1.14],0.1251619950298945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,1441,37,0.88 [0.33-2.36],0.7963274492299481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,1448,37,0.85 [0.50-1.46],0.5620353611661664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,1441,37,0.78 [0.43-1.42],0.4117209314283118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,1506,38,0.79 [0.55-1.13],0.1985198957466175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACYBP,Calcyclin-binding protein,1475,37,0.87 [0.63-1.19],0.3825598089448396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CADPS,Calcium-dependent secretion activator 1,1465,37,0.65 [0.29-1.46],0.2966573795315463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,1733,49,2.29 [1.36-3.85],0.0018507808523271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,1670,45,2.49 [1.21-5.15],0.0134963478218238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCA,Calcitonin,1714,47,1.21 [0.83-1.75],0.3157017577285455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCB,Calcitonin gene-related peptide 2,1497,38,1.30 [0.78-2.15],0.3080348379713023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,1743,50,0.95 [0.74-1.22],0.6829249100836905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,1469,38,0.72 [0.47-1.11],0.1366213222639579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALY,Neuron-specific vesicular protein calcyon,1448,37,0.87 [0.36-2.10],0.7519675049776601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,1682,45,1.10 [0.61-2.00],0.7478389814199302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,1465,37,0.60 [0.30-1.19],0.1424477952418894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,1506,38,0.83 [0.61-1.14],0.2529406499359881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CANT1,Soluble calcium-activated nucleotidase 1,1729,49,1.35 [0.43-4.20],0.6051716112300155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPG,Macrophage-capping protein,1725,50,1.44 [0.98-2.11],0.060888847702409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPN3,Calpain-3,1498,38,1.51 [0.71-3.18],0.283255439629539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPS,Calcyphosin,1497,38,1.00 [0.74-1.35],0.9824344676227968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CARHSP1,Calcium-regulated heat-stable protein 1,1670,45,1.13 [0.70-1.82],0.6168782691533152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASC3,Protein CASC3,1465,37,0.68 [0.31-1.51],0.3442128708392753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP1,Caspase-1,1670,45,1.14 [0.83-1.57],0.4057646916457569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP10,Caspase-10,1670,45,1.23 [0.85-1.77],0.2717691420656676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP2,Caspase-2,1726,49,0.93 [0.64-1.34],0.6838923930355225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP3,Caspase-3,1753,50,0.91 [0.68-1.21],0.5036608761066976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP4,Caspase-4,1483,38,0.93 [0.77-1.13],0.4721059628329658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP7,Caspase-7,1497,38,0.98 [0.67-1.44],0.938204475074374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP8,Caspase-8,1744,50,1.03 [0.71-1.51],0.8653767331658061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP9,Caspase-9,1453,37,1.06 [0.66-1.70],0.8089665209220814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASQ2,Calsequestrin-2,1448,37,0.62 [0.26-1.46],0.2730739477978478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAT,Catalase,1484,37,1.33 [0.81-2.20],0.2622343399658599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,1735,50,1.36 [1.03-1.80],0.0289409243434602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN1,Cerebellin-1,1441,37,0.94 [0.67-1.32],0.7194247047376532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,1751,50,0.35 [0.17-0.70],0.0029749255891106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBS,Cystathionine beta-synthase,1469,38,0.77 [0.43-1.38],0.3846667888007757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBX2,Chromobox protein homolog 2,1448,37,1.03 [0.45-2.35],0.9380891657797422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,1718,47,1.15 [0.82-1.61],0.4134478681545473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCAR2,Cell cycle and apoptosis regulator protein 2,1497,38,1.41 [0.94-2.13],0.0980901512764984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC134,Coiled-coil domain-containing protein 134,1498,38,0.75 [0.39-1.44],0.3867991180452502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC28A,Coiled-coil domain-containing protein 28A,1465,37,0.60 [0.20-1.75],0.3486037703609985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC50,Coiled-coil domain-containing protein 50,1506,38,0.89 [0.59-1.37],0.6072654760141111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,1735,50,2.01 [1.18-3.40],0.009676448791816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,1469,38,1.08 [0.70-1.68],0.7158337528804299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL11,Eotaxin,1751,50,1.84 [0.94-3.60],0.073060774539359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL13,C-C motif chemokine 13,1749,50,1.14 [0.79-1.64],0.4788633724108696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,1736,48,2.47 [1.42-4.30],0.0013707865863123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,1753,50,1.99 [1.25-3.16],0.0035342623437123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,1753,50,1.69 [1.08-2.65],0.0223217596700571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL17,C-C motif chemokine 17,1725,49,0.96 [0.73-1.28],0.8041261474696271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL18,C-C motif chemokine 18,1720,48,1.22 [0.90-1.64],0.2006150286416031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL19,C-C motif chemokine 19,1748,49,1.00 [0.84-1.19],0.9946967654006376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL2,C-C motif chemokine 2,1715,47,1.41 [0.90-2.21],0.1363874837505762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL20,C-C motif chemokine 20,1751,50,0.87 [0.66-1.15],0.3288784926892583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL21,C-C motif chemokine 21,1738,49,1.29 [0.88-1.89],0.1904019571688242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL22,C-C motif chemokine 22,1711,46,1.22 [0.75-2.00],0.4226812049955101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL23,C-C motif chemokine 23,1738,49,1.01 [0.58-1.75],0.9697741218381964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL24,C-C motif chemokine 24,1733,49,0.93 [0.69-1.25],0.6394867014273349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,1751,50,2.27 [1.35-3.81],0.0019540672220689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL26,C-C motif chemokine 26,1726,49,0.81 [0.60-1.11],0.1934835899072454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL27,C-C motif chemokine 27,1735,50,0.93 [0.63-1.37],0.7119141010621202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL28,C-C motif chemokine 28,1715,47,0.99 [0.64-1.54],0.979512879548206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,1726,49,1.31 [1.03-1.67],0.0259856830238798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL4,C-C motif chemokine 4,1733,49,1.06 [0.76-1.47],0.7336037684500776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL5,C-C motif chemokine 5,1743,49,1.03 [0.80-1.33],0.790570230594084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL7,C-C motif chemokine 7,1726,49,1.30 [0.85-2.00],0.2258629357190231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL8,C-C motif chemokine 8,1749,50,0.85 [0.57-1.27],0.4306169499994599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN1,CCN family member 1,1731,49,1.16 [0.81-1.66],0.4103993268868827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN2,CCN family member 2,1730,49,1.08 [0.69-1.70],0.7391180050117174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,1745,50,3.28 [1.99-5.41],3.3555374233456667e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,1751,50,2.42 [1.42-4.12],0.0011453902486198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,1741,50,3.05 [1.85-5.04],1.2998340911257011e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCND2,G1/S-specific cyclin-D2,1483,38,0.89 [0.38-2.05],0.7804751460816831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCNE1,G1/S-specific cyclin-E1,1453,37,0.97 [0.64-1.45],0.8730853479725749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCS,Copper chaperone for superoxide dismutase,1718,47,0.94 [0.56-1.58],0.8259872594666813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCT5,T-complex protein 1 subunit epsilon,1682,45,0.98 [0.55-1.77],0.9555169594801192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD101,Immunoglobulin superfamily member 2,1487,38,1.40 [0.71-2.77],0.326790665365216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD109,CD109 antigen,1741,50,1.53 [0.75-3.11],0.2426056645772832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,1709,45,1.56 [0.89-2.71],0.1198792166037574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,1751,50,2.02 [1.25-3.26],0.0039398709803267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,1743,49,0.96 [0.55-1.66],0.8714739057646627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,1741,50,1.51 [1.05-2.15],0.0246274254044835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164L2,CD164 sialomucin-like 2 protein,1465,37,1.15 [0.55-2.41],0.7037052587732081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD177,CD177 antigen,1737,50,0.95 [0.80-1.13],0.5753199958139409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD1C,T-cell surface glycoprotein CD1c,1741,50,0.67 [0.25-1.84],0.4404433396883658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2,T-cell surface antigen CD2,1448,37,1.52 [0.96-2.42],0.0752338588021539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200,OX-2 membrane glycoprotein,1726,49,1.99 [0.94-4.21],0.0738715771786685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,1721,49,0.81 [0.37-1.79],0.6033060134020785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,1710,49,2.57 [1.45-4.57],0.0012505861153635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD209,CD209 antigen,1731,47,0.78 [0.39-1.58],0.4900926018685919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD22,B-cell receptor CD22,1751,50,1.07 [0.63-1.81],0.8083771017178596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD226,CD226 antigen,1453,37,1.28 [0.61-2.68],0.5075285956302327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD244,Natural killer cell receptor 2B4,1751,50,0.85 [0.36-2.01],0.7179178361567813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD248,Endosialin,1508,38,0.88 [0.42-1.85],0.7289758625205114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,1741,50,3.05 [1.99-4.66],2.730361118556368e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,1718,47,1.82 [0.94-3.54],0.0779640906195908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,1726,49,3.24 [1.94-5.41],7.626223405304471e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD28,T-cell-specific surface glycoprotein CD28,1682,45,1.57 [0.87-2.82],0.1356173257605631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2AP,CD2-associated protein,1735,50,0.95 [0.65-1.39],0.7967698524849778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300A,CMRF35-like molecule 8,1479,37,2.50 [0.96-6.52],0.0614709701520177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,1748,49,3.63 [1.90-6.93],9.484686037623414e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,1744,50,2.04 [1.21-3.45],0.0076311205238041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LF,CMRF35-like molecule 1,1751,50,1.22 [0.82-1.83],0.3276102587759242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,1741,50,2.67 [1.52-4.70],0.000616231680978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,1733,49,3.43 [1.84-6.37],9.987463294181751e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD33,Myeloid cell surface antigen CD33,1741,50,1.28 [0.92-1.79],0.1479679015690251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD34,Hematopoietic progenitor cell antigen CD34,1743,49,2.30 [0.89-5.98],0.0868423238816675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD36,Platelet glycoprotein 4,1453,37,1.68 [0.87-3.23],0.1240201269890812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1733,49,2.54 [1.33-4.84],0.0047519155496747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3D,T-cell surface glycoprotein CD3 delta chain,1441,37,0.65 [0.21-2.06],0.4661696892539704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,1483,38,1.20 [0.47-3.06],0.7020638225645426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,1453,37,0.93 [0.60-1.43],0.7274458421106049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,1720,47,1.73 [0.95-3.16],0.0752460499906316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40,Tumor necrosis factor receptor superfamily member 5,1728,49,1.31 [0.81-2.13],0.2761469451784968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40LG,CD40 ligand,1751,50,1.06 [0.76-1.47],0.7421662623396927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,1729,48,2.07 [0.92-4.67],0.0796986008795598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,1733,49,1.96 [0.91-4.24],0.0878125596549692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,1749,50,2.44 [1.24-4.80],0.010155996769783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,1669,47,3.42 [1.63-7.19],0.0011328656434273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD58,Lymphocyte function-associated antigen 3,1725,49,0.71 [0.18-2.81],0.6290760163479097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,1670,50,3.55 [1.63-7.72],0.0014116249275146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5L,CD5 antigen-like,1505,37,0.68 [0.36-1.31],0.2521924989247692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD6,T-cell differentiation antigen CD6,1749,50,0.76 [0.47-1.22],0.2513290448931424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD63,CD63 antigen,1715,47,0.92 [0.54-1.56],0.756776123207641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD69,Early activation antigen CD69,1726,49,0.87 [0.65-1.16],0.3373801779034134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD7,T-cell antigen CD7,1449,37,1.66 [0.86-3.20],0.1286253498907422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD70,CD70 antigen,1726,49,1.71 [0.93-3.14],0.086443103714972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD72,B-cell differentiation antigen CD72,1479,37,1.00 [0.50-2.01],0.9920999211361442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,1748,49,3.96 [2.13-7.39],1.4739012950186697e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,1751,50,1.67 [1.05-2.66],0.031513540614686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,1502,38,2.44 [1.21-4.91],0.0122271661073208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD82,CD82 antigen,1483,38,1.07 [0.58-1.95],0.8370950890222449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,1726,49,2.24 [1.23-4.10],0.0084817278610807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD84,SLAM family member 5,1726,49,0.81 [0.36-1.86],0.6249710283677894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD86,T-lymphocyte activation antigen CD86,1487,38,0.51 [0.22-1.16],0.1083155946849152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,1748,49,0.78 [0.48-1.25],0.2986963431770145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,1667,42,2.19 [1.04-4.60],0.0386595975186645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99,CD99 antigen,1741,50,2.81 [0.91-8.63],0.0718463988806801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99L2,CD99 antigen-like protein 2,1741,50,2.27 [0.87-5.92],0.0950006181194892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDA,Cytidine deaminase,1501,38,1.06 [0.57-1.95],0.8576148127613468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDAN1,Codanin-1,1497,38,0.67 [0.13-3.34],0.6212179498720126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC123,Cell division cycle protein 123 homolog,1449,38,0.79 [0.46-1.36],0.3885176170339788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC25A,M-phase inducer phosphatase 1,1449,38,1.23 [0.56-2.70],0.597218860850562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC26,Anaphase-promoting complex subunit CDC26,1484,37,0.96 [0.60-1.54],0.8602023080262049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC27,Cell division cycle protein 27 homolog,1682,45,0.70 [0.43-1.14],0.14858231432439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC37,Hsp90 co-chaperone Cdc37,1741,50,0.98 [0.73-1.32],0.9074292239073654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,1487,38,0.85 [0.61-1.16],0.3025546849088644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDCP1,CUB domain-containing protein 1,1718,47,1.36 [0.89-2.08],0.1505025439801319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,1667,47,1.94 [1.28-2.94],0.0016926318590861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,1744,49,1.66 [1.19-2.32],0.002910960047597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH17,Cadherin-17,1735,50,1.11 [0.80-1.56],0.5250607171223549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH2,Cadherin-2,1735,50,1.02 [0.54-1.94],0.9528014721304802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH22,Cadherin-22,1483,38,0.61 [0.19-1.93],0.4017940865352964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH23,Cadherin-23,1497,38,1.15 [0.34-3.84],0.8241923471507412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,1748,49,2.39 [1.35-4.24],0.0028565575607181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH4,Cadherin-4,1441,37,1.28 [0.90-1.83],0.168170898468996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH5,Cadherin-5,1753,50,0.83 [0.37-1.86],0.6538959965490916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH6,Cadherin-6,1735,50,1.07 [0.60-1.90],0.8287210480089886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR1,Cadherin-related family member 1,1670,45,0.87 [0.44-1.71],0.6846987419054374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR2,Cadherin-related family member 2,1733,49,0.84 [0.62-1.13],0.2428517245384294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR5,Cadherin-related family member 5,1735,50,0.92 [0.48-1.75],0.7945918131898514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK1,Cyclin-dependent kinase 1,1449,38,1.10 [0.48-2.51],0.8238332012442289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,1506,38,0.72 [0.40-1.28],0.2635193774761908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKL5,Cyclin-dependent kinase-like 5,1441,37,0.82 [0.42-1.59],0.5544330960979651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,1733,49,1.12 [0.88-1.41],0.3554245594580039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,1733,49,0.97 [0.74-1.28],0.8508877696020463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,1733,49,2.31 [1.19-4.50],0.0136185855270072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1730,49,3.24 [1.31-7.97],0.0106472564412503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,1742,50,1.86 [1.10-3.14],0.0207903700177535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,1736,50,0.66 [0.28-1.54],0.33336388251997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,1487,38,0.97 [0.65-1.44],0.8650074642047374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,1483,38,1.33 [1.00-1.77],0.0471616754935046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,1487,38,1.75 [0.83-3.68],0.1440356752294722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,1483,38,1.13 [0.59-2.14],0.7137945332184525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,1726,49,1.25 [0.96-1.64],0.0960904937776782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,1682,45,0.87 [0.49-1.54],0.6311500030408926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,1660,42,1.29 [0.88-1.89],0.1915668025970936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,1508,38,1.01 [0.46-2.22],0.9847540104975452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,1701,48,1.33 [0.81-2.20],0.2635383448944601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPA,CCAAT/enhancer-binding protein alpha,1453,37,1.24 [0.61-2.49],0.5527463220307617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPB,CCAAT/enhancer-binding protein beta,1701,48,0.41 [0.19-0.86],0.0177263228486038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA2A,Chymotrypsin-like elastase family member 2A,1508,38,0.71 [0.47-1.09],0.1147876720824728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA3A,Chymotrypsin-like elastase family member 3A,1751,50,0.75 [0.52-1.07],0.1097406029168656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,1479,37,2.82 [1.07-7.43],0.0365375524495455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEMIP2,Cell surface hyaluronidase,1453,37,1.29 [0.69-2.43],0.4231686988540539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,1441,37,1.28 [0.84-1.94],0.2532671390661158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPF,Centromere protein F,1483,38,1.13 [0.69-1.85],0.6317720739530626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPJ,Centromere protein J,1483,38,1.25 [0.88-1.77],0.2202865799900564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP112,Centrosomal protein of 112 kDa,1448,37,0.84 [0.36-1.97],0.6836300997189371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP152,Centrosomal protein of 152 kDa,1449,38,1.00 [0.50-1.98],0.9980245752799088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP164,Centrosomal protein of 164 kDa,1687,47,1.09 [0.79-1.51],0.6061936274423758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP170,Centrosomal protein of 170 kDa,1469,38,0.92 [0.59-1.44],0.7287867391459788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP20,Centrosomal protein 20,1682,45,1.04 [0.74-1.45],0.8259940172931246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP290,Centrosomal protein of 290 kDa,1483,38,0.87 [0.48-1.56],0.6305138866138917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP350,Centrosome-associated protein 350,1449,38,1.57 [1.07-2.28],0.0196380934308702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP43,Centrosomal protein 43,1689,46,0.99 [0.66-1.47],0.9461738563738492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP85,Centrosomal protein of 85 kDa,1682,45,0.72 [0.47-1.13],0.1520574015656798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CERT,Ceramide transfer protein,1670,45,1.02 [0.65-1.61],0.9159882159376812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES1,Liver carboxylesterase 1,1733,50,0.97 [0.76-1.23],0.7865011353407556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,1733,49,1.86 [1.27-2.72],0.001418097531225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES3,Carboxylesterase 3,1733,49,1.11 [0.80-1.54],0.5496583035427307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN2,Centrin-2,1670,45,1.06 [0.71-1.59],0.7599232202265152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN3,Centrin-3,1487,38,0.84 [0.55-1.28],0.4144842060703562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFB,Complement factor B,1481,36,1.72 [0.63-4.66],0.2883012888358194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,1682,45,1.57 [1.06-2.31],0.0236414831493267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,1513,38,3.10 [0.93-10.30],0.0644027916621254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFH,Complement factor H,1405,33,1.64 [0.37-7.26],0.5137450814598774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR2,Complement factor H-related protein 2,1501,37,1.67 [0.94-3.00],0.0828596666803026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR4,Complement factor H-related protein 4,1509,38,0.73 [0.50-1.06],0.0995205384335466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR5,Complement factor H-related protein 5,1489,37,1.47 [0.68-3.17],0.3266308389804502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFI,Complement factor I,1513,38,1.05 [0.24-4.63],0.9516249476125288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFP,Properdin,1513,38,0.33 [0.11-1.06],0.0623581519705948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGA,Glycoprotein hormones alpha chain,1741,50,1.19 [0.85-1.66],0.3079336558435168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,1511,38,0.75 [0.35-1.58],0.4447548039004586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGN,Cingulin,1465,37,0.77 [0.32-1.84],0.5540912726669558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,1735,50,3.08 [2.02-4.69],1.873332043643526e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,1682,45,1.19 [0.83-1.71],0.3508154085681703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,1479,37,0.53 [0.31-0.91],0.0206278009242746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1497,38,2.94 [1.66-5.22],0.0002317298100768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,1498,38,2.03 [1.05-3.94],0.035718156471877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHEK2,Serine/threonine-protein kinase Chk2,1701,48,0.78 [0.37-1.67],0.5226809491249027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,1508,38,1.30 [1.05-1.60],0.0169961455392546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,1741,49,2.48 [1.60-3.84],4.963852590140754e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,1690,47,1.64 [1.25-2.16],0.0003742177078595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHIT1,Chitotriosidase-1,1735,50,1.08 [0.90-1.30],0.4291410382384358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHL1,Neural cell adhesion molecule L1-like protein,1739,47,1.08 [0.49-2.38],0.8561856207501045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHM,Rab proteins geranylgeranyltransferase component A 1,1465,37,0.84 [0.49-1.43],0.5139946527309047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP1A,Charged multivesicular body protein 1a,1718,47,1.20 [0.85-1.68],0.2969948647355226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP6,Charged multivesicular body protein 6,1502,38,1.00 [0.58-1.73],0.9936706427123724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHP1,Calcineurin B homologous protein 1,1441,37,0.89 [0.55-1.44],0.6333552123835766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,1733,49,3.43 [1.72-6.83],0.0004741991888081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL2,Chordin-like protein 2,1735,50,0.64 [0.41-1.02],0.0589604081953706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRM1,Muscarinic acetylcholine receptor M1,1465,37,1.16 [0.51-2.65],0.7209584363075023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIAPIN1,Anamorsin,1741,50,1.09 [0.73-1.62],0.6658297806074251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CILP,Cartilage intermediate layer protein 1,1508,38,1.67 [0.98-2.84],0.059762106126895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CINP,Cyclin-dependent kinase 2-interacting protein,1483,38,0.82 [0.39-1.70],0.5893544848642678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIRBP,Cold-inducible RNA-binding protein,1487,38,0.86 [0.61-1.20],0.3613737289883216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIT,Citron Rho-interacting kinase,1465,37,1.17 [0.61-2.25],0.6417187987658726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,1745,50,3.85 [2.19-6.78],3.0271303737463565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,1508,38,1.81 [1.21-2.72],0.0040345725103908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",1723,49,1.24 [0.85-1.82],0.2665946465086091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLASP1,CLIP-associating protein 1,1449,38,0.83 [0.50-1.39],0.4848448967966691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLC,Galectin-10,1732,50,1.35 [0.95-1.92],0.0971846270930376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,1718,47,2.76 [1.32-5.77],0.0070216578933309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC11A,C-type lectin domain family 11 member A,1737,50,1.02 [0.61-1.69],0.9469911806793322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC12A,C-type lectin domain family 12 member A,1453,37,0.98 [0.21-4.57],0.9790281931757602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,1741,50,3.23 [1.64-6.38],0.0007168291769065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1A,C-type lectin domain family 1 member A,1701,48,1.76 [0.91-3.41],0.0918836482287842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1B,C-type lectin domain family 1 member B,1748,49,0.97 [0.74-1.27],0.817224860190899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC2L,C-type lectin domain family 2 member L,1465,37,1.22 [0.72-2.05],0.4614156074215653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,1472,36,0.26 [0.09-0.77],0.0149822628832114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,1726,49,0.47 [0.24-0.93],0.0309462997900147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4C,C-type lectin domain family 4 member C,1726,49,0.63 [0.38-1.07],0.0868123912571057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4D,C-type lectin domain family 4 member D,1726,49,1.16 [0.80-1.69],0.4242914608776261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4G,C-type lectin domain family 4 member G,1726,49,1.04 [0.50-2.18],0.9073109095942188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4M,C-type lectin domain family 4 member M,1506,38,0.81 [0.41-1.61],0.5522875249959271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,1731,50,2.52 [1.15-5.53],0.0209859851808262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC6A,C-type lectin domain family 6 member A,1682,45,0.82 [0.45-1.48],0.5024506705308817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,1751,50,2.14 [1.27-3.62],0.0043732956006157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLGN,Calmegin,1465,37,0.80 [0.39-1.63],0.5354987833581885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIC5,Chloride intracellular channel protein 5,1465,37,0.45 [0.13-1.53],0.2013558548539236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLINT1,Clathrin interactor 1,1449,38,0.63 [0.26-1.52],0.3092080272507306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIP2,CAP-Gly domain-containing linker protein 2,1726,49,0.99 [0.79-1.24],0.9007430371454724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,1751,50,8.07 [3.15-20.66],1.364182291580726e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLNS1A,Methylosome subunit pICln,1465,37,1.21 [0.47-3.13],0.693697223749568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",1714,47,1.18 [0.90-1.53],0.2269793074662643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPS,Colipase,1739,50,0.74 [0.55-1.00],0.0491863440966938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSPN,Claspin,1666,45,0.90 [0.41-2.00],0.7978213143989612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN1,Calsyntenin-1,1670,45,0.53 [0.30-0.94],0.0309226521277866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN2,Calsyntenin-2,1751,50,1.49 [0.90-2.45],0.1187042616107822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN3,Calsyntenin-3,1497,38,0.90 [0.34-2.43],0.8375173115339546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLTA,Clathrin light chain A,1701,48,1.20 [0.71-2.03],0.5046872249334042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLU,Clusterin,1513,38,1.72 [0.74-3.99],0.2067802768310924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLUL1,Clusterin-like protein 1,1732,50,1.00 [0.59-1.69],0.9872130263833042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMC1,COX assembly mitochondrial protein homolog,1502,38,0.94 [0.67-1.32],0.7148148787414682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMIP,C-Maf-inducing protein,1498,38,0.86 [0.60-1.24],0.4237552345806865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNDP1,Beta-Ala-His dipeptidase,1743,49,1.16 [0.68-1.99],0.5777548952256091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,1441,37,1.22 [0.82-1.82],0.3155500575136727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",1464,38,0.90 [0.60-1.34],0.5883581703798595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY2,Protein canopy homolog 2,1701,48,1.21 [0.86-1.69],0.2781106404103797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY4,Protein canopy homolog 4,1733,49,1.05 [0.74-1.49],0.7767492872736658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNST,Consortin,1735,50,0.86 [0.69-1.09],0.2149431597115287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTF,Ciliary neurotrophic factor,1441,37,1.00 [0.38-2.62],0.9987457946480602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN1,Contactin-1,1753,50,1.25 [0.54-2.91],0.6059979385992608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN2,Contactin-2,1751,50,1.32 [0.79-2.22],0.2928398643368591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN3,Contactin-3,1741,50,1.45 [0.70-2.99],0.3189425150072211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN4,Contactin-4,1741,50,1.61 [0.62-4.19],0.3308701451389322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN5,Contactin-5,1732,49,0.39 [0.20-0.76],0.0053471209958023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP2,Contactin-associated protein-like 2,1726,49,1.21 [0.70-2.11],0.490156308179147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP4,Contactin-associated protein-like 4,1465,37,0.94 [0.66-1.32],0.7159094751606396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COCH,Cochlin,1502,38,1.19 [0.64-2.19],0.5830268921419371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL15A1,Collagen alpha-1(XV) chain,1508,38,1.25 [0.45-3.41],0.6697092912654217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,1734,48,8.44 [3.51-20.29],1.8680940700422911e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL1A1,Collagen alpha-1(I) chain,1753,50,0.91 [0.33-2.51],0.8572162794728393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,1487,38,2.28 [1.27-4.11],0.0059796014239083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL28A1,Collagen alpha-1(XXVIII) chain,1465,37,1.13 [0.77-1.67],0.5227738518498947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL2A1,Collagen alpha-1(II) chain,1469,38,1.13 [0.79-1.62],0.4999519045112343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL3A1,Collagen alpha-1(III) chain,1508,38,2.18 [0.78-6.09],0.1384607208436313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,1735,50,1.79 [1.07-2.99],0.0265893803291001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A4,Collagen alpha-4(IV) chain,1479,38,0.53 [0.33-0.86],0.0096347444743509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL5A1,Collagen alpha-1(V) chain,1479,37,1.44 [0.81-2.57],0.2094822692685141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,1753,50,3.94 [2.44-6.35],2.087767734352021e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A1,Collagen alpha-1(IX) chain,1726,49,0.82 [0.50-1.32],0.4128210015176919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A2,Collagen alpha-2(IX) chain,1483,38,1.10 [0.68-1.76],0.7063191095940025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,1726,49,5.65 [2.85-11.22],7.373119937555236e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD1,COMM domain-containing protein 1,1469,38,0.89 [0.53-1.50],0.6716878278829725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD9,COMM domain-containing protein 9,1498,38,1.44 [0.68-3.06],0.3459246010836088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMP,Cartilage oligomeric matrix protein,1715,48,0.57 [0.28-1.15],0.1177880343316269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMT,Catechol O-methyltransferase,1682,45,0.87 [0.63-1.21],0.4205194856623924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPB2,Coatomer subunit beta',1448,37,1.03 [0.52-2.05],0.9225099040145924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPE,Coatomer subunit epsilon,1670,45,1.02 [0.61-1.72],0.9340547595680072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",1469,38,0.96 [0.47-1.98],0.9213889025820136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO1A,Coronin-1A,1698,49,0.93 [0.69-1.25],0.6235087664618392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO6,Coronin-6,1441,37,0.94 [0.40-2.19],0.8809626644917675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",1733,49,1.25 [0.88-1.78],0.2104533070087915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX6B1,Cytochrome c oxidase subunit 6B1,1502,38,0.69 [0.27-1.76],0.4326902281429503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA1,Carboxypeptidase A1,1753,50,0.79 [0.56-1.12],0.1875262607405351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA2,Carboxypeptidase A2,1742,48,1.33 [0.97-1.83],0.0793476587455221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA4,Carboxypeptidase A4,1438,35,0.95 [0.45-1.99],0.8937780565386451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB1,Carboxypeptidase B,1753,50,0.78 [0.53-1.16],0.2210619355534812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB2,Carboxypeptidase B2,1508,37,0.88 [0.25-3.13],0.8431855808818014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPE,Carboxypeptidase E,1735,50,1.02 [0.54-1.95],0.9485004201207846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPLX2,Complexin-2,1449,38,1.23 [0.53-2.83],0.631270586509528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,1739,49,2.04 [1.04-3.97],0.0371773428420514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",1453,37,1.20 [0.42-3.40],0.730306716908548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,1748,49,0.90 [0.62-1.33],0.6063003142502353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPQ,Carboxypeptidase Q,1507,38,1.67 [0.71-3.93],0.2383392249478927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPTP,Ceramide-1-phosphate transfer protein,1448,37,1.28 [0.69-2.38],0.4405302675818681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPVL,Probable serine carboxypeptidase CPVL,1749,50,1.70 [0.86-3.36],0.1284310111275288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM1,Probable carboxypeptidase X1,1741,50,1.04 [0.73-1.47],0.8293985288748575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,1502,38,2.11 [0.73-6.12],0.1675784045743523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR1,Complement receptor type 1,1508,37,1.10 [0.48-2.52],0.82160812787184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR2,Complement receptor type 2,1743,49,1.38 [0.83-2.28],0.2120445787302393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,1682,45,0.84 [0.60-1.18],0.3128790014288508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRADD,Death domain-containing protein CRADD,1714,47,1.11 [0.79-1.57],0.5418881354945322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREB3,Cyclic AMP-responsive element-binding protein 3,1449,38,0.84 [0.43-1.67],0.6263872045554816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREBZF,CREB/ATF bZIP transcription factor,1449,38,1.58 [0.51-4.91],0.4258927748203682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREG1,Protein CREG1,1717,50,0.57 [0.30-1.10],0.0942969293993587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,1479,37,2.06 [1.03-4.11],0.040596758886557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD2,Protein disulfide isomerase CRELD2,1733,49,0.98 [0.62-1.56],0.94397347405064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRH,Corticoliberin,1678,45,0.73 [0.53-1.00],0.0482993481386632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHBP,Corticotropin-releasing factor-binding protein,1726,49,1.17 [0.49-2.78],0.7304168479831319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHR1,Corticotropin-releasing factor receptor 1,1701,48,1.12 [0.78-1.59],0.5458427958941207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,1738,49,2.11 [0.70-6.32],0.1819614419872673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,1718,47,2.11 [1.25-3.54],0.0050840076334963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP2,Cysteine-rich secretory protein 2,1751,50,0.90 [0.62-1.30],0.5650228012652359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP3,Cysteine-rich secretory protein 3,1495,38,0.37 [0.13-1.06],0.0637171824758308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRKL,Crk-like protein,1732,49,1.00 [0.79-1.28],0.9820509175047432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRLF1,Cytokine receptor-like factor 1,1738,49,0.81 [0.31-2.13],0.6631374714496558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRNN,Cornulin,1692,47,1.26 [0.91-1.74],0.1658278373024635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAC1,Cartilage acidic protein 1,1753,50,0.48 [0.22-1.03],0.0591470042639128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAM,Cytotoxic and regulatory T-cell molecule,1718,47,1.17 [0.72-1.91],0.5254479241501779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAP,Cartilage-associated protein,1465,37,1.20 [0.68-2.13],0.5309312697514544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRX,Cone-rod homeobox protein,1701,48,0.67 [0.44-1.01],0.0539829324459184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB1,Beta-crystallin B1,1502,38,0.96 [0.59-1.55],0.8553390260283382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB2,Beta-crystallin B2,1497,38,1.15 [0.84-1.57],0.3896957414709009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYGD,Gamma-crystallin D,1497,38,0.96 [0.71-1.29],0.7618965093267109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYM,Ketimine reductase mu-crystallin,1441,37,1.12 [0.77-1.62],0.5685098034596374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYZL1,Quinone oxidoreductase-like protein 1,1469,38,0.85 [0.61-1.20],0.3685327284772672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSDE1,Cold shock domain-containing protein E1,1448,37,0.96 [0.71-1.29],0.7914453801336212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,1738,49,2.55 [1.18-5.54],0.0178422395829031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,1511,38,1.37 [0.68-2.76],0.385422127820102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2,Granulocyte-macrophage colony-stimulating factor,1448,37,0.65 [0.25-1.70],0.3781569857988659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,1718,47,0.83 [0.53-1.31],0.4270745944527794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RB,Cytokine receptor common subunit beta,1453,37,0.90 [0.45-1.78],0.7519725503641488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3,Granulocyte colony-stimulating factor,1687,47,0.88 [0.51-1.54],0.6639760326674196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3R,Granulocyte colony-stimulating factor receptor,1453,37,1.25 [0.57-2.74],0.5751200489450223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSH1,Chorionic somatomammotropin hormone 1,1511,38,1.34 [0.46-3.91],0.5922160129650282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK1D,Casein kinase I isoform delta,1453,37,1.13 [0.69-1.85],0.6150422136749487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK2A1,Casein kinase II subunit alpha,1506,38,0.99 [0.50-1.98],0.9830599961909128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG4,Chondroitin sulfate proteoglycan 4,1508,38,1.30 [0.54-3.14],0.5610155365561044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG5,Chondroitin sulfate proteoglycan 5,1441,37,0.80 [0.40-1.57],0.5151713790715085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSRP3,Cysteine and glycine-rich protein 3,1448,37,0.88 [0.61-1.27],0.5099841535950136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST1,Cystatin-SN,1323,30,0.66 [0.45-0.96],0.0284649165491251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,1736,49,3.61 [1.92-6.79],7.030861532850263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST5,Cystatin-D,1703,47,1.23 [0.78-1.95],0.3767200855121985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST6,Cystatin-M,1685,50,1.01 [0.61-1.66],0.9739195626255662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST7,Cystatin-F,1733,49,1.08 [0.82-1.41],0.5823381986270647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,1708,50,1.87 [1.09-3.20],0.0232983084145591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,1478,38,1.25 [0.77-2.01],0.3667405517123591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTBS,Di-N-acetylchitobiase,1482,37,1.69 [0.52-5.52],0.3869852662461706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTF1,Cardiotrophin-1,1701,48,0.94 [0.68-1.28],0.6742129871410244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTHRC1,Collagen triple helix repeat-containing protein 1,1508,38,2.23 [0.93-5.36],0.072791431537931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTLA4,Cytotoxic T-lymphocyte protein 4,1508,38,0.59 [0.21-1.67],0.3158734263153493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTNNA1,Catenin alpha-1,1441,37,1.04 [0.41-2.67],0.9326720401993932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRB1,Chymotrypsinogen B,1741,50,0.76 [0.53-1.09],0.1352252058545071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,1726,49,0.67 [0.49-0.91],0.0095779019151714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRL,Chymotrypsin-like protease CTRL-1,1497,38,0.62 [0.42-0.92],0.0176617908855126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSB,Cathepsin B,1733,50,1.41 [0.90-2.21],0.1294182682683278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSC,Dipeptidyl peptidase 1,1734,49,1.20 [0.69-2.08],0.5234164643405619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSD,Cathepsin D,1625,44,1.17 [0.67-2.05],0.5869342929043003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,1479,37,1.95 [1.15-3.30],0.0125215868826394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,1741,50,2.63 [1.54-4.47],0.0003765033931737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSH,Pro-cathepsin H,1699,48,1.20 [0.84-1.71],0.3154570935643914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSL,Cathepsin L1,1735,50,1.85 [0.69-4.95],0.2213730432341101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSO,Cathepsin O,1751,50,1.81 [0.85-3.86],0.1257582258137687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,1353,41,3.94 [1.14-13.67],0.0306944026300283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSV,Cathepsin L2,1747,50,0.83 [0.48-1.43],0.4938708958339252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,1738,49,4.01 [2.01-8.01],8.217941176979093e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,1465,37,1.23 [0.66-2.31],0.5134574801769856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CWC15,Spliceosome-associated protein CWC15 homolog,1480,38,1.19 [0.78-1.82],0.418966235831985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,1718,47,2.94 [1.63-5.31],0.0003368308951908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXADR,Coxsackievirus and adenovirus receptor,1726,49,1.22 [0.77-1.93],0.393119735877327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL1,Growth-regulated alpha protein,1731,49,0.96 [0.73-1.25],0.7401908129444905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL10,C-X-C motif chemokine 10,1738,49,1.32 [0.95-1.84],0.0951553853686111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL11,C-X-C motif chemokine 11,1748,49,1.34 [1.01-1.78],0.0412612622136328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL12,Stromal cell-derived factor 1,1687,47,0.73 [0.38-1.39],0.3356636000219524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL13,C-X-C motif chemokine 13,1748,49,1.13 [0.78-1.64],0.5043025855357108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL14,C-X-C motif chemokine 14,1687,47,1.09 [0.74-1.60],0.6582464045341503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,1750,50,3.10 [1.31-7.37],0.0103288466385962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL17,C-X-C motif chemokine 17,1751,50,1.62 [0.90-2.92],0.1070535821708145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL3,C-X-C motif chemokine 3,1728,49,0.91 [0.70-1.20],0.5149628962448587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL5,C-X-C motif chemokine 5,1731,50,1.13 [0.92-1.40],0.2539056198137407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL6,C-X-C motif chemokine 6,1751,50,1.14 [0.83-1.55],0.4171756898840371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL8,Interleukin-8,1721,50,1.37 [1.05-1.77],0.0187186675949047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,1738,49,1.51 [1.14-2.01],0.0046763452552652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5A,Cytochrome b5,1449,38,0.98 [0.63-1.52],0.9290367559545484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5R2,NADH-cytochrome b5 reductase 2,1469,36,0.98 [0.55-1.73],0.9327995962871808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",1448,37,0.79 [0.50-1.25],0.3073021345488691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTH3,Cytohesin-3,1449,38,1.21 [0.85-1.72],0.2892311498081601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTL1,Cytokine-like protein 1,1508,38,1.17 [0.35-3.92],0.7980082115031206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAAM1,Disheveled-associated activator of morphogenesis 1,1479,37,0.77 [0.51-1.14],0.1880902241239886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAB2,Disabled homolog 2,1751,50,1.07 [0.85-1.35],0.5420768779139469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAG1,Dystroglycan,1738,49,1.14 [0.65-2.00],0.6577185583026666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAND5,DAN domain family member 5,1453,37,1.11 [0.74-1.66],0.6230612252761691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPK2,Death-associated protein kinase 2,1453,37,0.91 [0.51-1.63],0.7557271850517537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,1726,49,0.94 [0.76-1.15],0.5235966144344232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",1714,47,0.95 [0.66-1.35],0.760902188769999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBH,Dopamine beta-hydroxylase,1510,38,1.04 [0.75-1.43],0.8201968244992294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBI,Acyl-CoA-binding protein,1730,50,1.27 [0.92-1.76],0.1515767394633978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBN1,Drebrin,1453,37,1.09 [0.58-2.04],0.7987384367103586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBNL,Drebrin-like protein,1738,49,0.94 [0.72-1.24],0.6693166355167287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1741,50,2.99 [1.64-5.48],0.0003759279042482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCC,Netrin receptor DCC,1465,37,1.64 [0.44-6.11],0.4618226547863046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCDC2C,Doublecortin domain-containing protein 2C,1449,38,1.09 [0.68-1.74],0.718823422363775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCLRE1C,Protein artemis,1449,38,0.79 [0.28-2.20],0.6468173952667918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,1701,48,5.15 [2.03-13.11],0.000579265158211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTD,Deoxycytidylate deaminase,1479,37,0.85 [0.61-1.19],0.3531692685806628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN1,Dynactin subunit 1,1751,50,1.01 [0.68-1.48],0.976482668337634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN2,Dynactin subunit 2,1733,49,1.19 [0.92-1.54],0.1767059346712749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN6,Dynactin subunit 6,1670,45,0.97 [0.68-1.38],0.8561396505397258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTPP1,dCTP pyrophosphatase 1,1735,50,0.81 [0.37-1.77],0.5985435290508554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D1,DCN1-like protein 1,1441,37,1.14 [0.79-1.64],0.477322146718994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D2,DCN1-like protein 2,1449,38,1.24 [0.90-1.70],0.1874610024646155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCXR,L-xylulose reductase,1741,50,0.79 [0.50-1.25],0.312863964212923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDA1,DET1- and DDB1-associated protein 1,1448,37,1.08 [0.61-1.92],0.7975137100172408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1733,49,1.82 [1.09-3.03],0.0219759071645579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDC,Aromatic-L-amino-acid decarboxylase,1735,50,0.65 [0.41-1.03],0.065385065609542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDHD2,Phospholipase DDHD2,1506,38,0.76 [0.46-1.23],0.2612361155377604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDI2,Protein DDI1 homolog 2,1479,37,1.24 [0.87-1.77],0.2344806060022595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDR1,Epithelial discoidin domain-containing receptor 1,1748,49,2.41 [0.91-6.36],0.0755754241495739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDT,D-dopachrome decarboxylase,1508,38,1.48 [0.79-2.79],0.2246581044779118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX1,ATP-dependent RNA helicase DDX1,1487,38,1.34 [0.90-2.01],0.152099246247283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX25,ATP-dependent RNA helicase DDX25,1465,37,1.62 [1.07-2.45],0.0218645494618401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX39A,ATP-dependent RNA helicase DDX39A,1453,37,1.02 [0.26-3.94],0.9814229160755068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX4,Probable ATP-dependent RNA helicase DDX4,1453,37,0.46 [0.20-1.05],0.06430202969546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX53,Probable ATP-dependent RNA helicase DDX53,1465,37,0.37 [0.16-0.88],0.0234232779898143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX58,Antiviral innate immune response receptor RIG-I,1682,45,0.96 [0.62-1.49],0.8528574843666736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",1726,49,0.90 [0.69-1.18],0.4614638890905507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,1685,47,1.37 [0.94-2.01],0.1012476468463695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB103A_DEFB103B,Beta-defensin 103,1447,36,1.35 [0.82-2.24],0.24011567382694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB104A_DEFB104B,Beta-defensin 104,1441,37,0.82 [0.44-1.52],0.5261695396850782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB116,Beta-defensin 116,1441,37,1.35 [1.03-1.77],0.030485124210986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB118,Beta-defensin 118,1441,37,0.84 [0.46-1.54],0.5791831507357276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB4A_DEFB4B,Beta-defensin 4A,1721,49,1.07 [0.92-1.26],0.3789903279595953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENND2B,DENN domain-containing protein 2B,1448,37,1.12 [0.58-2.17],0.7391883236674333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENR,Density-regulated protein,1453,37,1.30 [0.75-2.28],0.3528068208227856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DFFA,DNA fragmentation factor subunit alpha,1751,50,1.06 [0.74-1.54],0.7363740034388129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGCR6,Protein DGCR6,1441,37,1.75 [1.07-2.86],0.0258675690251441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKA,Diacylglycerol kinase alpha,1453,37,1.06 [0.60-1.89],0.8396252042697173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKZ,Diacylglycerol kinase zeta,1687,47,0.61 [0.28-1.32],0.2111562160527917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHODH,Dihydroorotate dehydrogenase,1448,37,1.22 [0.75-2.00],0.4227298416138487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHPS,Deoxyhypusine synthase,1498,38,1.23 [0.62-2.45],0.5568898818142253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,1497,38,0.84 [0.41-1.74],0.6473826597529759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIABLO,"Diablo homolog, mitochondrial",1731,50,0.85 [0.68-1.07],0.1731364232634291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK1C,Divergent protein kinase domain 1C,1465,37,0.40 [0.15-1.05],0.0629553486100074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK2B,Divergent protein kinase domain 2B,1479,37,0.88 [0.28-2.72],0.823588374368638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK1,Dickkopf-related protein 1,1748,49,1.20 [0.79-1.84],0.3862045294308546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK3,Dickkopf-related protein 3,1753,50,1.82 [0.81-4.06],0.1450782122829051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,1717,47,2.85 [1.91-4.25],2.812567584583705e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKKL1,Dickkopf-like protein 1,1733,49,0.80 [0.62-1.04],0.0951616695375755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLG4,Disks large homolog 4,1497,38,0.86 [0.54-1.35],0.5062635109093727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLGAP5,Disks large-associated protein 5,1506,38,1.03 [0.60-1.78],0.9052130643053484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLK1,Protein delta homolog 1,1753,50,1.00 [0.65-1.53],0.9842138607282792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,1741,50,3.27 [1.75-6.11],0.0001970567053471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL4,Delta-like protein 4,1469,38,0.49 [0.22-1.09],0.080932670668129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMD,Dystrophin,1469,38,0.95 [0.49-1.82],0.8750736916479159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,1469,38,0.55 [0.38-0.81],0.0022956642224912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA1,DnaJ homolog subfamily A member 1,1449,38,0.71 [0.30-1.65],0.4242512324822437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA2,DnaJ homolog subfamily A member 2,1747,50,0.99 [0.73-1.35],0.9485425930212428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA4,DnaJ homolog subfamily A member 4,1497,38,1.20 [0.80-1.79],0.379724858451557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB1,DnaJ homolog subfamily B member 1,1733,49,1.07 [0.80-1.42],0.6625403711327438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB14,DnaJ homolog subfamily B member 14,1487,38,1.15 [0.74-1.80],0.538687142597458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB2,DnaJ homolog subfamily B member 2,1479,37,1.04 [0.60-1.78],0.8984697968064239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB6,DnaJ homolog subfamily B member 6,1466,36,0.88 [0.60-1.29],0.4975067650989655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB8,DnaJ homolog subfamily B member 8,1701,48,0.84 [0.50-1.40],0.4957122047189445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC21,DnaJ homolog subfamily C member 21,1497,38,0.81 [0.35-1.92],0.6392915174360149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,1469,38,0.95 [0.66-1.37],0.7846209039183561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC9,DnaJ homolog subfamily C member 9,1487,38,1.16 [0.78-1.72],0.4571956368607237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,1723,49,0.63 [0.24-1.63],0.3414442060512147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNLZ,DNL-type zinc finger protein,1441,37,0.83 [0.53-1.31],0.4318487674621742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM1,Dynamin-1,1487,38,0.90 [0.69-1.18],0.4356145378967995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM3,Dynamin-3,1506,38,1.16 [0.68-1.99],0.5893405276187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNMBP,Dynamin-binding protein,1718,47,1.02 [0.67-1.55],0.9326067921739286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPEP,Aspartyl aminopeptidase,1497,38,1.25 [0.74-2.11],0.4031862255885259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,1737,49,1.07 [0.67-1.68],0.7846667321205505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOC2B,Double C2-like domain-containing protein beta,1465,37,0.37 [0.15-0.89],0.0269018706185765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOCK9,Dedicator of cytokinesis protein 9,1441,37,0.97 [0.72-1.30],0.8450673861207124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK1,Docking protein 1,1497,38,0.92 [0.73-1.16],0.4734315269023942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK2,Docking protein 2,1735,50,0.94 [0.76-1.15],0.5327950870919649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP1,Dipeptidase 1,1714,47,0.78 [0.49-1.23],0.2859687861854963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP2,Dipeptidase 2,1733,49,1.28 [0.55-2.98],0.5720111720985017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP10,Inactive dipeptidyl peptidase 10,1726,49,1.18 [0.65-2.15],0.5937016812529667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP4,Dipeptidyl peptidase 4,1715,47,0.64 [0.30-1.39],0.2622271840985049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,1733,49,3.18 [1.66-6.12],0.0005082482584186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP7,Dipeptidyl peptidase 2,1724,50,1.29 [0.84-1.99],0.2413988327793023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPT,Dermatopontin,1753,50,1.29 [0.48-3.48],0.6107502591145473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPY30,Protein dpy-30 homolog,1744,50,1.32 [0.91-1.90],0.1394684259349632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,1718,47,2.07 [1.19-3.63],0.0106007627477898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRG2,Developmentally-regulated GTP-binding protein 2,1733,49,0.98 [0.63-1.54],0.946210590600268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,1722,49,2.10 [1.42-3.11],0.0002207418582979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSCAM,Down syndrome cell adhesion molecule,1506,38,1.01 [0.45-2.27],0.985136920171154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG2,Desmoglein-2,1741,50,2.02 [0.96-4.28],0.0653877212966846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG3,Desmoglein-3,1746,50,1.22 [0.59-2.51],0.5965349022645821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,1725,49,0.38 [0.23-0.61],5.940250518741509e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTD1,D-aminoacyl-tRNA deacylase 1,1479,37,0.87 [0.60-1.25],0.4515373096436095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTNB,Dystrobrevin beta,1495,37,1.58 [0.80-3.10],0.1886560060630401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,1465,37,1.05 [0.66-1.67],0.8284945031983062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,1733,49,1.90 [0.71-5.12],0.2019310456621774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTYMK,Thymidylate kinase,1502,38,1.06 [0.68-1.64],0.7905068502025758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUOX2,Dual oxidase 2,1701,48,0.89 [0.61-1.31],0.5653278474622233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,1498,38,0.60 [0.27-1.32],0.2016203076913009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP29,Dual specificity phosphatase 29,1465,37,0.85 [0.50-1.45],0.5548788945648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP3,Dual specificity protein phosphatase 3,1670,45,1.15 [0.89-1.50],0.2910875660333135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",1487,38,0.87 [0.64-1.19],0.388643910915167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DXO,Decapping and exoribonuclease protein,1497,38,0.94 [0.48-1.81],0.844115651421109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,1498,38,0.81 [0.35-1.85],0.6088157363101725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT1,Dynein light chain Tctex-type 1,1465,37,0.81 [0.53-1.23],0.327371405109727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT3,Dynein light chain Tctex-type 3,1498,38,0.54 [0.26-1.12],0.0993494591129247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,1718,47,0.97 [0.74-1.27],0.8334732673164136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,1746,50,1.77 [0.81-3.85],0.1509858250504413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECE1,Endothelin-converting enzyme 1,1670,45,0.50 [0.23-1.06],0.0688528936119712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",1502,38,1.01 [0.71-1.44],0.9638420093812377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",1469,38,0.80 [0.57-1.11],0.1762063090292583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECI2,Enoyl-CoA delta isomerase 2,1448,37,0.84 [0.48-1.45],0.5241701272693267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECM1,Extracellular matrix protein 1,1467,36,0.89 [0.37-2.14],0.7897319341718462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECSCR,Endothelial cell-specific chemotaxis regulator,1441,37,1.62 [0.95-2.75],0.0761865912383251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1751,50,3.49 [2.29-5.31],5.950406719782148e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,1726,49,0.98 [0.74-1.31],0.9049155848961008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDDM3B,Epididymal secretory protein E3-beta,1498,38,0.65 [0.28-1.48],0.3004546128608536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,1448,37,1.59 [0.74-3.44],0.2364875238249097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDF1,Endothelial differentiation-related factor 1,1506,38,1.05 [0.67-1.65],0.8362694861326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,1701,48,1.44 [0.71-2.89],0.3092502540376857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,1469,38,3.48 [1.33-9.08],0.0110284631094118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDNRB,Endothelin receptor type B,1453,37,0.59 [0.22-1.62],0.3085142885448813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EEF1D,Elongation factor 1-delta,1502,38,0.92 [0.65-1.31],0.6615912354749576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,1487,38,3.36 [1.49-7.59],0.0034825295482492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB2,Dynein regulatory complex protein 8,1483,38,0.72 [0.30-1.72],0.4589538466289837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1740,49,2.39 [1.21-4.73],0.0122618167649427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,1506,38,2.26 [1.21-4.23],0.0106730623117045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,1740,50,4.39 [2.41-8.01],1.3771281745928886e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,1715,47,5.77 [3.31-10.04],5.891906511632281e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNB2,Ephrin-B2,1465,37,1.23 [0.80-1.88],0.3446053834686221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGF,Pro-epidermal growth factor,1722,48,1.05 [0.81-1.35],0.7267546224140491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFL7,Epidermal growth factor-like protein 7,1682,45,1.36 [0.72-2.61],0.3455586604274796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFLAM,Pikachurin,1487,38,1.50 [0.64-3.54],0.3504200985525061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFR,Epidermal growth factor receptor,1753,50,0.31 [0.09-1.05],0.0604326033468143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGLN1,Egl nine homolog 1,1726,49,1.07 [0.73-1.57],0.7225280111260219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHBP1,EH domain-binding protein 1,1502,38,0.90 [0.58-1.39],0.633092546028988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHD3,EH domain-containing protein 3,1469,38,0.93 [0.70-1.22],0.5803650487473124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",1497,38,1.10 [0.66-1.81],0.721290213268774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",1480,38,0.92 [0.69-1.22],0.5542241608890119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,1448,37,0.67 [0.39-1.15],0.1482811252216113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,1469,38,0.47 [0.19-1.18],0.107488497453847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4B,Eukaryotic translation initiation factor 4B,1718,47,1.04 [0.67-1.62],0.8536910695330555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4E,Eukaryotic translation initiation factor 4E,1453,37,0.96 [0.67-1.38],0.8251515263019844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,1735,50,1.21 [0.85-1.72],0.2915656338243916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,1751,50,0.98 [0.76-1.27],0.8878834556005042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,1506,38,0.65 [0.40-1.07],0.0908894303253731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5,Eukaryotic translation initiation factor 5,1448,37,0.88 [0.42-1.84],0.7397289666540081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5A,Eukaryotic translation initiation factor 5A-1,1687,47,0.70 [0.28-1.74],0.4405176013682881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,1506,38,0.89 [0.61-1.30],0.5571373117900638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAVL4,ELAV-like protein 4,1441,37,1.15 [0.83-1.60],0.3859748044575081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,1502,38,2.76 [1.35-5.64],0.0053578252949722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOA,Elongin-A,1733,49,1.04 [0.66-1.66],0.8555408615141638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOB,Elongin-B,1448,37,0.65 [0.26-1.65],0.3673109128745991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENAH,Protein enabled homolog,1687,47,0.95 [0.54-1.67],0.8573819679288134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENDOU,Poly(U)-specific endoribonuclease,1380,33,1.19 [0.60-2.36],0.6190099869354478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENG,Endoglin,1753,50,0.74 [0.19-2.84],0.6593396362433178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO1,Alpha-enolase,1731,48,0.98 [0.70-1.38],0.9034186521529785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO2,Gamma-enolase,1748,49,1.02 [0.69-1.49],0.92502037909379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO3,Beta-enolase,1469,38,0.72 [0.42-1.24],0.2333693710957577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOPH1,Enolase-phosphatase E1,1498,38,0.70 [0.36-1.37],0.2983262184003137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,1448,37,0.48 [0.14-1.65],0.2448889239119347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPEP,Glutamyl aminopeptidase,1448,37,1.08 [0.53-2.21],0.8338686143030338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,1753,50,1.16 [0.56-2.41],0.6946357066299937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,1738,49,0.63 [0.35-1.11],0.1110676849355548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,1469,38,0.98 [0.43-2.25],0.9658958975730066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,1667,48,0.99 [0.75-1.30],0.9214793040560108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENSA,Alpha-endosulfine,1498,38,1.02 [0.59-1.76],0.9496742539856884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,1682,45,1.05 [0.64-1.75],0.836807854814323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,1701,48,0.88 [0.26-3.03],0.8443070666884922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,1701,48,3.29 [1.11-9.77],0.0319407718628626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTR1,Endosome-associated-trafficking regulator 1,1469,38,0.99 [0.62-1.57],0.949887147261518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EP300,Histone acetyltransferase p300,1453,37,1.64 [0.70-3.84],0.2510758769352927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPB41L5,Band 4.1-like protein 5,1465,37,1.19 [0.73-1.93],0.4932346233681302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPCAM,Epithelial cell adhesion molecule,1727,48,0.86 [0.65-1.15],0.3094980311161339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPGN,Epigen,1498,38,1.02 [0.50-2.06],0.962346395941033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA1,Ephrin type-A receptor 1,1737,49,2.03 [1.00-4.12],0.0515017375400957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA10,Ephrin type-A receptor 10,1670,45,1.18 [0.82-1.70],0.3836549206026787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,1674,45,3.19 [1.96-5.20],2.972125937758258e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA4,Ephrin type-A receptor 4,1479,37,1.03 [0.35-3.05],0.9591165592985192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,1753,50,2.82 [1.41-5.63],0.0032767560293145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,1714,47,2.28 [1.14-4.55],0.0192684481807927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHX2,Bifunctional epoxide hydrolase 2,1701,48,0.81 [0.50-1.30],0.37646629869724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPN1,Epsin-1,1483,38,0.87 [0.39-1.93],0.7359477435492123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPO,Erythropoietin,1726,49,1.37 [1.06-1.77],0.014957293261233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPPK1,Epiplakin,1469,38,0.87 [0.58-1.32],0.5251270399508203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,1749,50,1.56 [0.78-3.10],0.2089280863973245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,1741,50,0.70 [0.28-1.72],0.4331641877212614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,1724,49,1.45 [0.40-5.18],0.5692096001300452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,1741,50,0.99 [0.41-2.38],0.9741410047348276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBIN,Erbin,1733,49,0.96 [0.75-1.24],0.7738286810101784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERC2,ERC protein 2,1465,37,0.80 [0.48-1.34],0.3948246929622744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERCC1,DNA excision repair protein ERCC-1,1449,38,0.74 [0.25-2.15],0.5812997193802851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EREG,Proepiregulin,1714,47,1.09 [0.80-1.50],0.5882503131206501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERI1,3'-5' exoribonuclease 1,1483,38,0.69 [0.26-1.84],0.4520626382069143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERMAP,Erythroid membrane-associated protein,1453,37,1.69 [0.83-3.45],0.1471958233745594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,1498,38,1.14 [0.53-2.47],0.7388937264599174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP29,Endoplasmic reticulum resident protein 29,1479,37,0.89 [0.68-1.16],0.3867652790500947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP44,Endoplasmic reticulum resident protein 44,1731,49,0.85 [0.32-2.24],0.741265504852751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,1448,37,0.84 [0.40-1.75],0.6463710289463448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,1753,50,2.42 [1.22-4.79],0.0113100203625314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESM1,Endothelial cell-specific molecule 1,1726,49,0.95 [0.47-1.92],0.8858415202396518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESPL1,Separin,1449,38,1.56 [1.06-2.30],0.0225387588554538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESR1,Estrogen receptor,1453,37,0.80 [0.38-1.69],0.5663491127069638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESYT2,Extended synaptotagmin-2,1497,38,0.84 [0.56-1.25],0.3800018172295952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI2B,Protein EVI2B,1449,38,0.96 [0.40-2.29],0.9190127723636112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI5,Ecotropic viral integration site 5 protein homolog,1453,37,0.92 [0.64-1.32],0.6418375493648296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVPL,Envoplakin,1483,38,0.49 [0.16-1.46],0.2003703840171318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXOSC10,Exosome component 10,1448,37,1.17 [0.78-1.76],0.4472109169187755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXTL1,Exostosin-like 1,1448,37,1.54 [0.89-2.66],0.1218412801985269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EZR,Ezrin,1748,49,1.12 [0.40-3.12],0.8302678372425175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F10,Coagulation factor X,1511,38,1.26 [0.47-3.40],0.6500574587580727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11,Coagulation factor XI,1491,37,1.23 [0.40-3.81],0.7226707723352036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11R,Junctional adhesion molecule A,1741,50,1.09 [0.69-1.73],0.7146988298811583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F12,Coagulation factor XII,1513,38,1.00 [0.48-2.11],0.992414949619518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F13B,Coagulation factor XIII B chain,1505,37,0.93 [0.29-3.00],0.9067430319456012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2,Prothrombin,1513,38,1.22 [0.18-8.03],0.8389290790470485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2R,Proteinase-activated receptor 1,1733,49,1.49 [0.95-2.31],0.0797369841330644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F3,Tissue factor,1740,50,1.71 [0.78-3.76],0.1828384598899683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F7,Coagulation factor VII,1741,49,0.94 [0.45-1.97],0.866374980462501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F9,Coagulation factor IX,1742,49,1.37 [0.35-5.35],0.6548948138876045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",1726,49,1.43 [1.13-1.80],0.0024025316360756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",1735,50,1.47 [1.11-1.95],0.0080680826345764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",1502,38,2.53 [1.63-3.93],3.786242962031127e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",1753,50,2.00 [1.44-2.77],3.847964791952915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,1746,49,1.41 [1.01-1.98],0.0454217555694607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP6,Gastrotropin,1698,48,1.35 [0.91-2.02],0.1405339295583299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP9,Fatty acid-binding protein 9,1726,49,0.72 [0.46-1.14],0.159747629502264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FADD,FAS-associated death domain protein,1735,50,0.92 [0.66-1.29],0.6292038032520819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM13A,Protein FAM13A,1487,38,0.93 [0.58-1.51],0.7810719972244146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171A2,Protein FAM171A2,1506,38,1.11 [0.94-1.31],0.2109263396405361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171B,Protein FAM171B,1498,38,1.45 [0.59-3.54],0.420920611564151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM172A,Cotranscriptional regulator FAM172A,1469,38,0.69 [0.41-1.17],0.166541134022847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM20A,Pseudokinase FAM20A,1502,38,1.67 [0.55-5.10],0.3644290714034436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,1733,49,2.79 [1.53-5.09],0.000836036998908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,1735,50,4.63 [2.52-8.52],8.518761633723268e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,1487,38,1.63 [1.13-2.35],0.0086049726314785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAP,Prolyl endopeptidase FAP,1753,50,0.58 [0.26-1.28],0.1779140986560982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,1465,37,0.99 [0.63-1.57],0.9742757104700434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAS,Tumor necrosis factor receptor superfamily member 6,1748,50,1.31 [0.70-2.46],0.3936470203268501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FASLG,Tumor necrosis factor ligand superfamily member 6,1751,50,1.35 [0.69-2.62],0.3803293883556736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBLN2,Fibulin-2,1508,38,1.86 [0.81-4.25],0.1418492137824315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBN2,Fibrillin-2,1465,37,1.04 [0.60-1.82],0.8885858950429734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBP1,"Fructose-1,6-bisphosphatase 1",1735,50,1.04 [0.77-1.41],0.7798243307454745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,1502,38,1.30 [0.88-1.92],0.1812034089041472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAR,Immunoglobulin alpha Fc receptor,1726,49,1.06 [0.63-1.78],0.8385082735440765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,1506,38,0.74 [0.20-2.78],0.6541367123851622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,1741,50,1.65 [1.05-2.59],0.0283720897287288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,1734,47,0.99 [0.66-1.49],0.9652535207045984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,1682,45,0.60 [0.38-0.95],0.0310000745784942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,1740,49,0.98 [0.60-1.61],0.9337384268460464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,1510,38,2.24 [1.16-4.30],0.0157149496088761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN2,Ficolin-2,1730,48,0.81 [0.44-1.50],0.5078369446235672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL1,Fc receptor-like protein 1,1735,50,0.86 [0.51-1.45],0.5630713575048909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL2,Fc receptor-like protein 2,1741,50,1.28 [0.82-2.00],0.2701243678122745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL3,Fc receptor-like protein 3,1687,47,1.02 [0.65-1.59],0.925591290579722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL5,Fc receptor-like protein 5,1741,50,0.98 [0.64-1.50],0.9276286390770524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL6,Fc receptor-like protein 6,1726,49,1.32 [0.91-1.90],0.1423074156940539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRLB,Fc receptor-like B,1682,45,0.88 [0.55-1.40],0.5835093904704318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX1,"Adrenodoxin, mitochondrial",1448,37,1.28 [0.86-1.93],0.2264910908401388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX2,"Ferredoxin-2, mitochondrial",1448,37,1.40 [0.83-2.37],0.2073620329881377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FEN1,Flap endonuclease 1,1682,45,1.24 [0.95-1.63],0.1194091491146712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FES,Tyrosine-protein kinase Fes/Fps,1682,45,0.63 [0.34-1.18],0.1487900941817718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FETUB,Fetuin-B,1742,49,0.68 [0.45-1.03],0.0705413759956666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGA,Fibrinogen alpha chain,1464,36,0.94 [0.34-2.65],0.9135852598028912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",1506,38,0.93 [0.63-1.35],0.6895318816589875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF12,Fibroblast growth factor 12,1453,37,0.92 [0.42-2.04],0.8450966034407887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF16,Fibroblast growth factor 16,1453,37,0.51 [0.24-1.08],0.0785539694802751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF19,Fibroblast growth factor 19,1738,49,0.75 [0.55-1.02],0.0682627978527253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF2,Fibroblast growth factor 2,1726,49,1.08 [0.76-1.53],0.676568748505957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF20,Fibroblast growth factor 20,1453,37,0.67 [0.25-1.80],0.4306374484914352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,1746,50,1.47 [1.22-1.77],5.666312984416589e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,1748,50,1.68 [1.30-2.18],7.375218286938054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF3,Fibroblast growth factor 3,1453,37,1.07 [0.31-3.70],0.91005722090004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,1687,47,3.71 [1.87-7.38],0.0001820454636888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF6,Fibroblast growth factor 6,1453,37,1.27 [0.62-2.58],0.5173138634467582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF7,Fibroblast growth factor 7,1449,38,0.94 [0.60-1.46],0.7670477692063518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF9,Fibroblast growth factor 9,1446,38,0.92 [0.42-2.00],0.8301747476877479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,1741,50,0.32 [0.16-0.64],0.0012053274001245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP2,Fibroblast growth factor-binding protein 2,1508,38,1.07 [0.59-1.92],0.824253224616398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP3,Fibroblast growth factor-binding protein 3,1497,38,0.72 [0.31-1.65],0.4381121033139347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,1741,50,4.11 [1.77-9.50],0.0009692356739092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR4,Fibroblast growth factor receptor 4,1479,37,0.96 [0.53-1.73],0.8900764865642438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,1511,38,2.06 [1.30-3.29],0.002304068143052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGR,Tyrosine-protein kinase Fgr,1670,45,1.07 [0.74-1.55],0.7042451188746484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FH,"Fumarate hydratase, mitochondrial",1441,37,1.04 [0.75-1.45],0.8148764903861512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,1448,37,0.55 [0.26-1.17],0.1219522242501429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIT,Bis(5'-adenosyl)-triphosphatase,1670,45,0.93 [0.65-1.33],0.6948541985297179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FIS1,Mitochondrial fission 1 protein,1732,49,0.86 [0.62-1.20],0.3858220938414718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,1506,38,0.85 [0.62-1.18],0.3312665389257987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,1738,50,0.99 [0.80-1.24],0.9582118897402678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,1718,47,1.66 [0.89-3.09],0.1121363334034128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,1718,47,1.06 [0.80-1.40],0.7053406137668323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,1666,45,0.83 [0.45-1.52],0.5496032278921328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBPL,FK506-binding protein-like,1487,38,1.03 [0.61-1.74],0.9004723653454068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLI1,Friend leukemia integration 1 transcription factor,1682,45,1.09 [0.86-1.37],0.4751807703160012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1718,47,3.17 [1.60-6.28],0.0009103839112423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,1730,49,2.48 [1.08-5.73],0.0328864335825374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,1682,45,0.53 [0.21-1.32],0.1743300348795033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,1751,50,1.38 [0.65-2.92],0.3996492223483864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT4,Vascular endothelial growth factor receptor 3,1741,50,0.54 [0.27-1.09],0.0839812071038679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMNL1,Formin-like protein 1,1670,45,1.13 [0.85-1.51],0.3934164193452196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMR1,Synaptic functional regulator FMR1,1682,45,0.51 [0.24-1.10],0.0868233938852456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FN1,Fibronectin,1513,38,0.66 [0.21-2.05],0.4713679922439021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNDC1,Fibronectin type III domain-containing protein 1,1497,38,1.34 [0.73-2.46],0.34109826183649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,1498,38,0.70 [0.27-1.82],0.4631229874850967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLH1,Glutamate carboxypeptidase 2,1453,37,1.06 [0.79-1.43],0.6957677226283941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,1732,50,2.14 [1.01-4.55],0.0475320444148617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR2,Folate receptor beta,1748,49,1.67 [0.76-3.66],0.2014463565623077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR3,Folate receptor gamma,1733,50,1.10 [0.99-1.23],0.0791267748247179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOS,Proto-oncogene c-Fos,1446,38,1.36 [0.54-3.42],0.5116811030486652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOSB,Protein fosB,1670,45,0.82 [0.37-1.78],0.6084539943154768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXJ3,Forkhead box protein J3,1453,37,1.14 [0.57-2.27],0.7147583282201531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO1,Forkhead box protein O1,1726,49,1.02 [0.75-1.38],0.8914850232136645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO3,Forkhead box protein O3,1682,45,1.06 [0.80-1.41],0.6869134354380462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD4B,FERM domain-containing protein 4B,1448,37,0.73 [0.44-1.20],0.208054295051885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD7,FERM domain-containing protein 7,1465,37,1.04 [0.46-2.37],0.9227510173210094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRZB,Secreted frizzled-related protein 3,1712,47,0.54 [0.21-1.37],0.1932016415235291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSHB,Follitropin subunit beta,1469,38,0.88 [0.54-1.46],0.6302262154387821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FST,Follistatin,1733,49,1.18 [0.70-1.99],0.545066604981193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL1,Follistatin-related protein 1,1469,38,2.82 [0.85-9.34],0.0887273931947064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,1727,49,2.37 [1.30-4.32],0.0048064868842363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FTCD,Formimidoyltransferase-cyclodeaminase,1494,37,1.04 [0.77-1.39],0.800297363286769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUCA1,Tissue alpha-L-fucosidase,1747,50,1.41 [1.00-1.99],0.0487904158559573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUOM,Fucose mutarotase,1479,37,1.28 [0.85-1.92],0.2360829829634813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FURIN,Furin,1741,50,0.65 [0.33-1.30],0.2221153135071351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUS,RNA-binding protein FUS,1679,45,1.73 [0.89-3.36],0.1050610130813459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",1479,38,0.94 [0.57-1.53],0.7997212264163579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1748,49,1.80 [1.11-2.92],0.0175919163015049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT8,"Alpha-(1,6)-fucosyltransferase",1718,47,0.88 [0.56-1.38],0.5705930691567572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXN,"Frataxin, mitochondrial",1751,50,1.01 [0.72-1.41],0.9589905430814692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXYD5,FXYD domain-containing ion transport regulator 5,1687,47,0.94 [0.63-1.39],0.7539551081343046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FYB1,FYN-binding protein 1,1739,50,0.95 [0.72-1.26],0.7374243218798546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD10,Frizzled-10,1465,37,0.82 [0.44-1.53],0.5332585848729692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD8,Frizzled-8,1441,37,1.04 [0.54-2.01],0.9069359553846345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,1498,38,0.87 [0.45-1.68],0.6890136241656053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,1483,38,1.26 [0.85-1.85],0.247687556433007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,1441,37,1.11 [0.72-1.70],0.6311478910885118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD1,Glutamate decarboxylase 1,1449,38,1.56 [0.45-5.47],0.4869113247767456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD2,Glutamate decarboxylase 2,1453,37,0.67 [0.27-1.67],0.3913880002558446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,1483,38,0.83 [0.39-1.75],0.619995306886554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1469,38,0.66 [0.35-1.22],0.1810371022458803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAGE2A,G antigen 2A,1449,38,0.87 [0.51-1.47],0.5997120725943563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAL,Galanin peptides,1738,49,0.76 [0.51-1.15],0.1944661207430455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1733,49,2.82 [1.27-6.28],0.0108554536421477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,1751,50,0.60 [0.24-1.51],0.2788114558363572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,1687,47,0.78 [0.43-1.43],0.4272235812094834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,1502,38,2.09 [0.95-4.59],0.0660918875485293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT7,N-acetylgalactosaminyltransferase 7,1733,49,1.07 [0.34-3.39],0.9134432470566392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAMT,Guanidinoacetate N-methyltransferase,1448,37,0.67 [0.23-1.92],0.4537739931001953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,1438,35,2.15 [0.62-7.47],0.2302785802850682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GART,Trifunctional purine biosynthetic protein adenosine-3,1506,38,0.86 [0.28-2.69],0.7981753247317054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS2,Growth arrest-specific protein 2,1483,38,0.86 [0.46-1.62],0.6510906577490829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS6,Growth arrest-specific protein 6,1743,50,1.00 [0.40-2.51],0.9984838880933038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GASK1A,Golgi-associated kinase 1A,1448,37,0.62 [0.31-1.24],0.1797264266552806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAST,Gastrin,1497,38,1.12 [0.94-1.33],0.1965296862701039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,1449,38,0.57 [0.17-1.97],0.375879350969689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",1469,38,0.82 [0.55-1.23],0.3339927172285133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBA,Lysosomal acid glucosylceramidase,1465,37,1.09 [0.61-1.95],0.7651997195427858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP1,Guanylate-binding protein 1,1495,38,1.01 [0.64-1.60],0.951824957869653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP2,Guanylate-binding protein 2,1687,47,0.88 [0.55-1.41],0.5931803587152353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP4,Guanylate-binding protein 4,1670,45,0.74 [0.42-1.31],0.302805266776766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP6,Guanylate-binding protein 6,1448,37,0.90 [0.45-1.81],0.7648217992971404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GC,Vitamin D-binding protein,1513,38,2.27 [0.71-7.28],0.1666079883880847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCC1,GRIP and coiled-coil domain-containing protein 1,1497,38,0.89 [0.66-1.20],0.4325175408718456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,1682,45,1.26 [1.03-1.54],0.0261605285707263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,1442,36,1.35 [0.79-2.31],0.2649067332713828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCLM,Glutamate--cysteine ligase regulatory subunit,1448,37,1.17 [0.63-2.16],0.61153331880829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",1733,49,0.90 [0.43-1.86],0.7750110591900699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,1753,50,2.39 [1.70-3.37],5.837293344705847e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF2,Growth/differentiation factor 2,1735,50,1.52 [0.78-2.98],0.2183240091126643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDNF,Glial cell line-derived neurotrophic factor,1670,45,1.57 [0.87-2.82],0.1336021826457216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GET3,ATPase GET3,1502,38,0.66 [0.35-1.25],0.2022895491454322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFAP,Glial fibrillary acidic protein,1679,45,0.89 [0.50-1.60],0.7043249572180816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFER,FAD-linked sulfhydryl oxidase ALR,1682,45,0.91 [0.60-1.38],0.6694247871020327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,1682,45,1.02 [0.83-1.25],0.8470086302701757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,1746,50,5.26 [2.68-10.33],1.3633516707825678e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA2,GDNF family receptor alpha-2,1733,49,0.76 [0.24-2.40],0.6410169097770806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,1712,47,2.56 [1.18-5.54],0.0172331486924401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRAL,GDNF family receptor alpha-like,1452,38,1.27 [0.81-2.00],0.2988793483382334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGA1,ADP-ribosylation factor-binding protein GGA1,1670,45,1.09 [0.75-1.58],0.6545952717427791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGACT,Gamma-glutamylaminecyclotransferase,1502,38,0.92 [0.59-1.45],0.7303746545979833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGCT,Gamma-glutamylcyclotransferase,1501,38,0.95 [0.49-1.84],0.8750112639510919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGH,Gamma-glutamyl hydrolase,1705,48,0.81 [0.38-1.75],0.5962718442197175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT1,Glutathione hydrolase 1 proenzyme,1740,50,1.12 [0.73-1.70],0.605341334323842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,1718,47,5.31 [2.15-13.10],0.0002912855046904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH1,Somatotropin,1735,50,1.02 [0.88-1.18],0.8087379498500897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH2,Growth hormone variant,1682,45,0.96 [0.82-1.14],0.6623735321722598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHR,Growth hormone receptor,1479,37,0.43 [0.15-1.26],0.1245832718817814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRHR,Growth hormone-releasing hormone receptor,1670,45,1.25 [0.83-1.88],0.2837555614288279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRL,Appetite-regulating hormone,1735,50,1.24 [0.92-1.67],0.1643030979803094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GID8,Glucose-induced degradation protein 8 homolog,1506,38,0.86 [0.29-2.51],0.7829504134638685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIGYF2,GRB10-interacting GYF protein 2,1506,38,0.88 [0.57-1.37],0.5797781963001238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP7,GTPase IMAP family member 7,1479,37,0.71 [0.24-2.09],0.530847051127685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP8,GTPase IMAP family member 8,1449,38,0.99 [0.53-1.84],0.972825301089864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIP,Gastric inhibitory polypeptide,1469,38,1.41 [0.82-2.42],0.2148845486258487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,1497,38,2.96 [1.26-6.98],0.0128875781792909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC3,PDZ domain-containing protein GIPC3,1487,38,0.91 [0.66-1.26],0.5741231659646238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPR,Gastric inhibitory polypeptide receptor,1453,37,0.90 [0.44-1.80],0.7568001210187134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIT1,ARF GTPase-activating protein GIT1,1453,37,0.88 [0.63-1.22],0.4385521290865718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GJA8,Gap junction alpha-8 protein,1449,38,1.05 [0.62-1.77],0.8608549470813658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GKN1,Gastrokine-1,1634,43,1.22 [0.49-3.03],0.6680105121679785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLA,Alpha-galactosidase A,1475,37,2.32 [1.15-4.70],0.0189882996342027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLB1,Beta-galactosidase,1718,47,1.63 [0.91-2.95],0.1027479473055369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLI2,Zinc finger protein GLI2,1453,37,1.08 [0.39-2.94],0.8848242354845878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLO1,Lactoylglutathione lyase,1701,48,1.16 [0.76-1.78],0.4962217577352547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLOD4,Glyoxalase domain-containing protein 4,1727,49,1.05 [0.52-2.13],0.8818570660686823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLP1R,Glucagon-like peptide 1 receptor,1441,37,1.62 [0.94-2.79],0.0853935921809141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX,Glutaredoxin-1,1725,50,0.90 [0.58-1.40],0.6489628202948937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",1479,37,0.83 [0.57-1.21],0.3396512470936406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,1670,45,1.07 [0.66-1.74],0.7891459728689145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLYR1,Putative oxidoreductase GLYR1,1498,38,0.88 [0.51-1.52],0.6517891328822198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,1473,37,1.81 [0.98-3.33],0.0579771092854623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMFG,Glia maturation factor gamma,1502,38,0.95 [0.61-1.47],0.8182028221622446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR,GMP reductase 1,1751,50,1.37 [0.83-2.26],0.2185009391135277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR2,GMP reductase 2,1479,37,0.85 [0.53-1.36],0.4924903391071079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNAS,Neuroendocrine secretory protein 55,1506,38,0.86 [0.59-1.25],0.4221765847529719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,1682,45,0.69 [0.45-1.07],0.1012391853770845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,1465,37,0.72 [0.32-1.62],0.4274410533200721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNLY,Granulysin,1741,50,1.17 [0.73-1.86],0.5206280683325193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,1469,38,1.40 [0.82-2.39],0.2128427927691803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,1479,37,0.64 [0.28-1.48],0.2999057277719031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLGA3,Golgin subfamily A member 3,1506,38,0.98 [0.64-1.50],0.9351978233386692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLM2,Protein GOLM2,1748,49,1.75 [0.66-4.64],0.259564996134941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,1726,49,0.92 [0.71-1.18],0.5106068205493108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GORASP2,Golgi reassembly-stacking protein 2,1487,38,1.05 [0.54-2.04],0.884967932512563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOT1,"Aspartate aminotransferase, cytoplasmic",1508,38,0.66 [0.33-1.33],0.246027131618893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BA,Platelet glycoprotein Ib alpha chain,1733,48,1.01 [0.47-2.18],0.97216413962729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BB,Platelet glycoprotein Ib beta chain,1448,37,0.95 [0.60-1.50],0.8286294834725549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,1676,47,0.92 [0.69-1.23],0.5934020093538015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP5,Platelet glycoprotein V,1479,37,0.88 [0.35-2.22],0.7903029270670153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP6,Platelet glycoprotein VI,1739,50,0.99 [0.74-1.32],0.9297968751027964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,1733,49,0.76 [0.62-0.94],0.0097114912312993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC1,Glypican-1,1751,50,1.07 [0.49-2.34],0.8705189660169663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC5,Glypican-5,1718,47,1.31 [0.83-2.05],0.241089080363187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPD1,Glycerol-3-phosphate dehydrogenase,1498,38,1.25 [0.79-2.00],0.3403462072291917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPHA2,Glycoprotein hormone alpha-2,1487,38,1.24 [0.77-2.01],0.3789461739870721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPI,Glucose-6-phosphate isomerase,1511,38,0.85 [0.44-1.63],0.6258112843418597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,1487,38,0.91 [0.63-1.32],0.6175199352659178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPKOW,G-patch domain and KOW motifs-containing protein,1670,45,1.26 [0.59-2.66],0.5482202295650915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPNMB,Transmembrane glycoprotein NMB,1692,49,1.63 [0.71-3.77],0.2491526293195264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR101,Probable G-protein coupled receptor 101,1441,37,1.36 [0.90-2.05],0.1440432028940423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR158,Probable G-protein coupled receptor 158,1506,38,1.58 [0.85-2.92],0.1447463836481544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR15L,Protein GPR15L,1487,38,1.26 [0.78-2.03],0.3518442727302356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,1701,48,2.02 [1.43-2.87],7.688395197291649e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPRC5C,G-protein coupled receptor family C group 5 member C,1498,38,1.43 [1.04-1.97],0.0267888719889641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRAP2,GRB2-related adapter protein 2,1735,50,0.98 [0.80-1.19],0.8172737482527748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,1502,38,0.90 [0.55-1.47],0.6797552154657869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",1506,38,1.11 [0.57-2.14],0.7614778690354306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",1441,37,0.92 [0.50-1.68],0.7833225175251208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRK5,G protein-coupled receptor kinase 5,1701,48,0.46 [0.23-0.92],0.028569600438546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,1734,50,3.71 [1.36-10.08],0.0102215125666662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRP,Gastrin-releasing peptide,1469,38,1.14 [0.71-1.83],0.5997837933083521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",1733,49,1.10 [0.75-1.62],0.6197668790965924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRSF1,G-rich sequence factor 1,1441,38,0.94 [0.63-1.41],0.7804486362605191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSAP,Gamma-secretase-activating protein,1682,45,0.57 [0.34-0.96],0.0329572657392167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSN,Gelsolin,1505,38,1.56 [0.32-7.70],0.5829125005738034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSR,"Glutathione reductase, mitochondrial",1505,37,0.33 [0.08-1.33],0.1195020438947627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA1,Glutathione S-transferase A1,1732,50,0.93 [0.71-1.21],0.5684679450319928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA3,Glutathione S-transferase A3,1682,45,0.85 [0.63-1.16],0.3012830155898741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTM4,Glutathione S-transferase Mu 4,1448,37,0.95 [0.60-1.49],0.8118133729556016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTP1,Glutathione S-transferase P,1663,45,0.88 [0.58-1.32],0.5289183726423933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTT2B,Glutathione S-transferase theta-2B,1497,38,0.94 [0.83-1.07],0.3278105797278297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,1483,38,0.97 [0.58-1.62],0.9090704494735866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTPBP2,GTP-binding protein 2,1465,37,0.85 [0.56-1.27],0.4186451762155732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,1733,50,2.51 [1.51-4.16],0.0003721669507765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCY2C,Heat-stable enterotoxin receptor,1483,38,0.99 [0.69-1.42],0.951111895683892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUK1,Guanylate kinase,1448,37,0.97 [0.39-2.42],0.9523225245660268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUSB,Beta-glucuronidase,1743,50,0.97 [0.69-1.37],0.8598880521998211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GYS1,"Glycogen [starch] synthase, muscle",1701,48,0.82 [0.61-1.10],0.1822164098491148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMA,Granzyme A,1751,50,1.12 [0.56-2.23],0.7426956200777899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMB,Granzyme B,1726,49,0.89 [0.58-1.36],0.5955729955779119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMH,Granzyme H,1701,48,1.18 [0.85-1.65],0.3182125109256269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,H2AP,Huntingtin-interacting protein M,1449,38,0.72 [0.31-1.70],0.4563614898748726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",1448,37,0.92 [0.56-1.50],0.7301691856987684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",1744,50,1.19 [0.87-1.62],0.2866416989956031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAO1,Hydroxyacid oxidase 1,1751,50,0.98 [0.82-1.17],0.8296231868545385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",1741,50,0.98 [0.71-1.36],0.9077757961517464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,1749,50,1.87 [1.45-2.42],1.5295641117890807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,1741,50,2.49 [1.37-4.52],0.0027702811226417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBEGF,Proheparin-binding EGF-like growth factor,1744,50,1.15 [0.81-1.62],0.4386896877363647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBQ1,Hemoglobin subunit theta-1,1751,50,0.84 [0.55-1.29],0.4231231135875659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBZ,Hemoglobin subunit zeta,1502,38,0.71 [0.51-0.99],0.0431983944158816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCG22,Protein PBMUCL2,1448,37,0.84 [0.37-1.87],0.6621467817278444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCLS1,Hematopoietic lineage cell-specific protein,1751,50,0.93 [0.58-1.49],0.7618835236256365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC8,Histone deacetylase 8,1453,37,0.91 [0.51-1.64],0.7563531859203916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC9,Histone deacetylase 9,1441,37,0.81 [0.45-1.47],0.498224405238954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDDC2,5'-deoxynucleotidase HDDC2,1487,38,1.18 [0.62-2.24],0.6107216596174907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGF,Hepatoma-derived growth factor,1749,50,1.03 [0.79-1.34],0.8153432184292302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,1497,38,0.82 [0.49-1.37],0.447411477683221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEBP1,Heme-binding protein 1,1701,48,0.93 [0.56-1.54],0.7804184514454274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEG1,Protein HEG homolog 1,1479,37,2.83 [1.02-7.85],0.0462585952442676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPACAM2,HEPACAM family member 2,1497,38,0.89 [0.43-1.87],0.7656626394975417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPH,Hephaestin,1502,38,2.84 [0.93-8.69],0.0674805140640762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEXIM1,Protein HEXIM1,1726,49,0.85 [0.62-1.18],0.3391024978993091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGF,Hepatocyte growth factor,1751,50,1.34 [0.69-2.59],0.3844960576836049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGFAC,Hepatocyte growth factor activator,1499,37,1.29 [0.44-3.81],0.6410087933809312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,1682,45,1.00 [0.71-1.41],0.9933867388660572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,1497,38,1.12 [0.73-1.72],0.6115786981977963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIF1A,Hypoxia-inducible factor 1-alpha,1453,37,0.62 [0.30-1.28],0.1961949864463128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1,Huntingtin-interacting protein 1,1448,37,0.99 [0.39-2.51],0.9912486573010812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1R,Huntingtin-interacting protein 1-related protein,1495,38,1.16 [0.69-1.93],0.5804663582698436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HJV,Hemojuvelin,1506,38,1.32 [0.81-2.16],0.2703815396471747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HK2,Hexokinase-2,1701,48,0.42 [0.16-1.10],0.077792171782209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1506,38,3.61 [1.31-10.00],0.0133847641054952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",1721,47,0.94 [0.47-1.90],0.8722762828059973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1726,49,2.93 [1.47-5.83],0.0022433811726295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMBS,Porphobilinogen deaminase,1751,50,1.19 [0.70-2.01],0.5225932837774638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMCN2,Hemicentin-2,1475,37,1.28 [0.74-2.22],0.3729063261799857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",1469,38,0.87 [0.48-1.59],0.6579388964650363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",1448,37,0.85 [0.41-1.76],0.6561163627415207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMMR,Hyaluronan mediated motility receptor,1446,37,1.27 [0.78-2.08],0.3403252794807027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX1,Heme oxygenase 1,1724,50,0.52 [0.31-0.87],0.013124337022371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX2,Heme oxygenase 2,1670,45,1.58 [1.01-2.48],0.0456915328082872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNF1A,Hepatocyte nuclear factor 1-alpha,1465,37,1.11 [0.76-1.62],0.593463407535634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNMT,Histamine N-methyltransferase,1710,47,1.57 [1.01-2.44],0.0453868022892861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,1697,48,0.83 [0.59-1.17],0.2990833038970061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,1506,38,1.18 [0.66-2.11],0.5844450256069956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPCAL1,Hippocalcin-like protein 1,1751,50,0.95 [0.67-1.34],0.7591457484866608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPGDS,Hematopoietic prostaglandin D synthase,1682,45,1.04 [0.54-2.00],0.9081890695522312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPSE,Heparanase,1491,37,0.98 [0.69-1.38],0.902385510441556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRAS,GTPase Hras,1479,38,1.04 [0.80-1.37],0.7519362544803798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,1469,38,1.52 [0.93-2.48],0.0930412071648675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRG,Histidine-rich glycoprotein,1505,37,1.61 [0.62-4.21],0.3276715419815347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS1BP3,HCLS1-binding protein 3,1469,38,0.90 [0.62-1.30],0.5689237132536782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,1733,49,1.57 [0.84-2.95],0.1609171301828167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,1751,50,0.65 [0.34-1.26],0.2048469712661631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,1453,37,1.90 [0.87-4.15],0.1047612950178371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSBP1,Heat shock factor-binding protein 1,1469,38,0.83 [0.59-1.16],0.2753279235570992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,1726,49,1.16 [0.65-2.05],0.6181544502860367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,1497,38,1.23 [0.79-1.90],0.3530434020269241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,1448,37,0.64 [0.31-1.32],0.2262979444378059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,1469,38,0.61 [0.31-1.22],0.1617545213156338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSP90B1,Endoplasmin,1667,45,1.29 [0.97-1.72],0.0770491101780037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA1A,Heat shock 70 kDa protein 1A,1737,49,0.96 [0.68-1.36],0.8155452447094177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,1498,38,1.55 [0.73-3.33],0.256476213445575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB1,Heat shock protein beta-1,1708,49,1.01 [0.68-1.50],0.957962421851982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,1751,50,2.98 [1.79-4.94],2.474817293640529e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1726,47,4.11 [2.22-7.62],7.04036644228124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1A,5-hydroxytryptamine receptor 1A,1441,37,1.10 [0.76-1.58],0.6098993502421011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1B,5-hydroxytryptamine receptor 1B,1441,37,1.10 [0.54-2.24],0.7997505970576059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTRA2,"Serine protease HTRA2, mitochondrial",1741,50,0.99 [0.66-1.49],0.9551894590357968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,1720,48,3.25 [1.32-7.97],0.010177253572015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,1753,50,2.75 [1.00-7.55],0.0503999139266525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICA1,Islet cell autoantigen 1,1687,47,0.83 [0.60-1.16],0.2856999936962877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM1,Intercellular adhesion molecule 1,1731,48,1.25 [0.58-2.70],0.572368174737683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM2,Intercellular adhesion molecule 2,1753,50,1.12 [0.52-2.42],0.7751740760712147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM3,Intercellular adhesion molecule 3,1753,50,0.99 [0.40-2.48],0.9907810817625088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM4,Intercellular adhesion molecule 4,1726,49,0.62 [0.40-0.98],0.0411821478241327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM5,Intercellular adhesion molecule 5,1735,50,1.47 [0.88-2.47],0.1454212976687537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICOSLG,ICOS ligand,1733,49,1.98 [0.60-6.54],0.2601724193869004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ID4,DNA-binding protein inhibitor ID-4,1483,38,1.12 [0.61-2.06],0.7116811764358109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,1670,45,0.88 [0.49-1.56],0.660072957225649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDO1,"Indoleamine 2,3-dioxygenase 1",1469,38,1.04 [0.65-1.69],0.8589362063902786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDS,Iduronate 2-sulfatase,1751,50,0.42 [0.03-5.86],0.5151897302563573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDUA,Alpha-L-iduronidase,1751,50,1.64 [0.93-2.89],0.0904326904594547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,1452,37,1.85 [0.87-3.94],0.1106441428760277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,1483,38,0.82 [0.44-1.53],0.5283197224567135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,1483,38,0.80 [0.37-1.76],0.5851376453143662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNAR1,Interferon alpha/beta receptor 1,1487,38,1.76 [0.62-4.97],0.287770767366781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNG,Interferon gamma,1687,47,1.00 [0.79-1.27],0.9740176025125696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,1738,49,2.53 [0.88-7.25],0.0840462061011358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR2,Interferon gamma receptor 2,1718,47,1.32 [0.84-2.09],0.2303489945881278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL1,Interferon lambda-1,1670,45,1.55 [0.99-2.43],0.0557130560599352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL2,Interferon lambda-2,1441,37,1.19 [0.82-1.73],0.348796081745176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNLR1,Interferon lambda receptor 1,1726,49,0.81 [0.37-1.74],0.5818591460106499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNW1,Interferon omega-1,1448,37,0.72 [0.26-1.98],0.5199709815084015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFT20,Intraflagellar transport protein 20 homolog,1465,37,1.20 [0.62-2.35],0.5844978173627252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGBP1,Immunoglobulin-binding protein 1,1506,38,0.97 [0.60-1.58],0.9063180086249956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,1441,37,1.18 [0.66-2.10],0.5696069999377885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,1508,38,1.07 [0.35-3.28],0.9064109143097954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,1733,49,7.26 [2.53-20.87],0.0002321037785482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,1448,37,1.32 [0.74-2.35],0.3396796542910651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2R,Cation-independent mannose-6-phosphate receptor,1741,50,1.58 [0.57-4.40],0.3810979236904258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,1751,50,1.48 [1.21-1.82],0.0001809719487581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,1751,50,1.72 [1.25-2.38],0.0008425786409559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,1743,49,0.46 [0.27-0.81],0.006493210481948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,1716,48,2.29 [1.59-3.30],7.558887978147263e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,1734,48,2.96 [1.66-5.29],0.0002448840089316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,1753,50,2.08 [1.14-3.78],0.0165551714008775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,1735,50,2.48 [1.49-4.13],0.000505239152175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFL4,Insulin growth factor-like family member 4,1453,37,1.07 [0.73-1.58],0.7221842275784457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGHMBP2,DNA-binding protein SMUBP-2,1448,37,1.04 [0.60-1.80],0.8862400539181524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLC2,Immunoglobulin lambda constant 2,1508,38,0.51 [0.12-2.22],0.3694517161217846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLON5,IgLON family member 5,1449,38,1.24 [0.96-1.60],0.1032377004903032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF21,Immunoglobulin superfamily member 21,1469,38,0.50 [0.20-1.26],0.1397860987244535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF3,Immunoglobulin superfamily member 3,1733,49,1.53 [0.92-2.55],0.1011352670851698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,1735,50,2.44 [1.14-5.23],0.0213307912537032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF9,Protein turtle homolog A,1502,38,1.59 [1.16-2.17],0.0037174504870931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKBKG,NF-kappa-B essential modulator,1726,49,0.89 [0.67-1.18],0.4087861965453188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKZF2,Zinc finger protein Helios,1682,45,1.11 [0.87-1.43],0.3948753098411696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,1687,47,1.30 [1.05-1.61],0.0164840142462077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RA,Interleukin-10 receptor subunit alpha,1687,47,0.94 [0.59-1.51],0.8014566680161767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,1738,49,2.48 [1.22-5.05],0.012524875548246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL11,Interleukin-11,1687,47,1.24 [0.93-1.67],0.1465680446075729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,1733,49,1.37 [1.03-1.82],0.0279228110720535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,1751,50,1.61 [1.05-2.47],0.0299167409245849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB1,Interleukin-12 receptor subunit beta-1,1687,47,1.66 [0.87-3.17],0.1265316657744301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB2,Interleukin-12 receptor subunit beta-2,1453,37,1.10 [0.49-2.47],0.8259728612202699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13,Interleukin-13,1687,47,0.62 [0.31-1.26],0.1845745262202973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,1717,50,1.24 [0.39-3.94],0.7143776087352137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,1441,37,0.87 [0.28-2.69],0.8103046500552633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15,Interleukin-15,1726,49,1.61 [0.92-2.81],0.0961645479158235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,1687,47,2.44 [1.21-4.93],0.0125923882423209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL16,Pro-interleukin-16,1751,50,1.42 [0.91-2.22],0.1262377306595514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17A,Interleukin-17A,1684,47,0.64 [0.33-1.24],0.1879155144365109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17C,Interleukin-17C,1687,47,1.18 [0.86-1.61],0.3023418910865663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17D,Interleukin-17D,1687,47,1.69 [1.06-2.68],0.0266409269561554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17F,Interleukin-17F,1687,47,1.09 [0.80-1.49],0.5876401797579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RA,Interleukin-17 receptor A,1741,50,0.97 [0.55-1.69],0.9103730096670436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RB,Interleukin-17 receptor B,1704,48,0.88 [0.56-1.41],0.6063630821928574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,1724,49,1.80 [1.09-2.97],0.0224460765984656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,1743,49,2.15 [1.11-4.17],0.0232429625835025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,1751,50,1.85 [0.98-3.48],0.0583721924641043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18RAP,Interleukin-18 receptor accessory protein,1701,47,1.05 [0.91-1.21],0.4738378856423104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,1697,49,1.48 [1.11-1.96],0.0075934979136616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1A,Interleukin-1 alpha,1687,47,1.23 [0.88-1.72],0.2255994532542587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1B,Interleukin-1 beta,1681,47,0.78 [0.48-1.27],0.3254254441026804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,1740,50,2.15 [0.92-5.02],0.0759997420325239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R2,Interleukin-1 receptor type 2,1724,49,0.78 [0.25-2.43],0.6696220292581256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RAP,Interleukin-1 receptor accessory protein,1741,50,0.83 [0.47-1.47],0.5162573555238902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,1748,50,1.88 [1.16-3.05],0.0102457680960268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL2,Interleukin-1 receptor-like 2,1687,47,0.94 [0.48-1.83],0.8556723474277915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RN,Interleukin-1 receptor antagonist protein,1729,49,1.35 [0.98-1.87],0.0682133189699413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2,Interleukin-2,1687,47,1.98 [0.84-4.63],0.1164748194181124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20,Interleukin-20,1687,47,0.38 [0.19-0.76],0.0060124603406204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RA,Interleukin-20 receptor subunit alpha,1687,47,1.00 [0.53-1.87],0.9952429851705183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RB,Interleukin-20 receptor subunit beta,1453,37,1.01 [0.47-2.15],0.9823209663265736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL21R,Interleukin-21 receptor,1453,37,0.89 [0.48-1.65],0.7205287115317132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22,Interleukin-22,1498,38,1.29 [0.86-1.92],0.2142202752057603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,1687,47,1.05 [0.55-2.02],0.8725921561757115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL24,Interleukin-24,1687,47,1.20 [0.76-1.90],0.430476218375771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL25,Interleukin-25,1445,38,1.51 [0.67-3.39],0.3157500794412491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,1726,50,2.07 [1.24-3.44],0.005163373033038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RB,Interleukin-2 receptor subunit beta,1687,47,1.23 [0.76-1.99],0.4000995674508406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RG,Cytokine receptor common subunit gamma,1498,38,0.89 [0.46-1.74],0.740222654951715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3,Interleukin-3,1449,38,1.00 [0.60-1.68],0.9975315913600034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31,Interleukin-31,1453,37,1.05 [0.66-1.69],0.8294326192709731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31RA,Interleukin-31 receptor subunit alpha,1447,37,1.91 [0.93-3.89],0.0763813759618555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL32,Interleukin-32,1726,49,0.88 [0.53-1.45],0.6198568679241152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL33,Interleukin-33,1687,47,1.16 [0.60-2.27],0.6588122474709368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL34,Interleukin-34,1669,45,0.72 [0.37-1.38],0.3240046123928608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36A,Interleukin-36 alpha,1453,37,0.91 [0.54-1.54],0.7259853324631325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36G,Interleukin-36 gamma,1452,37,1.10 [0.71-1.72],0.6687586795400111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3RA,Interleukin-3 receptor subunit alpha,1687,47,0.72 [0.32-1.64],0.4334857596674671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4,Interleukin-4,1687,47,0.89 [0.72-1.11],0.3133635334298592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,1726,49,1.56 [0.89-2.73],0.1231306991239914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5,Interleukin-5,1687,47,0.81 [0.66-0.99],0.0437573723466878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5RA,Interleukin-5 receptor subunit alpha,1726,49,0.94 [0.61-1.46],0.7839236632146156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6,Interleukin-6,1733,49,1.01 [0.71-1.42],0.9770947135308736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6R,Interleukin-6 receptor subunit alpha,1729,48,0.82 [0.40-1.67],0.5824212372314133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6ST,Interleukin-6 receptor subunit beta,1735,50,1.50 [0.39-5.69],0.5526721254149627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7,Interleukin-7,1726,49,0.80 [0.53-1.20],0.2806469597042111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7R,Interleukin-7 receptor subunit alpha,1741,50,0.88 [0.55-1.41],0.606126967455346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL9,Interleukin-9,1483,38,1.07 [0.62-1.83],0.8188131779893002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,1666,45,1.01 [0.64-1.60],0.949694853437312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMMT,MICOS complex subunit MIC60,1498,38,1.66 [1.06-2.60],0.0263580704196592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPA1,Inositol monophosphatase 1,1718,47,1.00 [0.66-1.53],0.998722346817571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPACT,Protein IMPACT,1497,38,0.96 [0.56-1.66],0.8900860433720769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,1441,37,1.13 [0.50-2.55],0.7689002116027308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ING1,Inhibitor of growth protein 1,1666,45,0.94 [0.52-1.73],0.8517121522341576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,1479,37,2.12 [1.30-3.47],0.0026961461582108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBC,Inhibin beta C chain,1741,50,1.97 [1.01-3.84],0.0479742562927467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP1,Inositol polyphosphate 1-phosphatase,1733,49,1.20 [0.76-1.88],0.4396607346995209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",1469,38,0.89 [0.50-1.58],0.6885573688962121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1506,38,2.01 [1.18-3.40],0.0096569575255113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",1733,49,0.95 [0.73-1.23],0.6859326794962697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL3,Insulin-like 3,1497,38,0.83 [0.52-1.32],0.4284994709855115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL4,Early placenta insulin-like peptide,1498,38,1.43 [0.93-2.22],0.1062495451730214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL5,Insulin-like peptide INSL5,1487,38,1.17 [0.88-1.57],0.2856810096364631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,1453,37,8.89 [1.67-47.42],0.0105226838024727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,1715,47,1.16 [0.86-1.57],0.3358414156699192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,1733,49,1.07 [0.68-1.70],0.7720969764758321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",1701,48,0.85 [0.62-1.17],0.3277654311947153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK1,Interleukin-1 receptor-associated kinase 1,1687,47,0.90 [0.61-1.32],0.5863508106488968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK4,Interleukin-1 receptor-associated kinase 4,1726,49,1.00 [0.78-1.28],0.997239184467521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,1642,42,0.66 [0.33-1.34],0.2528263354980928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM1,Isthmin-1,1726,49,1.30 [0.68-2.46],0.4239867242123805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM2,Isthmin-2,1508,38,0.67 [0.30-1.53],0.3414083111716348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IST1,IST1 homolog,1475,38,0.94 [0.68-1.31],0.730358112065296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA11,Integrin alpha-11,1726,49,0.54 [0.28-1.06],0.0735439283814871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA2,Integrin alpha-2,1479,37,0.73 [0.30-1.77],0.4829230723138393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA5,Integrin alpha-5,1741,50,0.89 [0.37-2.15],0.7934091034334823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA6,Integrin alpha-6,1726,49,0.58 [0.34-0.99],0.0469820608872168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAL,Integrin alpha-L,1453,37,0.84 [0.42-1.70],0.6287031590100365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAM,Integrin alpha-M,1741,50,1.04 [0.49-2.19],0.9207636968911318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAV,Integrin alpha-V,1751,50,0.43 [0.11-1.67],0.2253728981913249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAX,Integrin alpha-X,1483,38,0.61 [0.31-1.21],0.1595102871903183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1,Integrin beta-1,1734,49,0.52 [0.17-1.60],0.2530039398355366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP1,Integrin beta-1-binding protein 1,1682,45,1.16 [0.63-2.13],0.6266450981713394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP2,Integrin beta-1-binding protein 2,1701,48,0.91 [0.73-1.15],0.4358196112729353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB2,Integrin beta-2,1719,50,1.11 [0.50-2.48],0.7919433295563909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB5,Integrin beta-5,1741,50,0.94 [0.51-1.74],0.8431252170611132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB6,Integrin beta-6,1687,47,0.88 [0.38-2.01],0.7579067900269196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB7,Integrin beta-7,1751,50,1.35 [0.81-2.25],0.2533305159813571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGBL1,Integrin beta-like protein 1,1508,38,1.30 [0.77-2.19],0.326587623440531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,1513,38,0.68 [0.16-2.84],0.5922063051133057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1743,49,1.95 [1.02-3.75],0.0442643303041161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,1513,38,1.24 [0.45-3.41],0.6831655346365458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,1498,38,1.26 [0.67-2.36],0.4788364639946836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITM2A,Integral membrane protein 2A,1726,49,1.03 [0.67-1.59],0.8798712891969304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPA,Inosine triphosphate pyrophosphatase,1448,37,0.79 [0.50-1.26],0.324616170257797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",1469,38,1.12 [0.72-1.75],0.6156781833487572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",1441,37,1.18 [0.65-2.13],0.5796109456803877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",1670,45,0.60 [0.33-1.10],0.0970511047638665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IZUMO1,Izumo sperm-egg fusion protein 1,1449,38,1.11 [0.67-1.83],0.6954865705811272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,1748,49,4.36 [2.32-8.22],5.032021727099544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM3,Junctional adhesion molecule C,1479,37,1.22 [0.71-2.11],0.4638755138568571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JCHAIN,Immunoglobulin J chain,1687,47,1.04 [0.68-1.58],0.8724927106293103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,1449,38,1.10 [0.61-1.96],0.7568672256447369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JPT2,Jupiter microtubule associated homolog 2,1487,38,0.97 [0.67-1.39],0.8518914913108292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JUN,Transcription factor AP-1,1687,47,1.27 [0.87-1.85],0.223663884549811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,1733,49,1.31 [0.75-2.29],0.3490225946260951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZN,Kazrin,1487,38,0.85 [0.63-1.15],0.2837802848170687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,1441,37,0.85 [0.46-1.55],0.5909119912418326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,1465,37,0.82 [0.48-1.38],0.4494418099095617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNIP4,Kv channel-interacting protein 4,1670,45,0.98 [0.58-1.67],0.9511030814203524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCTD5,BTB/POZ domain-containing protein KCTD5,1470,36,1.35 [0.72-2.54],0.3537820007287271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDM3A,Lysine-specific demethylase 3A,1453,37,1.13 [0.84-1.53],0.4238785934098742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDR,Vascular endothelial growth factor receptor 2,1741,50,0.56 [0.21-1.51],0.2529766818746928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KEL,Kell blood group glycoprotein,1670,45,0.85 [0.42-1.75],0.6624515468679597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHDC3L,KH domain-containing protein 3,1449,38,1.35 [0.96-1.90],0.0849275501475461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHK,Ketohexokinase,1469,38,0.81 [0.50-1.29],0.3702627343240557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA0319,Dyslexia-associated protein KIAA0319,1497,38,1.53 [0.64-3.69],0.3385733898821862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549,UPF0606 protein KIAA1549,1483,38,1.36 [0.96-1.94],0.0825564618643318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549L,UPF0606 protein KIAA1549L,1483,38,1.29 [0.46-3.60],0.6302613462375363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA2013,Uncharacterized protein KIAA2013,1498,38,1.12 [0.69-1.83],0.6391638785232336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF1C,Kinesin-like protein KIF1C,1448,37,1.70 [0.81-3.57],0.1581687008176248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF20B,Kinesin-like protein KIF20B,1441,37,1.30 [0.98-1.73],0.0666332903013995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF22,Kinesin-like protein KIF22,1448,37,0.86 [0.65-1.13],0.2702193534876906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIFBP,KIF-binding protein,1733,49,0.94 [0.69-1.29],0.7176907772720447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,1498,38,0.98 [0.70-1.37],0.9059172000913518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,1682,45,1.08 [0.78-1.48],0.6472869612782961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,1487,38,0.89 [0.73-1.07],0.2116376170024122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,1682,45,0.91 [0.74-1.13],0.3945831759621921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,1449,38,0.88 [0.57-1.35],0.550967803682993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL1,Kin of IRRE-like protein 1,1441,37,0.97 [0.49-1.92],0.9285102276334354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL2,Kin of IRRE-like protein 2,1670,45,0.82 [0.44-1.56],0.5526783202194019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIT,Mast/stem cell growth factor receptor Kit,1742,49,0.75 [0.33-1.68],0.4852356172391016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KITLG,Kit ligand,1735,50,0.84 [0.47-1.49],0.5442801654565785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLB,Beta-klotho,1670,45,1.43 [1.02-2.00],0.037234141211581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLF4,Krueppel-like factor 4,1441,37,2.48 [1.07-5.76],0.0345050430409472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLHL41,Kelch-like protein 41,1506,38,0.96 [0.49-1.89],0.9039566162842754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK1,Kallikrein-1,1718,50,1.03 [0.84-1.25],0.7841048543884759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,1734,50,2.12 [1.25-3.61],0.0055553539035423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,1719,49,3.06 [1.78-5.27],5.552147188564511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK12,Kallikrein-12,1682,45,0.91 [0.76-1.08],0.2904088386667718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK13,Kallikrein-13,1692,47,1.08 [0.65-1.79],0.7608902667760692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK14,Kallikrein-14,1751,50,1.31 [0.78-2.19],0.3098367464444044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK15,Kallikrein-15,1497,38,0.80 [0.43-1.48],0.4750297506012455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK3,Prostate-specific antigen,1508,38,0.93 [0.53-1.63],0.797464825378367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,1751,50,1.80 [1.33-2.44],0.0001287044068107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK6,Kallikrein-6,1739,50,2.09 [1.00-4.38],0.0505408011860286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK7,Kallikrein-7,1433,35,0.78 [0.32-1.88],0.5782747611888592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK8,Kallikrein-8,1676,49,1.77 [0.94-3.32],0.0767221811433505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLKB1,Plasma kallikrein,1477,37,1.39 [0.40-4.89],0.605114816344583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1751,50,2.11 [1.23-3.63],0.0067177556320168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,1441,37,0.87 [0.48-1.56],0.6354727552517034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,1751,50,1.81 [1.09-2.99],0.0209121605797567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,1453,37,1.64 [1.07-2.51],0.024155259448984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRK1,NKG2-D type II integral membrane protein,1497,38,1.34 [0.68-2.63],0.3954365540254488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT14,"Keratin, type I cytoskeletal 14",1618,45,0.89 [0.34-2.31],0.8055270039081253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT17,"Keratin, type I cytoskeletal 17",1448,37,0.58 [0.24-1.40],0.2278649404354986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT18,"Keratin, type I cytoskeletal 18",1733,49,1.19 [0.94-1.50],0.1486274468799461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",1721,49,1.53 [1.15-2.05],0.0036767797597447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT5,"Keratin, type II cytoskeletal 5",1670,45,1.05 [0.61-1.80],0.8618892141666362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT6C,"Keratin, type II cytoskeletal 6C",1448,37,1.33 [0.74-2.42],0.3400598556618447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT8,"Keratin, type II cytoskeletal 8",1441,37,1.10 [0.90-1.34],0.35792052404091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,1732,50,0.99 [0.64-1.54],0.9730513112369712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYNU,Kynureninase,1751,50,0.67 [0.40-1.10],0.1124708356780221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L1CAM,Neural cell adhesion molecule L1,1741,50,1.01 [0.45-2.29],0.9719532255656066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,1502,38,0.94 [0.66-1.35],0.7436034157038864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACRT,Extracellular glycoprotein lacritin,1494,38,1.18 [0.72-1.95],0.50537782089879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACTB2,Endoribonuclease LACTB2,1735,50,0.95 [0.64-1.39],0.782514745658536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,1733,49,1.81 [1.10-2.99],0.0204054847777268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1726,49,2.39 [1.65-3.45],3.987288918351566e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,1718,47,1.05 [0.82-1.35],0.6741889725385422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA1,Laminin subunit alpha-1,1448,37,0.68 [0.32-1.45],0.3150156095516168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA4,Laminin subunit alpha-4,1738,49,1.78 [0.90-3.52],0.0985895293322779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMB1,Laminin subunit beta-1,1469,38,1.16 [0.44-3.08],0.759869891717326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP1,Lysosome-associated membrane glycoprotein 1,1466,38,1.50 [0.62-3.63],0.3720186395062678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP2,Lysosome-associated membrane glycoprotein 2,1686,45,1.43 [0.34-5.97],0.6233188222980381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP3,Lysosome-associated membrane glycoprotein 3,1749,50,0.98 [0.61-1.57],0.9210541712379516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMTOR5,Ragulator complex protein LAMTOR5,1498,38,1.14 [0.58-2.24],0.6984567232461785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAP3,Cytosol aminopeptidase,1687,47,0.56 [0.30-1.03],0.0636594676144456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LARP1,La-related protein 1,1498,38,0.88 [0.51-1.49],0.6270209237452125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT,Linker for activation of T-cells family member 1,1751,50,0.99 [0.71-1.40],0.9709221730969712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT2,Linker for activation of T-cells family member 2,1733,49,0.98 [0.80-1.19],0.8113757760100395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LATS1,Serine/threonine-protein kinase LATS1,1453,37,0.98 [0.67-1.45],0.9253199228910798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,1714,47,4.03 [2.50-6.50],1.141648927688673e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBP,Lipopolysaccharide-binding protein,1743,49,1.24 [0.80-1.90],0.3336926341654706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBR,Delta(14)-sterol reductase LBR,1748,49,1.13 [0.81-1.57],0.466707923498053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCAT,Phosphatidylcholine-sterol acyltransferase,1511,38,0.72 [0.18-2.95],0.6525626976742154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,1506,38,1.61 [1.14-2.27],0.0063931065827536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,1686,48,1.78 [1.06-2.98],0.0295863828920252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCP1,Plastin-2,1508,38,1.18 [0.62-2.24],0.6208324540113628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLR,Low-density lipoprotein receptor,1736,50,1.02 [0.63-1.65],0.9276237385407242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,1506,38,0.95 [0.69-1.32],0.7732566609071073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LECT2,Leukocyte cell-derived chemotaxin-2,1502,38,1.56 [1.08-2.25],0.0176738450750282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEFTY2,Left-right determination factor 2,1746,50,1.54 [0.96-2.47],0.0753536629247795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEG1,Protein LEG1 homolog,1428,34,1.51 [0.98-2.34],0.0626546170071361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LELP1,Late cornified envelope-like proline-rich protein 1,1441,37,0.56 [0.35-0.89],0.0145498112013624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEO1,RNA polymerase-associated protein LEO1,1506,38,1.27 [0.72-2.25],0.4150499164225866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEP,Leptin,1735,50,0.98 [0.62-1.54],0.9156325896214934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEPR,Leptin receptor,1735,50,2.03 [0.97-4.28],0.0618011252952838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LETM1,Mitochondrial proton/calcium exchanger protein,1506,38,1.38 [0.79-2.40],0.2606475528482789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,1735,50,2.12 [1.09-4.10],0.0261312038148442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,1732,50,2.55 [1.17-5.56],0.0181543749316396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3BP,Galectin-3-binding protein,1513,38,1.07 [0.42-2.71],0.8840096922124452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,1726,49,2.14 [1.48-3.11],6.33371925794879e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS7_LGALS7B,Galectin-7,1736,50,1.54 [0.90-2.65],0.1152869880538293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS8,Galectin-8,1748,49,0.83 [0.54-1.28],0.396192403341684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,1728,49,2.50 [1.26-4.97],0.0085470898786755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGMN,Legumain,1738,49,1.46 [0.73-2.91],0.2820389365101705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHB,Lutropin subunit beta,1682,45,0.93 [0.66-1.32],0.6896571488921599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,1734,49,0.90 [0.59-1.36],0.6166932629577435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIF,Leukemia inhibitory factor,1670,45,1.41 [0.96-2.05],0.0760929214686338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,1726,49,2.62 [1.20-5.72],0.0159392955114406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,1741,50,0.54 [0.29-1.01],0.0543363036083609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,1508,38,0.95 [0.79-1.13],0.559517953753724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,1448,37,1.01 [0.58-1.76],0.9706493453157676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,1735,50,1.10 [0.51-2.38],0.8070059082742745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,1502,38,0.71 [0.48-1.06],0.0930742521493781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,1753,50,0.48 [0.20-1.11],0.0866035386033429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,1746,50,0.55 [0.29-1.04],0.0664044011133851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,1687,47,1.51 [0.89-2.55],0.1281096602192057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,1753,50,0.84 [0.60-1.19],0.33334096816084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIPF,Gastric triacylglycerol lipase,1469,38,0.93 [0.58-1.49],0.7549858215271001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB1,Lamin-B1,1483,38,1.05 [0.67-1.63],0.8377977966568351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB2,Lamin-B2,1497,38,2.24 [0.80-6.27],0.124685440326538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,1506,38,2.44 [1.31-4.57],0.0051975785501258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD2,Leiomodin-2,1441,37,0.94 [0.56-1.57],0.8118365157724028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LONP1,"Lon protease homolog, mitochondrial",1469,38,0.83 [0.57-1.21],0.32452820838887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPA,Apolipoprotein(a),1463,36,0.95 [0.80-1.13],0.5867509442520225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,1733,49,1.23 [0.86-1.76],0.2650116379301921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPL,Lipoprotein lipase,1735,50,1.19 [0.70-2.01],0.5282292777994648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,1677,47,1.79 [1.28-2.49],0.0006027465860612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPP,Lipoma-preferred partner,1448,37,0.95 [0.59-1.53],0.8215199399558945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,1448,37,1.08 [0.66-1.77],0.773761653661424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,1465,37,1.28 [0.74-2.21],0.37820310129481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRG1,Leucine-rich alpha-2-glycoprotein,1513,38,1.72 [0.54-5.49],0.3598947136994882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1744,50,2.11 [1.07-4.15],0.0316039331987937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,1449,37,1.85 [1.01-3.38],0.0460419302113255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,1733,49,2.20 [0.93-5.21],0.0732715782748763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,1735,50,2.10 [1.18-3.74],0.0113894935715155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2,Low-density lipoprotein receptor-related protein 2,1465,37,0.85 [0.35-2.03],0.7090226750135505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2BP,LRP2-binding protein,1465,37,1.10 [0.80-1.51],0.5685065635730365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,1748,49,1.08 [0.72-1.62],0.7111285002891383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC25,Leucine-rich repeat-containing protein 25,1733,49,0.94 [0.50-1.76],0.8437495516474738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,1487,38,1.56 [0.77-3.16],0.2198465950286432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC38,Leucine-rich repeat-containing protein 38,1465,37,1.05 [0.57-1.94],0.8635517649019401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC59,Leucine-rich repeat-containing protein 59,1502,38,0.68 [0.34-1.35],0.2647595352084506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,1498,38,0.61 [0.31-1.21],0.1550160401542624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,1687,47,0.43 [0.23-0.81],0.0092024823749105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,1465,37,0.64 [0.26-1.56],0.322396735270187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,1506,38,1.11 [0.31-3.96],0.8684283513156332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,1682,45,1.07 [0.69-1.66],0.7684839746195418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,1483,38,0.56 [0.31-1.03],0.0607224502826676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSP1,Lymphocyte-specific protein 1,1726,49,1.18 [0.63-2.20],0.6093067121327593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA,Lymphotoxin-alpha,1726,49,0.86 [0.47-1.58],0.6319718071579183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA4H,Leukotriene A-4 hydrolase,1751,50,1.08 [0.71-1.64],0.7245239188131112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTB,Lymphotoxin-beta,1498,38,1.21 [0.58-2.53],0.614564895886896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,1753,50,2.10 [1.12-3.92],0.0206486169529876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,1682,45,1.37 [0.95-1.98],0.0871040097238611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,1720,49,2.75 [1.47-5.15],0.0015629274481047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTO1,Protein LTO1 homolog,1687,47,0.72 [0.36-1.44],0.3552582951800833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LUZP2,Leucine zipper protein 2,1498,38,1.26 [0.76-2.10],0.3638401114435655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LXN,Latexin,1705,47,1.29 [0.91-1.85],0.1563049431313438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,1719,48,2.02 [1.25-3.28],0.0041519324963302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY75,Lymphocyte antigen 75,1726,49,0.99 [0.53-1.83],0.967956646607958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY9,T-lymphocyte surface antigen Ly-9,1718,50,1.56 [0.73-3.33],0.2535480470324268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY96,Lymphocyte antigen 96,1718,47,1.92 [1.03-3.59],0.0399896293534541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYAR,Cell growth-regulating nucleolar protein,1682,45,1.15 [0.69-1.93],0.5916536162610275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYN,Tyrosine-protein kinase Lyn,1733,49,1.02 [0.75-1.39],0.877889489149495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD1,Ly6/PLAUR domain-containing protein 1,1670,45,0.97 [0.61-1.55],0.904702662560342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD3,Ly6/PLAUR domain-containing protein 3,1717,49,1.71 [0.84-3.48],0.1387225927062731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD8,Ly6/PLAUR domain-containing protein 8,1682,45,1.20 [0.74-1.95],0.4546748661394639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPLA2,Acyl-protein thioesterase 2,1441,37,0.92 [0.68-1.23],0.5614235681855919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,1465,37,0.88 [0.62-1.23],0.4463863103954786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,1513,38,1.28 [0.30-5.56],0.7405902903948176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYZL2,Lysozyme-like protein 2,1449,38,1.62 [0.81-3.23],0.174405977311872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LZTFL1,Leucine zipper transcription factor-like protein 1,1479,37,0.90 [0.57-1.42],0.644747658138304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,M6PR,Cation-dependent mannose-6-phosphate receptor,1469,38,0.55 [0.21-1.44],0.2248301415219439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,1711,47,1.34 [0.94-1.90],0.1015615792002032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAEA,E3 ubiquitin-protein transferase MAEA,1682,45,0.56 [0.27-1.15],0.1138591537634372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAG,Myelin-associated glycoprotein,1465,37,0.54 [0.28-1.06],0.0731833813136666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGEA3,Melanoma-associated antigen 3,1483,38,0.89 [0.65-1.23],0.4860558636409517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGED1,Melanoma-associated antigen D1,1682,45,0.88 [0.50-1.53],0.6446580587426567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,1502,38,2.14 [1.05-4.38],0.0361581546815469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC4,Apical endosomal glycoprotein,1498,38,1.47 [0.92-2.37],0.109161093872564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",1469,38,0.87 [0.26-2.97],0.8283507483939108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN2B2,Epididymis-specific alpha-mannosidase,1502,38,1.34 [0.81-2.22],0.2544235575505744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",1449,38,1.49 [0.93-2.37],0.0958930373374125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,1738,49,1.02 [0.82-1.27],0.8752911924298419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,1741,50,2.22 [1.03-4.81],0.041999470128294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC4,MANSC domain-containing protein 4,1448,37,0.70 [0.42-1.18],0.1793449516195231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,1441,37,0.64 [0.22-1.81],0.3968628310365387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,1448,37,0.72 [0.36-1.47],0.3734945844049818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2,Microtubule-associated protein 2,1497,38,1.00 [0.53-1.91],0.9913490583284932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,1487,38,1.09 [0.68-1.75],0.7151372679084249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,1726,49,0.90 [0.70-1.16],0.407649408754492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,1682,45,0.83 [0.62-1.12],0.2230223358373625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,1714,47,1.01 [0.80-1.27],0.9343800417024524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK13,Mitogen-activated protein kinase 13,1449,38,1.17 [0.66-2.05],0.5945677063657966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK9,Mitogen-activated protein kinase 9,1726,49,1.35 [0.76-2.41],0.3079793723185069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPKAPK2,MAP kinase-activated protein kinase 2,1483,38,0.77 [0.49-1.19],0.2405618086310291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,1449,38,0.96 [0.76-1.22],0.7451517723325722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPT,Microtubule-associated protein tau,1670,45,1.15 [0.70-1.88],0.5791136421676188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARCO,Macrophage receptor MARCO,1735,50,0.84 [0.35-2.07],0.7117640057035106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",1475,37,0.87 [0.59-1.27],0.461823273070165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MASP1,Mannan-binding lectin serine protease 1,1714,47,0.71 [0.24-2.05],0.5242403081004918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN2,Matrilin-2,1730,49,1.21 [0.56-2.62],0.6284286929662211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN3,Matrilin-3,1715,47,0.57 [0.25-1.29],0.175289436160403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAVS,Mitochondrial antiviral-signaling protein,1682,45,0.84 [0.62-1.15],0.2743263219688719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAX,Protein max,1670,45,1.05 [0.81-1.36],0.6995182213760166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,1753,50,1.55 [1.01-2.38],0.0443131180694475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MBL2,Mannose-binding protein C,1486,36,1.03 [0.78-1.38],0.8172651796962791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCAM,Cell surface glycoprotein MUC18,1743,49,1.17 [0.60-2.28],0.6492336430644574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",1506,38,0.77 [0.33-1.80],0.545452390282785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEMP1,Mast cell-expressed membrane protein 1,1453,37,1.01 [0.71-1.44],0.9633173584222768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCFD2,Multiple coagulation factor deficiency protein 2,1726,49,1.23 [0.69-2.19],0.4746347435165802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCTS1,Malignant T-cell-amplified sequence 1,1487,38,1.43 [0.50-4.15],0.5058617635912018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,1718,47,1.19 [0.85-1.66],0.3135993231353972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDH1,"Malate dehydrogenase, cytoplasmic",1504,37,0.95 [0.44-2.05],0.9054359157830716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,1738,50,2.52 [1.64-3.88],2.664417745863904e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDM1,Nuclear protein MDM1,1465,37,0.79 [0.29-2.18],0.6525252463348685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",1469,38,0.82 [0.58-1.17],0.2847504228439871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED18,Mediator of RNA polymerase II transcription subunit 18,1682,45,0.92 [0.65-1.30],0.6359657296872696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED21,Mediator of RNA polymerase II transcription subunit 21,1448,37,1.00 [0.53-1.90],0.9980227394677924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,1726,49,0.96 [0.49-1.86],0.8939751967150799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,1448,37,2.05 [1.02-4.11],0.0437496865008851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,1748,50,1.09 [0.34-3.48],0.8909116676416418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,1502,38,2.68 [1.39-5.14],0.0030938481609192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MENT,Protein MENT,1479,37,0.67 [0.18-2.52],0.5496184514569091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1A,Meprin A subunit alpha,1487,38,1.16 [0.76-1.76],0.4879316780592859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1B,Meprin A subunit beta,1735,50,0.86 [0.70-1.04],0.126861189247018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEPE,Matrix extracellular phosphoglycoprotein,1726,49,0.41 [0.19-0.88],0.0218053140116487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MERTK,Tyrosine-protein kinase Mer,1751,50,1.98 [0.85-4.62],0.1131546731670073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MESD,LRP chaperone MESD,1741,50,0.97 [0.79-1.20],0.8078716153215193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MET,Hepatocyte growth factor receptor,1734,48,1.12 [0.35-3.61],0.8488664717250589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1,Methionine aminopeptidase 1,1670,45,0.41 [0.15-1.07],0.0692832345622991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",1726,49,0.98 [0.71-1.35],0.8809848603308549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP2,Methionine aminopeptidase 2,1746,50,0.98 [0.62-1.55],0.9422877663896791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3,Microfibril-associated glycoprotein 3,1701,48,0.84 [0.48-1.47],0.549942689248119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3L,Microfibrillar-associated protein 3-like,1465,37,0.93 [0.57-1.51],0.7556915623677178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,1479,37,2.40 [1.03-5.60],0.0428990942081712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,1753,50,2.39 [1.40-4.09],0.0015075561653129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,1741,50,1.73 [1.15-2.59],0.0081199407382601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGLL,Monoglyceride lipase,1733,49,0.98 [0.73-1.32],0.8992687594061379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,1726,49,0.96 [0.78-1.19],0.7096470799239484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIA,Melanoma-derived growth regulatory protein,1741,50,1.05 [0.55-2.02],0.8734178266740078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICALL2,MICAL-like protein 2,1465,37,0.71 [0.40-1.24],0.2257474996110215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,1726,49,1.03 [0.88-1.21],0.7018357122721545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIF,Macrophage migration inhibitory factor,1738,50,1.07 [0.73-1.55],0.7363556204593906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MILR1,Allergin-1,1687,47,1.40 [0.88-2.24],0.1543137936543543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,1498,38,0.83 [0.62-1.11],0.2128078226144089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINK1,Misshapen-like kinase 1,1497,38,0.98 [0.69-1.39],0.9189660480161318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MITD1,MIT domain-containing protein 1,1718,47,0.96 [0.73-1.26],0.762646042263025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MKI67,Proliferation marker protein Ki-67,1453,37,1.03 [0.46-2.31],0.948213953252359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLLT1,Protein ENL,1449,38,1.06 [0.71-1.58],0.7726074871023405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLN,Promotilin,1726,49,1.05 [0.79-1.40],0.7248534503249953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MME,Neprilysin,1733,49,1.16 [0.88-1.52],0.2903631901041678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP1,Interstitial collagenase,1671,46,1.05 [0.79-1.40],0.7205257102502896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,1727,49,1.52 [1.05-2.20],0.0280307595627046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,1737,50,1.90 [1.26-2.85],0.0021063504240896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP13,Collagenase 3,1670,45,1.54 [0.70-3.43],0.2858356241119733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP15,Matrix metalloproteinase-15,1502,38,0.91 [0.42-1.99],0.8190903279314362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP3,Stromelysin-1,1741,50,1.38 [0.89-2.14],0.1466226367669824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,1699,48,1.71 [1.03-2.86],0.0398754946493768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP8,Neutrophil collagenase,1745,49,1.22 [0.89-1.66],0.2154845186305869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP9,Matrix metalloproteinase-9,1740,50,1.20 [0.81-1.78],0.3615918970979563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",1448,37,0.80 [0.39-1.64],0.5489872539609604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MN1,Transcriptional activator MN1,1465,37,1.43 [0.97-2.12],0.0724729745732843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNAT1,CDK-activating kinase assembly factor MAT1,1483,38,0.88 [0.42-1.84],0.7245462814270067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNDA,Myeloid cell nuclear differentiation antigen,1732,50,1.01 [0.80-1.28],0.9323980300223292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOCS2,Molybdopterin synthase catalytic subunit,1479,37,0.75 [0.46-1.22],0.2469355357048241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,1751,50,2.32 [1.25-4.31],0.0075164276523902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORC3,MORC family CW-type zinc finger protein 3,1497,38,0.96 [0.36-2.61],0.9415687593045736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L1,Mortality factor 4-like protein 1,1483,38,0.93 [0.47-1.85],0.8391713650680162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L2,Mortality factor 4-like protein 2,1449,38,1.27 [0.65-2.48],0.4876852258141576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORN4,MORN repeat-containing protein 4,1449,38,0.57 [0.32-1.00],0.0510540644685698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPHOSPH8,M-phase phosphoprotein 8,1701,48,0.85 [0.59-1.21],0.3615369625631238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPI,Mannose-6-phosphate isomerase,1733,49,1.10 [0.82-1.48],0.5270955489906828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,1733,49,0.93 [0.66-1.30],0.6627404673901953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPO,Myeloperoxidase,1741,50,1.00 [0.58-1.70],0.9887451281777472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPRIP,Myosin phosphatase Rho-interacting protein,1494,38,1.07 [0.56-2.05],0.8434223144281662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRC1,Macrophage mannose receptor 1,1511,38,1.10 [0.42-2.90],0.8487120503287809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRI1,Methylthioribose-1-phosphate isomerase,1465,37,0.93 [0.59-1.47],0.7540865908023914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL24,"39S ribosomal protein L24, mitochondrial",1448,37,1.54 [1.01-2.34],0.042483036852458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL28,"39S ribosomal protein L28, mitochondrial",1506,38,1.19 [0.68-2.10],0.5474996379452222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL46,"39S ribosomal protein L46, mitochondrial",1670,45,0.62 [0.22-1.74],0.3628491932708703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL52,"39S ribosomal protein L52, mitochondrial",1446,37,1.37 [0.47-3.98],0.5584656785755411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",1506,38,0.87 [0.55-1.38],0.5503753362744107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPS16,"28S ribosomal protein S16, mitochondrial",1453,37,0.49 [0.13-1.90],0.3026188617394598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLN,Mesothelin,1726,48,1.33 [0.91-1.95],0.1456041296544426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLNL,Mesothelin-like protein,1465,37,0.37 [0.14-0.98],0.045839991394997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSMB,Beta-microseminoprotein,1733,50,1.37 [0.98-1.93],0.0661939040755001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,1748,49,1.83 [1.08-3.09],0.025341623683919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,1741,50,1.00 [0.70-1.42],0.9971907492967133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MST1,Hepatocyte growth factor-like protein,1483,37,1.28 [0.64-2.54],0.4810425908979896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSTN,Growth/differentiation factor 8,1701,48,0.57 [0.35-0.94],0.0267683889535549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTDH,Protein LYRIC,1453,37,0.94 [0.67-1.32],0.7354508776564861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",1497,38,1.15 [0.35-3.78],0.8144037680206836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,1483,38,0.94 [0.71-1.24],0.6630053489165819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",1487,38,0.79 [0.55-1.13],0.199179866136731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTPN,Myotrophin,1701,48,0.49 [0.18-1.30],0.1509414025155365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTR,Methionine synthase,1448,37,1.03 [0.70-1.51],0.8868690608484256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS1,Protein MTSS 1,1487,38,1.04 [0.79-1.38],0.7618217058831411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS2,Protein MTSS 2,1498,38,0.95 [0.70-1.30],0.7584354734507484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTUS1,Microtubule-associated tumor suppressor 1,1483,38,0.98 [0.58-1.67],0.9465018661702308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,1670,45,1.74 [1.23-2.48],0.0019341579585795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC16,Mucin-16,1733,49,1.02 [0.89-1.18],0.7495906890446008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC2,Mucin-2,1508,38,1.35 [0.98-1.85],0.0637027885735177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUCL3,Mucin-like protein 3,1449,38,1.30 [0.68-2.46],0.4307582026238976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MVK,Mevalonate kinase,1687,47,0.87 [0.65-1.19],0.3887099352775717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MXRA8,Matrix remodeling-associated protein 8,1479,37,0.50 [0.19-1.35],0.174331046343492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC1,"Myosin-binding protein C, slow-type",1502,38,1.42 [0.97-2.09],0.0710783240492084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC2,"Myosin-binding protein C, fast-type",1469,38,1.09 [0.79-1.52],0.6005992723709059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,1506,38,0.84 [0.50-1.41],0.5137636263494557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYDGF,Myeloid-derived growth factor,1502,38,1.01 [0.73-1.40],0.940398061512211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH4,Myosin-4,1448,37,1.35 [0.81-2.23],0.2460917802350098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH7B,Myosin-7B,1449,38,1.21 [0.72-2.04],0.4622642831909104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH9,Myosin-9,1508,38,0.91 [0.68-1.21],0.5070726101763099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",1448,37,0.90 [0.38-2.13],0.8042217957215761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL3,Myosin light chain 3,1469,38,0.98 [0.64-1.50],0.9084090675333284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL4,Myosin light chain 4,1469,38,1.30 [0.81-2.10],0.2828795793259336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL6B,Myosin light chain 6B,1465,37,0.94 [0.66-1.35],0.7393860320696564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1465,37,1.84 [1.08-3.14],0.0244552227400104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO6,Unconventional myosin-VI,1506,38,1.12 [0.51-2.47],0.7796108750661197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO9B,Unconventional myosin-IXb,1687,47,0.66 [0.42-1.04],0.0754755243259333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOC,Myocilin,1741,50,0.83 [0.50-1.40],0.4895102671785476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM1,Myomesin-1,1441,37,0.97 [0.48-1.93],0.9208055272180324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM2,Myomesin-2,1448,37,0.60 [0.27-1.33],0.2090647715427015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM3,Myomesin-3,1479,37,0.96 [0.68-1.35],0.8178958819905324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZB1,Marginal zone B- and B1-cell-specific protein,1735,49,0.84 [0.51-1.38],0.4934874598500363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZT1,Mitotic-spindle organizing protein 1,1682,45,0.60 [0.33-1.12],0.1113023392983811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA10,N-alpha-acetyltransferase 10,1448,37,0.79 [0.44-1.42],0.4313725802847626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA80,N-alpha-acetyltransferase 80,1465,37,0.94 [0.72-1.23],0.6585558054749452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,1711,47,1.48 [0.98-2.23],0.0647698456850261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NACC1,Nucleus accumbens-associated protein 1,1498,38,0.55 [0.29-1.01],0.0544427689510481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NADK,NAD kinase,1735,50,0.75 [0.46-1.23],0.2616089854730075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGA,Alpha-N-acetylgalactosaminidase,1449,37,1.15 [0.68-1.95],0.6055932106134949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGK,N-acetyl-D-glucosamine kinase,1464,38,0.59 [0.33-1.04],0.0668630304321317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1479,37,4.29 [1.17-15.76],0.0281641100229635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAMPT,Nicotinamide phosphoribosyltransferase,1682,45,1.10 [0.75-1.63],0.6223763853249478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAP1L4,Nucleosome assembly protein 1-like 4,1484,37,0.96 [0.45-2.04],0.9115878621035942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAPRT,Nicotinate phosphoribosyltransferase,1497,38,1.36 [0.61-3.06],0.4511610327140578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",1506,38,0.98 [0.51-1.89],0.953128565623213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,1741,50,4.62 [2.25-9.49],3.087259715149018e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBN,Nibrin,1687,47,0.96 [0.58-1.60],0.8778520196102797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM1,Neural cell adhesion molecule 1,1743,49,0.56 [0.24-1.27],0.1647896200832586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM2,Neural cell adhesion molecule 2,1741,50,1.06 [0.43-2.60],0.9020074813790304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAN,Neurocan core protein,1748,49,0.65 [0.36-1.17],0.1534087906248286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCF2,Neutrophil cytosol factor 2,1723,49,1.01 [0.77-1.34],0.9219938753887532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCK2,Cytoplasmic protein NCK2,1738,49,0.99 [0.78-1.26],0.9471893370994732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCLN,Nicalin,1687,47,0.72 [0.37-1.43],0.3531811110873405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,1726,49,2.88 [1.63-5.09],0.0002880943795321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1487,38,3.79 [1.79-8.03],0.0004910057482289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,1751,50,4.28 [2.03-9.02],0.0001364081543723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDRG1,Protein NDRG1,1670,45,1.29 [1.00-1.65],0.0478577391301762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,1498,38,1.31 [0.90-1.89],0.1560258612804185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,1450,37,0.69 [0.28-1.68],0.4147362123926795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,1487,38,0.89 [0.62-1.27],0.517207749433951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",1682,45,0.99 [0.69-1.44],0.9766493532188228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEB,Nebulin,1448,37,1.04 [0.41-2.60],0.9391029373652235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECAP2,Adaptin ear-binding coat-associated protein 2,1448,37,0.97 [0.60-1.57],0.9069161732660672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN1,Nectin-1,1453,37,1.05 [0.37-3.02],0.9221750716463756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,1735,50,2.91 [1.54-5.51],0.0010226188720993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,1741,50,2.43 [1.60-3.68],2.7924678495367504e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,1453,37,0.83 [0.44-1.55],0.5565544126187831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD9,Enhancer of filamentation 1,1453,37,1.99 [0.92-4.34],0.0818047007064274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,1665,45,3.69 [2.52-5.40],1.879371469853093e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEK7,Serine/threonine-protein kinase Nek7,1483,38,0.70 [0.42-1.17],0.1721248712161922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,1741,50,0.32 [0.21-0.50],4.013679445009887e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL2,Protein kinase C-binding protein NELL2,1738,49,0.54 [0.24-1.23],0.141331642658577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NENF,Neudesin,1498,38,1.19 [0.96-1.46],0.1152039531235168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEO1,Neogenin,1506,38,1.34 [0.32-5.54],0.6848453059983834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEXN,Nexilin,1511,38,0.71 [0.45-1.14],0.1568076037795833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,1751,50,2.60 [1.28-5.29],0.0080576130331369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFAT5,Nuclear factor of activated T-cells 5,1453,37,0.75 [0.49-1.13],0.1703131012028712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",1726,49,0.93 [0.71-1.21],0.5851067135585036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",1687,47,0.75 [0.48-1.16],0.194137189686532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFE2,Transcription factor NF-E2 45 kDa subunit,1469,38,0.79 [0.51-1.22],0.2865317675173284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFIC,Nuclear factor 1 C-type,1506,38,1.20 [0.75-1.90],0.4486858001131706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,1448,37,0.86 [0.55-1.34],0.499930847031882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,1483,38,0.85 [0.41-1.78],0.6681510785875233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKBIE,NF-kappa-B inhibitor epsilon,1682,45,0.93 [0.53-1.62],0.7913964417472261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",1487,38,0.88 [0.64-1.20],0.4168629855801098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFX1,Transcriptional repressor NF-X1,1448,37,0.98 [0.64-1.50],0.9178338055108878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFYA,Nuclear transcription factor Y subunit alpha,1448,37,1.24 [0.55-2.77],0.6022879473599492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGF,Beta-nerve growth factor,1718,47,14.10 [1.55-128.04],0.0187021054860756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGFR,Tumor necrosis factor receptor superfamily member 16,1502,38,1.79 [0.76-4.23],0.1818207562988218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGRN,Neugrin,1497,38,0.85 [0.19-3.88],0.838727839264823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NHLRC3,NHL repeat-containing protein 3,1435,36,2.03 [0.73-5.65],0.1739324621750541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID1,Nidogen-1,1741,48,1.41 [0.77-2.60],0.2659378944668118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID2,Nidogen-2,1741,50,1.09 [0.79-1.51],0.6041922560589387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NINJ1,Ninjurin-1,1682,45,1.08 [0.66-1.78],0.7604713874512548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT1,Deaminated glutathione amidase,1469,38,0.87 [0.44-1.72],0.6859473077222494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT2,Omega-amidase NIT2,1491,38,0.90 [0.58-1.40],0.6361801814346335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN1,Neuroligin-1,1465,37,1.12 [0.77-1.63],0.5572552135476985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN2,Neuroligin-2,1441,37,1.21 [0.65-2.26],0.551349140889242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME1,Nucleoside diphosphate kinase A,1453,37,1.05 [0.28-3.96],0.9420268713494168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME3,Nucleoside diphosphate kinase 3,1730,49,0.54 [0.24-1.22],0.1397594960101262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMI,N-myc-interactor,1490,38,0.77 [0.48-1.24],0.2780087060291078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,1718,47,1.17 [0.90-1.53],0.2417297754051683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMRK2,Nicotinamide riboside kinase 2,1449,38,1.08 [0.58-2.01],0.8074850766294481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,1506,38,0.66 [0.38-1.15],0.139676978630302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOMO1,Nodal modulator 1,1741,50,2.21 [1.05-4.68],0.0375787657753218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOP56,Nucleolar protein 56,1448,37,1.19 [0.94-1.50],0.1426187262824063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",1670,45,2.19 [1.40-3.42],0.0005537692286654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS2,"Nitric oxide synthase, inducible",1448,37,0.59 [0.22-1.55],0.2851699258142079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS3,"Nitric oxide synthase, endothelial",1670,45,1.23 [0.80-1.90],0.336417874274177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,1753,50,2.71 [0.61-12.11],0.1908466590643578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,1508,38,3.38 [1.13-10.11],0.0291881977541309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH3,Neurogenic locus notch homolog protein 3,1753,50,1.06 [0.55-2.05],0.850608818277601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,1491,37,3.93 [1.72-9.00],0.0011969590406283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,1735,50,2.62 [1.61-4.28],0.0001175969905447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS1,Nephrin,1453,37,0.87 [0.34-2.26],0.7821262863614291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS2,Podocin,1453,37,0.84 [0.59-1.21],0.3581660134183183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPL,N-acetylneuraminate lyase,1502,38,1.36 [0.72-2.55],0.3461596453669561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPB,Natriuretic peptides B,1701,48,1.14 [0.94-1.37],0.1799522958998468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPC,C-type natriuretic peptide,1726,49,1.25 [0.79-1.97],0.3338461462602569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPR1,Atrial natriuretic peptide receptor 1,1448,37,1.37 [0.61-3.06],0.4436273792725591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTN,Neuroplastin,1682,45,1.20 [0.92-1.57],0.1829904311205487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX1,Neuronal pentraxin-1,1741,50,0.90 [0.50-1.65],0.7408160739938514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX2,Neuronal pentraxin-2,1508,38,1.45 [0.60-3.51],0.4075070342686488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTXR,Neuronal pentraxin receptor,1735,50,0.97 [0.51-1.84],0.9180451336028272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,1751,50,1.71 [1.16-2.52],0.0066454501344573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRCAM,Neuronal cell adhesion molecule,1735,50,1.17 [0.55-2.49],0.6859438147748979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRGN,Neurogranin,1511,38,0.93 [0.66-1.30],0.6612627450406452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRN1,Neuritin,1506,38,0.46 [0.14-1.50],0.1956237173820096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,1744,49,2.28 [1.02-5.10],0.0436798887994231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP2,Neuropilin-2,1741,50,1.33 [0.59-3.02],0.494095493899222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRTN,Neurturin,1687,47,0.87 [0.48-1.56],0.633325676210134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRXN3,Neurexin-3,1465,37,0.61 [0.19-1.92],0.3939709118218081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NSFL1C,NSFL1 cofactor p47,1748,49,1.09 [0.75-1.58],0.6638670500886366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",1502,38,0.96 [0.62-1.47],0.835376636454103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,1497,38,2.04 [1.12-3.71],0.0196319926318756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,1725,49,0.87 [0.65-1.15],0.3282885170131721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5E,5'-nucleotidase,1741,50,0.95 [0.61-1.48],0.8314831651148292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF3,Neurotrophin-3,1726,49,1.48 [0.83-2.65],0.1817545794788349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF4,Neurotrophin-4,1682,45,0.64 [0.27-1.54],0.3208946609810364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK2,BDNF/NT-3 growth factors receptor,1735,50,1.05 [0.42-2.62],0.9236849126763446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK3,NT-3 growth factor receptor,1748,49,0.55 [0.18-1.64],0.2845059961100078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,1735,50,1.41 [1.16-1.71],0.0005218387785531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUB1,NEDD8 ultimate buster 1,1726,49,0.91 [0.67-1.24],0.5602477551581251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,1498,38,0.96 [0.68-1.35],0.8224571606450441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,1750,50,2.06 [1.10-3.87],0.0237186694714744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDC,Nuclear migration protein nudC,1751,50,0.87 [0.58-1.32],0.5194441263389744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,1469,38,0.63 [0.16-2.46],0.5032480278475946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,1448,37,0.84 [0.44-1.60],0.6035971910998124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT16,U8 snoRNA-decapping enzyme,1485,38,0.90 [0.62-1.30],0.567821057455189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],1733,49,0.94 [0.60-1.47],0.7758216149298488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT5,ADP-sugar pyrophosphatase,1741,50,1.00 [0.61-1.64],0.9959206824838288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUMB,Protein numb homolog,1453,37,0.99 [0.67-1.47],0.9596607763970708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUP50,Nuclear pore complex protein Nup50,1448,37,1.43 [0.93-2.21],0.1055899881220414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPE4,NXPE family member 4,1448,37,0.79 [0.32-1.93],0.6061440625557077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH1,Neurexophilin-1,1670,45,1.91 [1.17-3.12],0.0094644258425794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH3,Neurexophilin-3,1453,37,2.48 [0.87-7.06],0.0894963409804847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OBP2B,Odorant-binding protein 2b,1713,47,1.34 [0.91-1.98],0.1432030192225828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,1506,38,1.85 [1.03-3.35],0.0410861148747482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ODAM,Odontogenic ameloblast-associated protein,1669,45,1.32 [0.93-1.89],0.12134242839746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OFD1,Oral-facial-digital syndrome 1 protein,1483,38,1.17 [0.80-1.69],0.4160507321924352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGA,Protein O-GlcNAcase,1487,38,0.80 [0.51-1.27],0.3495460994361618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGFR,Opioid growth factor receptor,1733,49,0.92 [0.42-2.03],0.8299430911303528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,1741,50,3.34 [2.15-5.21],9.455415034334e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,1483,38,0.66 [0.33-1.31],0.237823982811448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLFM4,Olfactomedin-4,1421,35,1.26 [0.97-1.63],0.0824993875185653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLR1,Oxidized low-density lipoprotein receptor 1,1727,50,1.17 [0.79-1.74],0.4186146157442825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMD,Osteomodulin,1738,49,0.66 [0.40-1.08],0.0946529654736992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMG,Oligodendrocyte-myelin glycoprotein,1733,49,0.84 [0.58-1.22],0.3661260547272551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMP,Olfactory marker protein,1441,37,1.37 [0.84-2.22],0.2066101109772707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPHN1,Oligophrenin-1,1497,38,0.86 [0.64-1.16],0.3320000351212613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPLAH,5-oxoprolinase,1469,38,0.99 [0.63-1.57],0.9653467262673686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,1733,49,1.90 [1.17-3.08],0.009765638961343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ORM1,Alpha-1-acid glycoprotein 1,1509,37,0.69 [0.15-3.14],0.6338760844007327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSBPL2,Oxysterol-binding protein-related protein 2,1497,38,1.39 [0.84-2.29],0.2029902262391842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,1730,49,1.42 [0.69-2.93],0.346759024244862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSM,Oncostatin-M,1720,49,1.05 [0.75-1.48],0.759000531876651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSMR,Oncostatin-M-specific receptor subunit beta,1744,49,0.65 [0.20-2.12],0.475412062186786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSTN,Osteocrin,1465,37,0.79 [0.33-1.89],0.5963649176918904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTOA,Otoancorin,1441,37,1.10 [0.68-1.76],0.7002138918714368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD6B,Deubiquitinase OTUD6B,1487,38,1.01 [0.60-1.71],0.96164960558336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD7B,OTU domain-containing protein 7B,1506,38,0.92 [0.55-1.52],0.7343532149184051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",1469,38,0.69 [0.45-1.08],0.1018971661500034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXT,Oxytocin-neurophysin 1,1748,49,1.14 [0.95-1.36],0.17270014190326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,P4HB,Protein disulfide-isomerase,1722,50,1.86 [0.97-3.57],0.0612129452665977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PACS2,Phosphofurin acidic cluster sorting protein 2,1448,37,0.67 [0.39-1.15],0.1461053867783543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI2,Protein-arginine deiminase type-2,1687,47,0.90 [0.53-1.54],0.7069316668695614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI4,Protein-arginine deiminase type-4,1669,45,1.04 [0.77-1.40],0.8200010217283856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAEP,Glycodelin,1718,47,1.12 [0.91-1.38],0.2652585691969022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,1506,38,1.05 [0.82-1.36],0.6835981371429056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",1483,38,0.72 [0.38-1.36],0.3068792796873772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,1701,48,1.12 [0.70-1.78],0.6289678190919137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,1469,38,0.96 [0.51-1.79],0.888112307032722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,1446,38,1.10 [0.60-2.00],0.7619951684990851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAK4,Serine/threonine-protein kinase PAK 4,1670,45,1.10 [0.71-1.71],0.6594306684118221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALLD,Palladin,1453,37,1.01 [0.47-2.17],0.9727126496585512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,1479,37,2.26 [1.04-4.91],0.0393113518276441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,1497,38,2.91 [1.58-5.36],0.0005818497485042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM3,Paralemmin-3,1448,37,1.10 [0.74-1.65],0.6352257093463649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,1747,50,1.16 [0.51-2.62],0.7300052209361214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAMR1,Inactive serine protease PAMR1,1741,50,0.97 [0.41-2.32],0.9532830088331972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAPPA,Pappalysin-1,1687,47,0.83 [0.48-1.43],0.4959666763915022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARD3,Partitioning defective 3 homolog,1483,38,1.00 [0.66-1.53],0.9902793980951332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARK7,Parkinson disease protein 7,1741,50,0.99 [0.62-1.57],0.9607663542719886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARP1,Poly [ADP-ribose] polymerase 1,1726,49,1.13 [0.76-1.68],0.5580708490660246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAXX,Protein PAXX,1479,37,0.97 [0.50-1.88],0.9324970253959556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,1449,38,0.95 [0.33-2.69],0.9201359394717626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBLD,Phenazine biosynthesis-like domain-containing protein,1670,45,0.83 [0.51-1.35],0.4422435250314023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,1487,38,2.05 [0.84-5.02],0.1162329023467257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCARE,Photoreceptor cilium actin regulator,1441,37,1.13 [0.83-1.54],0.4486625190928963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,1477,36,1.13 [0.67-1.91],0.6434593117723337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBP2,Poly(rC)-binding protein 2,1506,38,1.00 [0.66-1.52],0.9989300136540716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,1745,50,2.41 [1.16-5.00],0.0187716053112251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH12,Protocadherin-12,1506,38,1.25 [0.38-4.11],0.7152202822465905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH17,Protocadherin-17,1735,50,1.01 [0.55-1.86],0.9747065206494432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,1487,38,1.80 [1.14-2.83],0.011480521631693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH9,Protocadherin-9,1487,38,1.19 [0.53-2.66],0.6754520990886385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDHB15,Protocadherin beta-15,1498,38,1.42 [0.81-2.49],0.2205801712825474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCNA,Proliferating cell nuclear antigen,1449,38,1.09 [0.73-1.63],0.6797910106380016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,1498,38,0.97 [0.54-1.73],0.9200996215407212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,1753,50,1.50 [0.81-2.76],0.1971860670039798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,1487,38,0.98 [0.64-1.51],0.9341673411824496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,1502,38,1.09 [0.78-1.51],0.6229300014855033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,1749,49,1.68 [1.14-2.46],0.0080722843800795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,1733,49,3.11 [1.46-6.61],0.0031896648178159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD5,Programmed cell death protein 5,1748,49,1.10 [0.72-1.70],0.6550182548546976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD6,Programmed cell death protein 6,1735,50,1.59 [0.95-2.66],0.0747591207318106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCL2,Phosducin-like protein 2,1449,38,0.54 [0.23-1.25],0.1509107252705325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",1449,38,0.71 [0.33-1.53],0.3786004078629664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1448,37,0.87 [0.48-1.59],0.6533661100653518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",1479,37,0.89 [0.66-1.21],0.4549756065414957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFA,Platelet-derived growth factor subunit A,1753,50,0.92 [0.65-1.31],0.6455083486531017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFB,Platelet-derived growth factor subunit B,1738,49,1.04 [0.77-1.41],0.7841762346065578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFC,Platelet-derived growth factor C,1682,45,0.77 [0.31-1.89],0.5646990886546743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,1735,50,2.50 [1.16-5.41],0.0199371541860607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRB,Platelet-derived growth factor receptor beta,1753,50,1.00 [0.50-1.99],0.9934625660892984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA2,Protein disulfide-isomerase A2,1449,38,0.91 [0.36-2.28],0.8334077263199416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA3,Protein disulfide-isomerase A3,1479,37,1.16 [0.33-4.02],0.8191867799433561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA4,Protein disulfide-isomerase A4,1508,38,0.77 [0.46-1.32],0.3456363668458633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA5,Protein disulfide-isomerase A5,1449,38,0.86 [0.50-1.48],0.5916951020976082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM5,PDZ and LIM domain protein 5,1506,38,0.84 [0.65-1.09],0.1966124098616012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM7,PDZ and LIM domain protein 7,1738,49,0.98 [0.80-1.20],0.8568970997827722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",1682,45,0.84 [0.45-1.58],0.5896097476513782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDRG1,p53 and DNA damage-regulated protein 1,1465,37,1.08 [0.63-1.82],0.7879200207450876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,1449,38,0.82 [0.44-1.50],0.516007157141958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZD2,PDZ domain-containing protein 2,1448,37,0.55 [0.29-1.04],0.0656898040705411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,1453,37,1.41 [0.86-2.30],0.1747975020152476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEAR1,Platelet endothelial aggregation receptor 1,1753,50,0.59 [0.20-1.73],0.3367203003185929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEBP1,Phosphatidylethanolamine-binding protein 1,1741,50,1.15 [0.76-1.74],0.5179251736267576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECAM1,Platelet endothelial cell adhesion molecule,1741,50,0.61 [0.26-1.40],0.2408327704501959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,1469,38,0.57 [0.16-2.07],0.3923405638196519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PENK,Proenkephalin-A,1479,37,2.19 [0.96-5.01],0.0631160423556277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEPD,Xaa-Pro dipeptidase,1511,38,0.62 [0.19-1.95],0.4099944903678758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PER3,Period circadian protein homolog 3,1453,37,1.05 [0.82-1.33],0.7170331768514904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PF4,Platelet factor 4,1502,38,1.11 [0.80-1.54],0.5374135735411606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN2,Prefoldin subunit 2,1670,45,1.42 [0.93-2.17],0.1055066416578949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN4,Prefoldin subunit 4,1449,38,1.09 [0.65-1.82],0.7448158189136689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN6,Prefoldin subunit 6,1465,37,1.35 [0.94-1.94],0.1062684619893153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",1731,49,0.93 [0.67-1.29],0.663294418247769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGA4,Pepsin A-4,1511,38,1.42 [1.00-2.02],0.0522056733025659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",1502,38,1.21 [0.68-2.15],0.519442441639171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,1751,50,3.26 [1.65-6.46],0.0006907178427651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP1,Peptidoglycan recognition protein 1,1746,50,1.27 [0.75-2.17],0.37371896187034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,1496,36,0.58 [0.21-1.57],0.281734993710666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP4,Peptidoglycan recognition protein 4,1448,37,1.01 [0.59-1.73],0.9764636447059616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGM2,Phosphoglucomutase-2,1465,37,0.50 [0.22-1.13],0.0971222518208021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGR,Progesterone receptor,1453,37,0.90 [0.61-1.32],0.5839169347399699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHACTR2,Phosphatase and actin regulator 2,1506,38,0.92 [0.69-1.21],0.5295089056165045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB1,Pleckstrin homology-like domain family B member 1,1487,38,1.26 [0.69-2.28],0.4482206737334867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB2,Pleckstrin homology-like domain family B member 2,1449,38,0.81 [0.55-1.20],0.2932879068202952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1718,47,4.68 [2.17-10.08],8.310911363657527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,1479,37,0.83 [0.40-1.72],0.6080390843366602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI16,Peptidase inhibitor 16,1511,38,2.05 [0.64-6.57],0.227717952740288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,1714,50,1.72 [1.24-2.40],0.0012339285931957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",1506,38,0.86 [0.57-1.29],0.4622494727658572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,1720,50,2.51 [1.47-4.31],0.000800755509584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,1726,49,1.02 [0.69-1.51],0.9230209701373212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1741,50,5.20 [2.99-9.06],5.694332442333567e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,1453,37,0.85 [0.44-1.63],0.6223893439680666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,1741,50,2.63 [1.44-4.81],0.0016943238586141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,1735,50,1.83 [1.15-2.94],0.0113964985717494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,1479,37,0.89 [0.56-1.42],0.6226305036082043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PITHD1,PITH domain-containing protein 1,1446,38,1.04 [0.75-1.45],0.8084724770701193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,1502,38,4.86 [1.60-14.78],0.0053143507068856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD2,Polycystin-2,1448,37,0.74 [0.40-1.37],0.343347197514988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKLR,Pyruvate kinase PKLR,1732,49,0.98 [0.68-1.41],0.9055570530914367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKN3,Serine/threonine-protein kinase N3,1483,38,1.02 [0.69-1.51],0.9265614354375872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G10,Group 10 secretory phospholipase A2,1718,47,1.38 [0.92-2.09],0.1235064999201228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G15,Phospholipase A2 group XV,1741,50,1.60 [0.69-3.75],0.2762994227862339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G1B,Phospholipase A2,1750,50,0.72 [0.46-1.13],0.1507683311225846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G2A,"Phospholipase A2, membrane associated",1724,50,0.83 [0.52-1.33],0.4319004808470367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G4A,Cytosolic phospholipase A2,1738,49,0.94 [0.71-1.25],0.6877410439161065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,1741,50,0.35 [0.20-0.64],0.0005039485525195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAT,Tissue-type plasminogen activator,1748,50,0.93 [0.60-1.46],0.759180316202328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAU,Urokinase-type plasminogen activator,1741,50,0.58 [0.25-1.35],0.2079548591173194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,1719,49,3.47 [1.63-7.40],0.001234418015885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",1497,38,0.43 [0.25-0.72],0.0015093558654526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",1453,37,1.32 [0.71-2.44],0.3786524504829244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",1497,38,0.92 [0.67-1.27],0.6170178450680361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,1497,38,0.80 [0.51-1.26],0.343171342801536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLG,Plasminogen,1467,35,4.49 [0.99-20.41],0.0519980667820333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN1,Perilipin-1,1670,45,1.44 [0.78-2.64],0.2459940119894729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN3,Perilipin-3,1735,50,1.19 [0.68-2.08],0.5356680028030977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLPBP,Pyridoxal phosphate homeostasis protein,1735,50,0.99 [0.69-1.43],0.96979680576015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLSCR3,Phospholipid scramblase 3,1494,38,1.06 [0.61-1.83],0.83711235566471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLTP,Phospholipid transfer protein,1747,50,0.55 [0.30-1.00],0.0482886887916931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC1,Plexin domain-containing protein 1,1682,45,1.41 [0.72-2.76],0.3107117312538141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC2,Plexin domain-containing protein 2,1497,38,1.31 [0.48-3.61],0.6019505971560344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNA4,Plexin-A4,1726,49,0.94 [0.68-1.30],0.7127438892902025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,1741,50,4.81 [2.27-10.21],4.291932317356884e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB3,Plexin-B3,1728,49,0.79 [0.46-1.38],0.4153095094299543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,1732,50,1.07 [0.92-1.23],0.378437891987244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMCH,Pro-MCH,1448,37,1.27 [0.94-1.71],0.1181192839019252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMM2,Phosphomannomutase 2,1448,37,0.77 [0.43-1.36],0.3682857609440535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMS1,PMS1 protein homolog 1,1465,37,0.97 [0.52-1.79],0.9190058044421324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMVK,Phosphomevalonate kinase,1667,45,0.95 [0.74-1.21],0.673594801811499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIP,Pancreatic triacylglycerol lipase,1511,38,0.83 [0.53-1.31],0.4260941885468714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,1497,38,1.11 [0.78-1.59],0.567544445526572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP2,Pancreatic lipase-related protein 2,1726,49,1.03 [0.94-1.13],0.4759387892055544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA1,Paraneoplastic antigen Ma1,1469,38,0.71 [0.39-1.27],0.2445485171753821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA2,Paraneoplastic antigen Ma2,1441,37,0.98 [0.53-1.82],0.9601780257971392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",1687,47,1.11 [0.91-1.36],0.3003350890647799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL,Podocalyxin,1733,49,0.55 [0.12-2.59],0.4473866675067269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL2,Podocalyxin-like protein 2,1741,50,2.03 [0.98-4.19],0.0557222378771756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,1453,37,1.80 [1.10-2.94],0.0188203250370625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,1453,37,0.73 [0.21-2.48],0.6085659525011067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1733,49,1.89 [1.17-3.06],0.0089875569967987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POMC,Pro-opiomelanocortin,1469,38,0.95 [0.62-1.46],0.8179844044666598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON1,Serum paraoxonase/arylesterase 1,1511,38,0.78 [0.28-2.14],0.6229653848656839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON2,Serum paraoxonase/arylesterase 2,1701,48,0.45 [0.22-0.91],0.02545545521316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON3,Serum paraoxonase/lactonase 3,1738,49,0.48 [0.24-0.97],0.0415744992294177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POSTN,Periostin,1508,38,1.02 [0.47-2.22],0.9538253892488826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPBP,Platelet basic protein,1498,37,1.09 [0.74-1.60],0.665414241023349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,1748,49,0.89 [0.52-1.51],0.6538048850834526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,1733,50,0.96 [0.73-1.26],0.7615907481733013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,1483,38,0.59 [0.30-1.18],0.1389828584216838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",1508,38,0.67 [0.38-1.16],0.1538728321788465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPL,Periplakin,1453,37,1.32 [0.56-3.14],0.5238403317753301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1A,Protein phosphatase 1A,1682,45,0.95 [0.42-2.14],0.902197748735566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1B,Protein phosphatase 1B,1453,37,0.88 [0.46-1.68],0.7011840620602776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1F,Protein phosphatase 1F,1502,38,0.89 [0.49-1.63],0.7102263522194976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPME1,Protein phosphatase methylesterase 1,1733,49,1.16 [0.77-1.74],0.4863454713517262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,1498,38,0.81 [0.55-1.20],0.2980998676230528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,1741,50,0.98 [0.75-1.27],0.8774754392238535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,1483,38,1.01 [0.65-1.58],0.9480403398003052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,1506,38,0.81 [0.53-1.23],0.3149464929133831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,1506,38,1.42 [0.72-2.80],0.3058088862029965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R2,Protein phosphatase inhibitor 2,1735,50,0.92 [0.67-1.27],0.6150230924937863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R9B,Neurabin-2,1751,50,0.97 [0.73-1.27],0.7996808211254383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,1487,38,0.87 [0.66-1.13],0.2907644668042657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP3R1,Calcineurin subunit B type 1,1718,47,1.58 [0.86-2.89],0.140643677819171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPT1,Palmitoyl-protein thioesterase 1,1465,37,1.06 [0.74-1.51],0.7648205560086483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPY,Pancreatic prohormone,1734,50,1.06 [0.85-1.33],0.5965376690409548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PQBP1,Polyglutamine-binding protein 1,1682,45,1.02 [0.63-1.64],0.9366199579131708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAME,Melanoma antigen preferentially expressed in tumors,1449,38,0.58 [0.16-2.09],0.4023328533274722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,1508,38,5.89 [2.65-13.12],1.4194009507922664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRC1,Protein regulator of cytokinesis 1,1498,38,0.86 [0.40-1.85],0.698786713897745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRCP,Lysosomal Pro-X carboxypeptidase,1745,50,1.41 [0.72-2.77],0.312885902295917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX1,Peroxiredoxin-1,1675,46,1.10 [0.82-1.48],0.509523860482209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX2,Peroxiredoxin-2,1480,38,1.12 [0.72-1.74],0.6235802431917643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",1687,47,1.05 [0.72-1.53],0.81241740802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX5,"Peroxiredoxin-5, mitochondrial",1751,50,0.86 [0.59-1.24],0.4120878207995583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX6,Peroxiredoxin-6,1751,50,1.07 [0.72-1.60],0.7346401985027855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PREB,Prolactin regulatory element-binding protein,1687,47,1.36 [0.62-2.99],0.4483049054453567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,1726,49,3.34 [1.28-8.72],0.0139087716439828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG2,Bone marrow proteoglycan,1508,38,1.21 [0.71-2.06],0.4860190446779822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG3,Proteoglycan 3,1508,38,0.76 [0.42-1.38],0.3725669105152404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,1687,47,1.29 [0.81-2.07],0.2870618537839482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,1465,37,1.13 [0.45-2.88],0.7915756569304109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,1735,50,0.87 [0.64-1.18],0.3615594373743716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,1495,38,0.95 [0.64-1.42],0.8103322329209224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKCQ,Protein kinase C theta type,1687,47,0.50 [0.25-1.01],0.0547345404527981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKD2,Serine/threonine-protein kinase D2,1448,37,0.46 [0.16-1.32],0.1477266668626383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKG1,cGMP-dependent protein kinase 1,1479,37,0.80 [0.62-1.03],0.084176188210913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,1682,45,0.96 [0.64-1.42],0.8216297722992467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,1748,49,1.56 [1.23-1.98],0.0002319502417406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRND,Prion-like protein doppel,1497,38,1.21 [0.74-1.95],0.4475035982122421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROC,Vitamin K-dependent protein C,1742,49,1.32 [0.51-3.43],0.5623400780792382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROCR,Endothelial protein C receptor,1448,37,1.01 [0.41-2.51],0.9868613245453492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROK1,Prokineticin-1,1726,49,0.82 [0.54-1.23],0.3343927268670253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROS1,Vitamin K-dependent protein S,1513,38,1.54 [0.42-5.60],0.5120444715960664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR4,Proline-rich protein 4,1464,36,1.65 [1.09-2.52],0.0192339019168973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR5,Proline-rich protein 5,1453,37,0.51 [0.22-1.18],0.1176749881204269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRRT3,Proline-rich transmembrane protein 3,1469,38,1.61 [0.81-3.22],0.1774792819857838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS2,Trypsin-2,1743,49,1.17 [0.80-1.70],0.4102790895785072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS22,Brain-specific serine protease 4,1453,37,1.83 [0.84-3.98],0.1286472726053748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,1731,50,2.13 [1.19-3.82],0.0109534291288219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS53,Serine protease 53,1497,38,0.65 [0.28-1.47],0.298239494426128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,1728,49,2.20 [1.30-3.75],0.0034472504889238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,1670,45,0.92 [0.72-1.16],0.4644911118446956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,1751,50,2.45 [1.07-5.61],0.0336041337251793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTN3,Myeloblastin,1691,50,1.43 [0.90-2.27],0.1346806746348337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRUNE2,Protein prune homolog 2,1483,38,0.38 [0.11-1.31],0.1265144506632742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,1499,38,4.78 [1.75-13.05],0.0022812095936126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAPL1,Proactivator polypeptide-like 1,1487,38,0.86 [0.48-1.53],0.6112883587622682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSCA,Prostate stem cell antigen,1487,38,1.08 [0.95-1.22],0.2531218417791936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1718,47,1.51 [1.20-1.90],0.0005192610389079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSIP1,PC4 and SFRS1-interacting protein,1726,49,0.97 [0.66-1.44],0.8978519943109804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMA1,Proteasome subunit alpha type-1,1682,45,1.06 [0.60-1.89],0.833689786711364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMC3,26S proteasome regulatory subunit 6A,1449,38,0.98 [0.40-2.43],0.9674521936156169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,1506,38,0.78 [0.42-1.45],0.43482702251994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,1465,37,1.33 [0.87-2.01],0.1850974231891628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,1733,49,1.27 [0.86-1.87],0.2278376169747224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME1,Proteasome activator complex subunit 1,1717,47,1.29 [0.65-2.55],0.4636320791015377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME2,Proteasome activator complex subunit 2,1706,45,1.26 [0.60-2.63],0.541850917644298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG3,Proteasome assembly chaperone 3,1726,49,1.11 [0.70-1.77],0.6474021809747219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG4,Proteasome assembly chaperone 4,1453,37,1.06 [0.63-1.79],0.821713411386322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSPN,Persephin,1726,49,0.97 [0.77-1.22],0.7692155864911537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSRC1,Proline/serine-rich coiled-coil protein 1,1682,45,1.33 [0.90-1.97],0.1523773454274209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,1434,35,0.85 [0.63-1.14],0.2698343393502972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1670,45,0.90 [0.37-2.17],0.811626169479215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,1724,48,3.83 [2.19-6.71],2.587545286233928e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGES2,Prostaglandin E synthase 2,1442,37,0.93 [0.52-1.68],0.8160917838324085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGR1,Prostaglandin reductase 1,1502,38,0.77 [0.53-1.11],0.1564718884355449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH,Parathyroid hormone,1465,37,0.95 [0.67-1.36],0.7930992464956522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,1726,49,1.45 [0.89-2.36],0.1389600690700178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,1670,45,3.17 [1.73-5.81],0.0001855198718052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTN,Pleiotrophin,1701,48,1.43 [0.86-2.36],0.1701574866198991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,1453,37,1.48 [0.82-2.66],0.1964137217690805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,1718,47,0.94 [0.67-1.33],0.7440116939158503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,1733,49,0.97 [0.73-1.29],0.8298454342256523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,1453,37,1.26 [0.53-2.99],0.6075442677280543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,1502,38,1.88 [0.68-5.17],0.2204849896041574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,1508,38,2.26 [0.62-8.26],0.2163811493684288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,1753,50,1.09 [0.49-2.43],0.8393672935955767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,1487,38,0.84 [0.45-1.58],0.5896486010094218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,1487,38,1.79 [0.74-4.35],0.1964533593817189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,1723,49,0.42 [0.16-1.11],0.080609057882586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1713,47,2.55 [1.57-4.16],0.0001566313251731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,1497,38,1.18 [0.53-2.64],0.6912626536156532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,1753,50,1.23 [0.48-3.15],0.6663062509939301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,1502,38,1.17 [0.45-3.04],0.7458128623808762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,1479,37,0.84 [0.50-1.44],0.5308563108598665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,1661,45,0.92 [0.63-1.36],0.6775186608958939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTTG1,Securin,1483,38,0.57 [0.25-1.27],0.1677591906878064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTX3,Pentraxin-related protein PTX3,1726,49,1.69 [0.93-3.06],0.0860078434225606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVALB,Parvalbumin alpha,1742,50,1.10 [0.88-1.38],0.4068575285410775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,1748,49,1.85 [1.04-3.30],0.0361089014742453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXDNL,Peroxidasin-like protein,1498,38,1.51 [1.11-2.06],0.0088023912441413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXN,Paxillin,1670,45,1.64 [1.10-2.44],0.0153590300396687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYDC1,Pyrin domain-containing protein 1,1469,38,0.83 [0.39-1.77],0.6338178579040945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,1448,37,1.45 [1.13-1.85],0.0036815587900424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PZP,Pregnancy zone protein,1513,38,0.63 [0.38-1.04],0.0688407301492118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QDPR,Dihydropteridine reductase,1730,50,1.06 [0.60-1.89],0.8348664757143442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,1738,50,2.01 [0.83-4.89],0.1235062746382425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QSOX1,Sulfhydryl oxidase 1,1480,36,1.23 [0.57-2.67],0.596622290345478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB10,Ras-related protein Rab-10,1502,38,0.91 [0.51-1.60],0.7365791620806535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB11FIP3,Rab11 family-interacting protein 3,1502,38,0.94 [0.71-1.26],0.6994639053975427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB27B,Ras-related protein Rab-27B,1502,38,1.00 [0.67-1.50],0.998280622472547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB2B,Ras-related protein Rab-2B,1498,38,0.77 [0.46-1.29],0.3185271160193701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB33A,Ras-related protein Rab-33A,1448,37,0.74 [0.45-1.23],0.2473639708857752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB37,Ras-related protein Rab-37,1687,47,1.10 [0.83-1.48],0.5017617130043959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB39B,Ras-related protein Rab-39B,1448,37,0.69 [0.39-1.21],0.1921486365743052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,1441,37,1.25 [0.84-1.86],0.2758531733621064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB44,Ras-related protein Rab-44,1498,38,1.12 [0.69-1.85],0.6411966261764876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,1726,49,0.43 [0.26-0.72],0.0011277906128846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6B,Ras-related protein Rab-6B,1670,45,0.88 [0.50-1.56],0.6649098274418147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEP1,Rab GTPase-binding effector protein 1,1479,37,0.83 [0.54-1.25],0.3647043727956706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEPK,Rab9 effector protein with kelch motifs,1682,45,0.97 [0.61-1.56],0.9144820900102294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABGAP1L,Rab GTPase-activating protein 1-like,1687,47,1.04 [0.69-1.57],0.8356850681515432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAC3,Ras-related C3 botulinum toxin substrate 3,1465,37,0.74 [0.42-1.30],0.292359249993488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD23B,UV excision repair protein RAD23 homolog B,1682,45,1.11 [0.62-1.99],0.7160753178781447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD51,DNA repair protein RAD51 homolog 1,1483,38,1.11 [0.60-2.03],0.7426153389617074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALB,Ras-related protein Ral-B,1453,37,0.96 [0.32-2.91],0.949363014037654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALY,RNA-binding protein Raly,1498,38,1.16 [0.68-1.97],0.5902368019564903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP1,Ran-specific GTPase-activating protein,1469,38,1.09 [0.62-1.92],0.7621389818937099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP2,E3 SUMO-protein ligase RanBP2,1441,37,0.80 [0.29-2.20],0.659557915686656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANGAP1,Ran GTPase-activating protein 1,1682,45,1.15 [0.69-1.92],0.584555170151514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAP1A,Ras-related protein Rap-1A,1453,37,1.22 [0.89-1.69],0.2180451925546114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,1483,38,0.75 [0.40-1.41],0.3734279275099506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES1,Retinoic acid receptor responder protein 1,1682,45,1.17 [0.58-2.37],0.6593190216112329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,1744,49,1.89 [1.16-3.09],0.0107498114953455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASA1,Ras GTPase-activating protein 1,1670,45,0.71 [0.31-1.65],0.4305977920756446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,1449,38,0.88 [0.42-1.81],0.7212681223089359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASSF2,Ras association domain-containing protein 2,1682,45,1.26 [0.92-1.72],0.1524705310462916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,1506,38,1.81 [1.17-2.79],0.0071859459267981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBKS,Ribokinase,1692,46,0.89 [0.56-1.42],0.6327732524536642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM17,Splicing factor 45,1506,38,1.12 [0.75-1.66],0.5766364630563433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM19,Probable RNA-binding protein 19,1448,37,1.18 [0.57-2.43],0.6565372793643698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM25,RNA-binding protein 25,1449,38,0.55 [0.25-1.19],0.1298452245535434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP1,Retinol-binding protein 1,1465,37,1.19 [0.84-1.69],0.3304254672301764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,1733,49,1.67 [1.23-2.28],0.0011555530878503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP5,Retinol-binding protein 5,1733,49,1.33 [0.92-1.91],0.1265333381326038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP7,Retinoid-binding protein 7,1487,38,1.55 [1.08-2.22],0.0171352605846259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS,RNA-binding protein with multiple splicing,1453,37,1.07 [0.67-1.71],0.7870376398079818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS2,RNA-binding protein with multiple splicing 2,1469,38,0.86 [0.62-1.18],0.3411967368478169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCC1,Regulator of chromosome condensation,1498,38,1.37 [0.89-2.12],0.1517814674468718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCOR1,REST corepressor 1,1701,48,1.31 [0.87-1.97],0.1929518398658205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,1469,38,0.82 [0.16-4.09],0.8040761055713228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REEP4,Receptor expression-enhancing protein 4,1506,38,0.98 [0.58-1.64],0.9273542080821986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,1730,48,1.87 [1.33-2.62],0.0002711016034757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,1753,50,1.44 [1.05-1.98],0.0231101991151088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,1753,50,1.26 [0.90-1.76],0.1720036549334426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3G,Regenerating islet-derived protein 3-gamma,1498,38,1.66 [0.94-2.93],0.0789723120169982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,1730,49,2.51 [1.73-3.64],1.4234728445821545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELB,Transcription factor RelB,1453,37,1.53 [0.97-2.43],0.0692939692963028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,1741,50,3.33 [1.71-6.50],0.0004173515856746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,1735,50,1.49 [1.20-1.86],0.0003618491320191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REPS1,RalBP1-associated Eps domain-containing protein 1,1453,37,0.54 [0.21-1.36],0.1910590370235045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REST,RE1-silencing transcription factor,1449,38,1.24 [0.52-3.00],0.6290291507354258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,1733,49,0.76 [0.43-1.35],0.345669666114588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RETN,Resistin,1732,50,1.54 [0.92-2.58],0.1026127469182153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REXO2,"Oligoribonuclease, mitochondrial",1448,37,1.15 [0.65-2.06],0.628604124341744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RFC4,Replication factor C subunit 4,1498,38,0.89 [0.22-3.62],0.8730512617304609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGCC,Regulator of cell cycle RGCC,1506,38,0.86 [0.57-1.29],0.4643532122044927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,1483,38,0.79 [0.44-1.40],0.4119955302182205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMA,Repulsive guidance molecule A,1748,49,1.58 [0.74-3.37],0.2384222620257255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,1748,49,2.39 [1.10-5.18],0.0275675427652322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS10,Regulator of G-protein signaling 10,1506,38,0.79 [0.46-1.37],0.4089402992514424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS8,Regulator of G-protein signaling 8,1687,47,0.98 [0.64-1.48],0.9157806100693636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RHOC,Rho-related GTP-binding protein RhoC,1709,46,1.01 [0.80-1.27],0.9219490413920944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RICTOR,Rapamycin-insensitive companion of mTOR,1453,37,0.77 [0.37-1.59],0.4794408081888639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,1479,37,1.45 [0.89-2.37],0.1341786188694577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILP,Rab-interacting lysosomal protein,1744,50,1.09 [0.73-1.64],0.6745051050230684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILPL2,RILP-like protein 2,1502,38,0.90 [0.65-1.24],0.5082961627446525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,1448,37,1.49 [1.08-2.05],0.0140878470803515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN1,Prorelaxin H1,1506,38,1.29 [0.95-1.74],0.1013366223972058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN2,Prorelaxin H2,1474,37,1.02 [0.72-1.43],0.9175658312614692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,1511,38,3.86 [1.53-9.72],0.0041204255670452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE10,Inactive ribonuclease-like protein 10,1469,38,1.51 [0.85-2.70],0.1609650402602088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE3,Eosinophil cationic protein,1728,50,0.93 [0.74-1.18],0.5607562528502363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,1455,38,3.56 [1.27-9.93],0.0154471301737809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,1497,37,2.50 [1.21-5.20],0.0138198248026745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASEH2A,Ribonuclease H2 subunit A,1506,38,1.01 [0.55-1.84],0.9719840113215952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,1747,50,2.48 [1.55-3.96],0.0001448548847196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,1469,38,3.51 [1.63-7.56],0.0013761693504576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF168,E3 ubiquitin-protein ligase RNF168,1453,37,0.59 [0.22-1.59],0.2961109572496856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF31,E3 ubiquitin-protein ligase RNF31,1453,37,0.72 [0.26-1.98],0.5298236884571137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF4,E3 ubiquitin-protein ligase RNF4,1483,38,1.15 [0.75-1.75],0.5200376660968604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF41,E3 ubiquitin-protein ligase NRDP1,1682,45,0.91 [0.61-1.36],0.6391748006007507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF43,E3 ubiquitin-protein ligase RNF43,1483,38,0.98 [0.56-1.70],0.9358316122119146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF5,E3 ubiquitin-protein ligase RNF5,1469,38,0.77 [0.50-1.19],0.2392694648717097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO1,Roundabout homolog 1,1730,49,0.96 [0.44-2.12],0.923904584042712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO2,Roundabout homolog 2,1748,49,1.16 [0.41-3.27],0.7833663494230982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO4,Roundabout homolog 4,1469,38,0.68 [0.12-3.88],0.6674532070349212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1735,50,1.61 [0.78-3.32],0.2009622852391593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RP2,Protein XRP2,1733,49,0.75 [0.41-1.38],0.3543443389851544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPA2,Replication protein A 32 kDa subunit,1453,37,0.66 [0.21-2.10],0.4864015162769024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPE,Ribulose-phosphate 3-epimerase,1483,38,1.31 [0.90-1.92],0.1624743340124926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,1465,37,0.97 [0.50-1.87],0.9243625095847872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPL14,60S ribosomal protein L14,1469,38,1.21 [0.70-2.10],0.4974895390085269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPS10,40S ribosomal protein S10,1448,37,1.04 [0.51-2.16],0.9069784935720544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRAS,Ras-related protein R-Ras,1465,37,0.93 [0.72-1.19],0.5506632643171206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,1682,45,0.81 [0.46-1.43],0.4671072531607768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,1682,45,0.67 [0.45-1.01],0.0531289601372451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRP15,RRP15-like protein,1441,37,0.98 [0.70-1.37],0.923220334904422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO1,R-spondin-1,1718,47,1.70 [0.87-3.35],0.1222147372837259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,1751,50,2.67 [1.36-5.24],0.0043428932634299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTBDN,Retbindin,1733,49,1.66 [0.90-3.06],0.1035560282627012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTKN2,Rhotekin-2,1448,37,0.99 [0.55-1.80],0.9780089680071526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",1506,38,0.85 [0.60-1.21],0.3709746385448513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,1751,50,2.36 [1.16-4.81],0.0178452303559645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RUVBL1,RuvB-like 1,1682,45,1.00 [0.78-1.29],0.9737724599484016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RWDD1,RWD domain-containing protein 1,1748,49,1.02 [0.69-1.52],0.9135096062807254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RYR1,Ryanodine receptor 1,1448,37,1.34 [0.60-3.02],0.4754902721892773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A11,Protein S100-A11,1721,49,1.11 [0.69-1.79],0.6556313379557691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A12,Protein S100-A12,1718,47,1.21 [0.87-1.68],0.2564311610906584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A13,Protein S100-A13,1453,37,1.05 [0.43-2.58],0.9105447284975794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A14,Protein S100-A14,1506,38,0.56 [0.30-1.07],0.0798635278657571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A16,Protein S100-A16,1669,45,1.28 [0.85-1.93],0.2323243014864889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A3,Protein S100-A3,1498,38,1.09 [0.61-1.97],0.7644275391154258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A4,Protein S100-A4,1741,50,0.83 [0.54-1.28],0.3983728488364511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100G,Protein S100-G,1506,38,1.25 [0.68-2.29],0.477277654125969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,1701,48,1.65 [1.21-2.26],0.0015276194609314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAA4,Serum amyloid A-4 protein,1513,38,0.62 [0.11-3.39],0.5841225776749897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAFB2,Scaffold attachment factor B2,1506,38,1.13 [0.34-3.78],0.8377257764532459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAG,S-arrestin,1441,37,1.31 [0.86-2.01],0.2138480024295829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,1726,49,0.92 [0.64-1.31],0.6304628991642838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAP18,Histone deacetylase complex subunit SAP18,1483,38,0.84 [0.53-1.34],0.4695857705867535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SARG,Specifically androgen-regulated gene protein,1499,38,1.06 [0.80-1.40],0.6889265535146212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,1448,37,1.30 [0.64-2.65],0.463954799469325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT1,Diamine acetyltransferase 1,1448,37,1.00 [0.56-1.76],0.9884925599683848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT2,Thialysine N-epsilon-acetyltransferase,1483,38,0.64 [0.37-1.12],0.1191597774692242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SATB1,DNA-binding protein SATB1,1506,38,1.95 [0.93-4.11],0.0773636974683866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SBSN,Suprabasin,1503,38,0.52 [0.22-1.22],0.1300825776629295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCAMP3,Secretory carrier-associated membrane protein 3,1733,49,0.98 [0.72-1.33],0.8987923217587352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,1748,49,5.25 [2.89-9.54],5.27779183570103e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB1,Scavenger receptor class B member 1,1670,45,0.84 [0.51-1.39],0.4889237730138884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,1680,46,3.38 [2.04-5.63],2.570322189774244e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF1,Scavenger receptor class F member 1,1753,50,1.09 [0.61-1.96],0.762382517146257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,1748,49,4.89 [2.43-9.85],9.024179437501008e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,1743,50,3.62 [1.98-6.63],2.976894329702498e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,1730,49,2.13 [1.06-4.28],0.0331741550521815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,1735,49,1.97 [1.24-3.15],0.0043977307764901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB2A2,Mammaglobin-A,1448,37,0.42 [0.12-1.50],0.1831940453760326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A1,Secretoglobin family 3A member 1,1479,37,1.20 [0.34-4.23],0.774798013132068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A2,Secretoglobin family 3A member 2,1733,49,0.97 [0.76-1.25],0.8343081516051837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,1687,47,2.80 [1.78-4.40],8.26642881481056e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCIN,Adseverin,1441,37,0.91 [0.57-1.44],0.6772515826868273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCLY,Selenocysteine lyase,1744,50,0.80 [0.50-1.28],0.351767841550444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2A,Sodium channel protein type 2 subunit alpha,1441,37,1.07 [0.57-2.00],0.8360637891266356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2B,Sodium channel subunit beta-2,1465,37,1.25 [0.47-3.32],0.6501447860807494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3A,Sodium channel protein type 3 subunit alpha,1465,37,0.72 [0.28-1.91],0.5145521957024441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3B,Sodium channel subunit beta-3,1441,37,1.00 [0.55-1.82],0.9987975215747366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN4B,Sodium channel subunit beta-4,1469,38,0.93 [0.48-1.81],0.8349223013878456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCP2,Non-specific lipid-transfer protein,1682,45,1.13 [0.83-1.56],0.434942849043885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,1464,38,1.07 [0.59-1.95],0.8246448575567348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,1502,38,2.83 [1.17-6.86],0.0215402848677055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRIB,Protein scribble homolog,1469,38,0.94 [0.65-1.37],0.7586641514975694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRN1,Secernin-1,1726,49,0.83 [0.53-1.32],0.439842731572818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCT,Secretin,1465,37,1.30 [0.69-2.47],0.4143415480907632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC1,Syndecan-1,1735,50,1.12 [0.64-1.95],0.7008231383113048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC4,Syndecan-4,1735,50,0.61 [0.36-1.03],0.0657043207551534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDCCAG8,Serologically defined colon cancer antigen 8,1498,38,0.88 [0.66-1.17],0.3705773152683147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDHB,Succinate dehydrogenase,1487,38,0.80 [0.49-1.33],0.3940901417794789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDK2,Protein sidekick-2,1479,37,0.99 [0.46-2.10],0.9726998890017796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEC31A,Protein transport protein Sec31A,1469,38,0.92 [0.60-1.41],0.7050493623011453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEL1L,Protein sel-1 homolog 1,1469,38,1.24 [0.58-2.65],0.5864636030999988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELE,E-selectin,1753,50,0.79 [0.51-1.22],0.2827310696852841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELENOP,Selenoprotein P,1513,38,0.47 [0.14-1.55],0.2155109341968486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELL,L-selectin,1513,38,0.47 [0.14-1.54],0.2120300750644108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELP,P-selectin,1743,49,1.03 [0.66-1.62],0.8832827961051875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELPLG,P-selectin glycoprotein ligand 1,1726,49,1.42 [0.59-3.42],0.4343519107162967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3F,Semaphorin-3F,1735,50,0.96 [0.40-2.32],0.9303304814161276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3G,Semaphorin-3G,1479,37,0.77 [0.38-1.56],0.4718179316486613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4C,Semaphorin-4C,1733,49,0.83 [0.34-2.05],0.6852298958330867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4D,Semaphorin-4D,1748,49,0.78 [0.32-1.87],0.5699248747281254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA6C,Semaphorin-6C,1453,37,1.72 [0.60-4.91],0.3139940760917362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA7A,Semaphorin-7A,1748,50,1.61 [0.81-3.19],0.1727261105342074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN3,Neuronal-specific septin-3,1506,38,0.61 [0.40-0.95],0.0293776517959423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN7,Septin-7,1483,38,0.89 [0.46-1.72],0.7280657670045245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,1495,37,1.74 [0.93-3.28],0.0840995877779544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN9,Septin-9,1733,49,0.78 [0.32-1.90],0.584862461466501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA1,Alpha-1-antitrypsin,1483,37,4.30 [0.10-182.57],0.446169265269539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA11,Serpin A11,1753,50,1.20 [0.67-2.16],0.5403779838719305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA12,Serpin A12,1695,50,0.85 [0.65-1.11],0.2286167512638125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA3,Alpha-1-antichymotrypsin,1507,38,0.59 [0.09-3.90],0.5840092475465397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA4,Kallistatin,1474,35,1.59 [0.43-5.81],0.4850328405111249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA5,Plasma serine protease inhibitor,1489,36,1.93 [0.85-4.39],0.1176633469096564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA6,Corticosteroid-binding globulin,1513,38,1.77 [0.31-10.05],0.5217154121942705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA7,Thyroxine-binding globulin,1513,38,0.86 [0.17-4.39],0.8535673716399601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA9,Serpin A9,1721,49,1.07 [0.77-1.49],0.6726131635336227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB1,Leukocyte elastase inhibitor,1737,50,1.02 [0.77-1.34],0.8861164283061637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB5,Serpin B5,1701,48,1.48 [0.88-2.47],0.1365795298200335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB6,Serpin B6,1743,49,1.06 [0.69-1.62],0.7936978226603966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB8,Serpin B8,1751,50,1.22 [0.90-1.67],0.2048127796262628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB9,Serpin B9,1718,47,1.82 [0.78-4.28],0.1688587980608806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINC1,Antithrombin-III,1508,37,1.66 [0.26-10.68],0.5936124840332178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPIND1,Heparin cofactor 2,1508,37,3.60 [1.19-10.95],0.0238662850668327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE1,Plasminogen activator inhibitor 1,1753,50,0.85 [0.57-1.25],0.3959676315390679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE2,Glia-derived nexin,1502,38,1.02 [0.64-1.64],0.919759137015298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,1482,37,3.00 [1.05-8.56],0.0401198530298512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF2,Alpha-2-antiplasmin,1477,36,1.71 [0.19-15.14],0.6307819615235524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPING1,Plasma protease C1 inhibitor,1508,37,7.05 [1.41-35.33],0.0175460603002739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINH1,Serpin H1,1483,38,0.97 [0.76-1.23],0.8074706408939474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI1,Neuroserpin,1475,37,1.07 [0.48-2.42],0.8639582157723205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI2,Serpin I2,1487,38,1.23 [0.72-2.07],0.4481039289642076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,1670,45,0.97 [0.64-1.47],0.8885213130993537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,1711,47,0.97 [0.39-2.39],0.9444575320188956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6,Seizure protein 6 homolog,1465,37,0.79 [0.29-2.16],0.6499190366257509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L,Seizure 6-like protein,1741,50,1.80 [0.81-4.01],0.147908405471123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L2,Seizure 6-like protein 2,1733,49,1.48 [0.54-4.09],0.4469999896620308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SF3B4,Splicing factor 3B subunit 4,1733,49,1.13 [0.81-1.59],0.4590803161772583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,1714,47,2.01 [1.24-3.25],0.0046474979864217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP4,Secreted frizzled-related protein 4,1479,37,0.92 [0.45-1.90],0.831430522614357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA1,Pulmonary surfactant-associated protein A1,1682,45,1.13 [0.75-1.72],0.549284237105619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA2,Pulmonary surfactant-associated protein A2,1682,45,0.86 [0.51-1.45],0.5729275597558248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPD,Pulmonary surfactant-associated protein D,1735,50,1.09 [0.75-1.59],0.6378615087915858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SGSH,N-sulphoglucosamine sulphohydrolase,1479,38,1.48 [0.92-2.38],0.1102937096285571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2B3,SH2B adapter protein 3,1682,45,0.92 [0.70-1.21],0.5546101319371537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2D1A,SH2 domain-containing protein 1A,1726,49,1.10 [0.71-1.71],0.6744259473683899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,1441,37,0.93 [0.53-1.65],0.815808043195779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BP1,SH3 domain-binding protein 1,1487,38,0.89 [0.45-1.74],0.724173687014358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GL3,Endophilin-A3,1471,38,1.20 [0.83-1.73],0.334448600535289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GLB2,Endophilin-B2,1497,38,1.23 [0.79-1.91],0.3689458268457973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHBG,Sex hormone-binding globulin,1511,38,1.22 [0.75-2.00],0.4221925819155988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHC1,SHC-transforming protein 1,1449,38,1.06 [0.81-1.37],0.6870335299081209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHD,SH2 domain-containing adapter protein D,1444,37,1.13 [0.86-1.48],0.3849229936138497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHH,Sonic hedgehog protein,1453,37,0.68 [0.30-1.54],0.3566225780337807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,1508,38,3.84 [1.79-8.22],0.0005411551050615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",1733,49,0.93 [0.69-1.25],0.6342869434277856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHPK,Sedoheptulokinase,1483,38,1.04 [0.51-2.10],0.9208760192381408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIAE,Sialate O-acetylesterase,1740,50,1.40 [0.83-2.37],0.2101364245292168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,1738,49,1.30 [0.75-2.25],0.3524523658713285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,1726,49,1.76 [0.89-3.49],0.1039221255812519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,1670,45,1.17 [0.89-1.55],0.2702694099613429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,1741,50,0.99 [0.80-1.24],0.9586849986183033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,1751,50,1.80 [0.88-3.71],0.1079790511572745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,1735,50,1.23 [0.52-2.91],0.6424636399169101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,1469,38,1.02 [0.52-1.98],0.956127456413664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,1749,50,0.55 [0.25-1.22],0.1390574366293728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIL1,Nucleotide exchange factor SIL1,1469,38,1.81 [0.93-3.52],0.0814162572411957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,1731,50,1.11 [0.71-1.72],0.645544187574896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,1725,49,1.31 [0.78-2.21],0.3125494814446767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,1453,37,1.00 [0.66-1.51],0.9973551401937182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,1733,49,1.09 [0.82-1.46],0.5433856920860791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",1670,45,1.10 [0.73-1.64],0.6559690924010105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,1687,47,1.59 [1.02-2.48],0.0417451799993038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP1,Src kinase-associated phosphoprotein 1,1714,47,1.13 [0.79-1.61],0.5107456126037343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP2,Src kinase-associated phosphoprotein 2,1738,49,0.93 [0.72-1.19],0.5688323003054241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKIV2L,Helicase SKI2W,1448,37,1.48 [0.85-2.58],0.1658500244941727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLA2,Src-like-adapter 2,1506,38,1.03 [0.76-1.39],0.8713407637596855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF1,Signaling lymphocytic activation molecule,1687,47,1.00 [0.65-1.55],0.9967823611162148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF6,SLAM family member 6,1682,45,1.28 [0.68-2.41],0.448455622867864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF7,SLAM family member 7,1726,49,1.37 [0.92-2.04],0.1212315413828063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF8,SLAM family member 8,1682,45,1.03 [0.64-1.65],0.906107387830863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC12A2,Solute carrier family 12 member 2,1448,37,0.64 [0.19-2.17],0.4697067564310739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC13A1,Solute carrier family 13 member 1,1498,38,1.30 [0.80-2.11],0.294296350738361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC16A1,Monocarboxylate transporter 1,1670,45,1.31 [0.93-1.86],0.1223710340443255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC1A4,Neutral amino acid transporter A,1465,37,0.71 [0.35-1.44],0.3384570961967709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC27A4,Long-chain fatty acid transport protein 4,1670,45,0.82 [0.51-1.33],0.4243553753193745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC28A1,Sodium/nucleoside cotransporter 1,1449,38,1.15 [0.72-1.83],0.54948499745421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,1449,38,1.04 [0.53-2.04],0.9180119312915992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,1670,45,1.73 [1.18-2.53],0.0045968049882555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A5,Zinc transporter ZIP5,1726,49,1.52 [0.92-2.50],0.1001440263542461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC44A4,Choline transporter-like protein 4,1465,37,0.98 [0.65-1.48],0.9155572972083909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC4A1,Band 3 anion transport protein,1508,38,1.54 [0.84-2.82],0.1620766373975743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC51B,Organic solute transporter subunit beta,1448,37,1.12 [0.73-1.72],0.6083453675062361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,1479,37,0.96 [0.66-1.40],0.8356689498682079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,1487,38,1.23 [0.80-1.91],0.3422284280653489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",1449,38,0.89 [0.51-1.56],0.6810896746598085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIT2,Slit homolog 2 protein,1670,45,0.93 [0.55-1.57],0.7975523499048598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK1,SLIT and NTRK-like protein 1,1453,37,0.79 [0.29-2.20],0.6566619167723504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK2,SLIT and NTRK-like protein 2,1751,50,1.39 [0.73-2.64],0.3174253560389543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,1701,48,2.30 [1.17-4.55],0.0160602241987994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLK,STE20-like serine/threonine-protein kinase,1483,38,0.73 [0.43-1.25],0.2533542709258974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLMAP,Sarcolemmal membrane-associated protein,1487,38,0.83 [0.57-1.22],0.3371949057496244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,1491,38,0.98 [0.46-2.09],0.9669509652576184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD1,Mothers against decapentaplegic homolog 1,1682,45,1.02 [0.74-1.39],0.9165095903596208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD2,Mothers against decapentaplegic homolog 2,1498,38,0.95 [0.62-1.45],0.8113007130698655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD3,Mothers against decapentaplegic homolog 3,1498,38,0.67 [0.35-1.28],0.2264568772626675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD5,Mothers against decapentaplegic homolog 5,1733,49,0.54 [0.15-1.95],0.3444294936730395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMARCA2,Probable global transcription activator SNF2L2,1670,45,1.46 [1.11-1.92],0.0066857308280658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMC3,Structural maintenance of chromosomes protein 3,1449,38,1.01 [0.58-1.77],0.9761189085897308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,1487,38,1.18 [0.77-1.80],0.4424669498316681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,1751,50,3.29 [1.61-6.73],0.0011171212099082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,1738,49,2.14 [1.30-3.51],0.0025976050504285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD1,Sphingomyelin phosphodiesterase,1736,49,1.61 [1.00-2.59],0.0493306757513609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD3,Sphingomyelin phosphodiesterase 3,1453,37,0.73 [0.33-1.60],0.4317624195087096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,1737,49,1.02 [0.69-1.50],0.915525877341358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,1498,38,0.75 [0.44-1.28],0.2947182958041814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMS,Spermine synthase,1441,37,0.91 [0.55-1.49],0.6986626074450029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMTN,Smoothelin,1494,38,0.83 [0.58-1.19],0.3043609429572823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP23,Synaptosomal-associated protein 23,1735,50,0.88 [0.66-1.18],0.4004777118184089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP25,Synaptosomal-associated protein 25,1441,37,1.14 [0.62-2.08],0.671394286857938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP29,Synaptosomal-associated protein 29,1741,50,1.00 [0.75-1.32],0.9785727598573892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAPIN,SNARE-associated protein Snapin,1506,38,0.96 [0.56-1.63],0.86840396991337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCA,Alpha-synuclein,1479,37,1.07 [0.82-1.40],0.614861795493118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,1718,47,1.91 [1.36-2.67],0.0001655235394771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",1469,38,0.83 [0.35-1.97],0.6716716169138759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',1497,38,1.18 [0.75-1.87],0.4757639585109421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNU13,NHP2-like protein 1,1448,37,1.29 [0.82-2.02],0.2682550437982237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX15,Sorting nexin-15,1479,37,1.09 [0.63-1.88],0.7635102465154351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX18,Sorting nexin-18,1487,38,1.39 [0.83-2.34],0.2144659114614462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX2,Sorting nexin-2,1498,38,1.22 [0.86-1.74],0.2690107814337964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX5,Sorting nexin-5,1469,38,0.66 [0.23-1.90],0.4402198669583735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX9,Sorting nexin-9,1735,50,1.02 [0.71-1.47],0.9124364231631116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD1,Superoxide dismutase [Cu-Zn],1700,45,1.39 [0.84-2.32],0.2034545286822571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",1741,50,0.78 [0.45-1.35],0.3665643922831745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD3,Extracellular superoxide dismutase,1511,38,0.87 [0.46-1.62],0.6525427573122109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORBS1,Sorbin and SH3 domain-containing protein 1,1506,38,1.20 [0.67-2.16],0.5360511981180559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,1682,45,2.77 [1.50-5.13],0.0011706110394719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORD,Sorbitol dehydrogenase,1741,50,0.93 [0.66-1.30],0.6767813695764393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORT1,Sortilin,1735,50,1.12 [0.59-2.13],0.731467962483333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOST,Sclerostin,1735,50,0.94 [0.50-1.75],0.8442415879924461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,1465,37,0.85 [0.42-1.73],0.6582275902748783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX2,Transcription factor SOX-2,1503,37,0.83 [0.21-3.24],0.791475503462911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX9,Transcription factor SOX-9,1465,37,1.56 [0.46-5.25],0.4747016964537779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,1506,38,1.17 [0.42-3.24],0.7584921439023689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPAG1,Sperm-associated antigen 1,1506,38,0.57 [0.31-1.03],0.0618997473802302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARC,SPARC,1741,50,1.02 [0.71-1.47],0.9079911970837534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARCL1,SPARC-like protein 1,1732,49,1.36 [0.58-3.18],0.477143144669658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPART,Spartin,1479,37,0.89 [0.58-1.36],0.5996354597741673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,1502,38,2.86 [1.06-7.68],0.0372504248610743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,1741,50,1.91 [1.37-2.66],0.000140280774206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK2,Serine protease inhibitor Kazal-type 2,1479,37,1.28 [0.59-2.75],0.5303161726359205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,1726,49,2.54 [1.88-3.43],1.190458829849791e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK5,Serine protease inhibitor Kazal-type 5,1741,50,1.15 [0.54-2.44],0.7187315069770117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK6,Serine protease inhibitor Kazal-type 6,1751,50,1.02 [0.65-1.60],0.9379801602770153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK8,Serine protease inhibitor Kazal-type 8,1448,37,0.47 [0.17-1.28],0.1378797848376581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT1,Kunitz-type protease inhibitor 1,1737,50,0.90 [0.36-2.26],0.8280004826071731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,1738,49,1.52 [0.82-2.82],0.184542731370254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT3,Kunitz-type protease inhibitor 3,1487,38,0.97 [0.76-1.22],0.773824748655521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPOCK1,Testican-1,1718,47,0.68 [0.27-1.68],0.3984977098646278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,1730,49,1.70 [0.88-3.29],0.1137958916684091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,1729,49,2.80 [1.59-4.94],0.0003652787812564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPP1,Osteopontin,1751,50,1.50 [0.94-2.39],0.0869781186652002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",1453,37,0.70 [0.30-1.64],0.4154505646215047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRING1,SREBP regulating gene protein,1449,38,1.19 [0.72-1.97],0.5038147750826387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR1B,Cornifin-B,1483,38,1.13 [0.86-1.48],0.3744802857097725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR3,Small proline-rich protein 3,1497,38,1.27 [0.86-1.88],0.2222469394067243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRY2,Protein sprouty homolog 2,1687,47,0.87 [0.65-1.16],0.3381409544622817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",1441,37,1.04 [0.46-2.33],0.9312900166544232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTLC1,Serine palmitoyltransferase 1,1497,38,0.53 [0.19-1.49],0.2301785211106513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRC,Proto-oncogene tyrosine-protein kinase Src,1737,50,0.97 [0.79-1.20],0.7766826356234943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRP14,Signal recognition particle 14 kDa protein,1733,49,1.25 [0.84-1.87],0.2663018846479141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPK2,SRSF protein kinase 2,1726,49,0.89 [0.65-1.21],0.4615876042105286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPX,Sushi repeat-containing protein SRPX,1502,38,1.85 [0.86-3.99],0.1177041949268275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSB,Lupus La protein,1670,45,1.05 [0.69-1.59],0.8165796032901692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",1453,37,0.57 [0.20-1.59],0.2795523022852391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,1735,50,0.85 [0.69-1.05],0.1254665630923977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,1743,49,1.02 [0.56-1.86],0.9419146448501502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSH3,Protein phosphatase Slingshot homolog 3,1449,38,0.84 [0.27-2.59],0.757021397469262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,1487,38,0.94 [0.54-1.65],0.8250648174563275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST13,Hsc70-interacting protein,1479,37,0.96 [0.56-1.65],0.8866530580723853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1733,49,1.88 [1.12-3.15],0.0168032040188213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",1753,50,2.18 [0.94-5.05],0.0703470391592306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",1453,37,1.69 [1.12-2.55],0.0122202251496562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAB2,Stabilin-2,1508,38,1.57 [0.52-4.75],0.4265157986178387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAM,Signal transducing adapter molecule 1,1498,38,0.89 [0.38-2.10],0.7987449919738293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAMBP,STAM-binding protein,1714,47,1.09 [0.73-1.62],0.6670490655117437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT2,Signal transducer and activator of transcription 2,1453,37,0.89 [0.57-1.37],0.587826378545355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT5B,Signal transducer and activator of transcription 5B,1733,49,0.97 [0.81-1.16],0.7184609234623133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,1449,38,1.20 [0.83-1.74],0.3407746239327028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,1748,49,2.31 [1.42-3.74],0.0006800799417645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC2,Stanniocalcin-2,1737,48,1.07 [0.41-2.82],0.8867362681211614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STEAP4,Metalloreductase STEAP4,1441,37,1.03 [0.68-1.56],0.871591257674432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STIP1,Stress-induced-phosphoprotein 1,1738,50,0.97 [0.67-1.41],0.8680077479804028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK11,Serine/threonine-protein kinase STK11,1701,48,0.98 [0.69-1.40],0.9140783753354308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK24,Serine/threonine-protein kinase 24,1670,45,0.89 [0.57-1.39],0.6051694998679255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK4,Serine/threonine-protein kinase 4,1735,50,0.86 [0.64-1.16],0.3301559247816669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STOML2,"Stomatin-like protein 2, mitochondrial",1449,38,0.96 [0.69-1.33],0.8049890211723467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX16,Syntaxin-16,1682,45,0.64 [0.38-1.07],0.0857472105210194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX1B,Syntaxin-1B,1465,37,1.34 [0.78-2.29],0.2948068700628942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX3,Syntaxin-3,1497,38,0.80 [0.32-1.99],0.6357616456321238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX4,Syntaxin-4,1733,49,1.13 [0.76-1.68],0.5362898823372394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX5,Syntaxin-5,1453,37,1.32 [0.80-2.18],0.2697137484528601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX6,Syntaxin-6,1682,45,0.79 [0.49-1.27],0.3283345105332333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX7,Syntaxin-7,1453,37,1.55 [0.80-3.01],0.198880013804704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX8,Syntaxin-8,1726,49,0.94 [0.56-1.60],0.8283396720576675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP1,Syntaxin-binding protein 1,1506,38,0.79 [0.53-1.18],0.2492633228390622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP3,Syntaxin-binding protein 3,1682,45,0.65 [0.32-1.30],0.2184077455251316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGP1,SURP and G-patch domain-containing protein 1,1487,38,0.71 [0.31-1.60],0.4040907432200283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGT1,Protein SGT1 homolog,1682,45,0.91 [0.66-1.26],0.5759470804798368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT1A1,Sulfotransferase 1A1,1748,49,0.90 [0.75-1.09],0.3006162650002996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT2A1,Bile salt sulfotransferase,1726,49,0.98 [0.68-1.40],0.90428647420588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF1,Formylglycine-generating enzyme,1453,37,0.86 [0.48-1.54],0.6060800074823323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,1748,49,1.25 [0.76-2.06],0.3851024199637379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUOX,"Sulfite oxidase, mitochondrial",1506,38,1.11 [0.72-1.71],0.6219571867853642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD1,Sushi domain-containing protein 1,1701,48,0.78 [0.46-1.33],0.3601180011548366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD2,Sushi domain-containing protein 2,1741,50,1.13 [0.49-2.59],0.771102339993506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD4,Sushi domain-containing protein 4,1498,38,1.16 [0.64-2.12],0.6285606669383079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD5,Sushi domain-containing protein 5,1471,37,1.32 [0.55-3.17],0.5397740684043331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SV2A,Synaptic vesicle glycoprotein 2A,1465,37,0.44 [0.24-0.80],0.007477165364824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SWAP70,Switch-associated protein 70,1487,38,0.75 [0.30-1.88],0.5353834579168337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYAP1,Synapse-associated protein 1,1479,37,0.84 [0.49-1.45],0.5382602004642657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,1441,37,0.49 [0.23-1.05],0.0663836395127695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYT1,Synaptotagmin-1,1497,38,1.44 [0.76-2.73],0.2697329552977154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYTL4,Synaptotagmin-like protein 4,1502,38,0.88 [0.58-1.35],0.5723390502738732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,1483,38,0.85 [0.63-1.17],0.3229831299041954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACC3,Transforming acidic coiled-coil-containing protein 3,1733,49,0.98 [0.79-1.22],0.8858977810170333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,1550,46,1.63 [0.67-3.98],0.2816658775848014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TADA3,Transcriptional adapter 3,1498,38,0.90 [0.41-1.95],0.7860677471731989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,1733,49,2.71 [1.67-4.42],5.986425566401445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAGLN3,Transgelin-3,1449,38,0.94 [0.58-1.50],0.7814207096042415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TALDO1,Transaldolase,1506,38,1.12 [0.57-2.20],0.7479687506891006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TANK,TRAF family member-associated NF-kappa-B activator,1687,47,0.90 [0.62-1.32],0.5888954063865905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAP1,Antigen peptide transporter 1,1483,38,0.82 [0.44-1.52],0.5251975693131414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARBP2,RISC-loading complex subunit TARBP2,1670,45,0.99 [0.70-1.41],0.9500313103068704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",1465,37,0.85 [0.52-1.40],0.5337008447269155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",1498,38,0.89 [0.39-2.01],0.7782189222439235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAX1BP1,Tax1-binding protein 1,1497,38,0.87 [0.52-1.44],0.5784197177771997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D17,TBC1 domain family member 17,1670,45,1.35 [0.85-2.17],0.2063347344805594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D23,TBC1 domain family member 23,1733,49,0.85 [0.64-1.14],0.2761194930519797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D5,TBC1 domain family member 5,1726,49,0.83 [0.59-1.17],0.2857913655903192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCA,Tubulin-specific chaperone A,1479,37,0.98 [0.68-1.40],0.8983053196517706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCB,Tubulin-folding cofactor B,1718,47,1.03 [0.79-1.34],0.8085923722201347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCC,Tubulin-specific chaperone C,1718,47,1.13 [0.82-1.56],0.4640698249430239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,1682,45,1.05 [0.77-1.44],0.7449515628944041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBR1,T-box brain protein 1,1465,37,1.06 [0.58-1.93],0.8505065953664632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1A,T-cell leukemia/lymphoma protein 1A,1716,47,1.00 [0.77-1.30],0.9788373529428536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1B,T-cell leukemia/lymphoma protein 1B,1701,48,0.74 [0.48-1.13],0.160021554288903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN1,Transcobalamin-1,1474,37,0.64 [0.23-1.77],0.3867240208054338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,1751,50,2.18 [1.29-3.71],0.0037569679473102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCOF1,Treacle protein,1502,38,2.02 [0.83-4.94],0.1223991255346079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCP11,T-complex protein 11 homolog,1483,38,0.86 [0.46-1.62],0.6444121789051925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCTN3,Tectonic-3,1502,38,1.88 [0.72-4.94],0.1997985644825487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDGF1,Teratocarcinoma-derived growth factor 1,1670,45,0.84 [0.69-1.03],0.0909993593856493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDO2,"Tryptophan 2,3-dioxygenase",1465,37,0.32 [0.11-0.96],0.041180078763778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,1498,38,1.08 [0.73-1.61],0.699750732133849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDRKH,Tudor and KH domain-containing protein,1670,45,0.91 [0.65-1.27],0.5849016064117494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEF,Thyrotroph embryonic factor,1448,37,0.80 [0.37-1.72],0.5658494226928581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEK,Angiopoietin-1 receptor,1741,50,0.92 [0.31-2.71],0.8835383980260042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TERF1,Telomeric repeat-binding factor 1,1453,37,0.92 [0.32-2.65],0.8747908574283336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TET2,Methylcytosine dioxygenase TET2,1479,38,1.04 [0.80-1.35],0.7709759038800084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX101,Testis-expressed protein 101,1465,37,1.42 [0.65-3.13],0.3788192576463629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX33,Testis-expressed protein 33,1483,38,0.40 [0.15-1.06],0.0664654325395048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TF,Serotransferrin,1513,38,2.90 [0.77-10.92],0.1157615676278102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFAP2A,Transcription factor AP-2-alpha,1441,37,0.83 [0.47-1.45],0.5081822593895791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,1733,50,1.65 [1.30-2.09],4.5933792408612856e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,1733,49,2.20 [1.59-3.04],1.986141871469732e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,1725,49,2.11 [1.53-2.90],5.659875097370885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI,Tissue factor pathway inhibitor,1736,48,1.55 [0.76-3.18],0.2313991110692052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI2,Tissue factor pathway inhibitor 2,1736,50,1.55 [1.08-2.24],0.0174380652731223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFRC,Transferrin receptor protein 1,1742,48,0.88 [0.46-1.68],0.6978439150792188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TG,Thyroglobulin,1498,38,1.05 [0.83-1.34],0.664981642166053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFA,Protransforming growth factor alpha,1726,49,1.43 [0.90-2.26],0.1306036098437887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB1,Transforming growth factor beta-1 proprotein,1749,50,1.64 [0.89-3.02],0.1162165417325267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB2,Transforming growth factor beta-2 proprotein,1498,38,1.15 [0.69-1.91],0.6022919731930181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,1729,48,0.37 [0.15-0.88],0.0247690378609285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR1,TGF-beta receptor type-1,1453,37,2.71 [0.74-10.00],0.1340987083706698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,1741,50,2.71 [1.74-4.24],1.1447827943001576e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,1753,50,2.13 [1.11-4.09],0.0232297058414582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,1730,49,1.16 [0.84-1.60],0.3610126360154423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGOLN2,Trans-Golgi network integral membrane protein 2,1511,38,2.02 [0.74-5.52],0.1684953880534197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,1446,38,0.64 [0.39-1.05],0.0781684547248346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBD,Thrombomodulin,1735,50,2.01 [0.97-4.17],0.0609065121096993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,1741,50,1.59 [1.06-2.39],0.0242327182647993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS4,Thrombospondin-4,1741,48,0.96 [0.57-1.60],0.8719962366228775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THOP1,Thimet oligopeptidase,1729,50,0.50 [0.23-1.09],0.0826916214188383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THPO,Thrombopoietin,1701,48,0.85 [0.45-1.60],0.6075650237916647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THRAP3,Thyroid hormone receptor-associated protein 3,1448,37,1.03 [0.78-1.35],0.8506940019934155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THSD1,Thrombospondin type-1 domain-containing protein 1,1441,36,1.17 [0.53-2.59],0.6969768159074312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THTPA,Thiamine-triphosphatase,1495,38,0.94 [0.66-1.34],0.747106508270299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,1748,49,2.95 [1.46-5.95],0.0024642329797607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIA1,Nucleolysin TIA-1 isoform p40,1678,46,0.96 [0.78-1.20],0.7319667883972567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIE1,Tyrosine-protein kinase receptor Tie-1,1753,50,0.90 [0.51-1.60],0.7209359897113997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",1666,45,0.82 [0.46-1.47],0.5074598999303115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,1483,38,1.20 [0.61-2.37],0.5925664916007272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,1743,49,0.79 [0.46-1.34],0.3829085443240546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,1502,38,0.87 [0.40-1.90],0.7282029877212841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,1497,38,0.98 [0.68-1.42],0.9322856896099836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,1713,48,1.68 [0.83-3.40],0.1506993724992008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP2,Metalloproteinase inhibitor 2,1502,38,1.39 [0.41-4.72],0.6017054473385733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP3,Metalloproteinase inhibitor 3,1738,49,0.92 [0.77-1.11],0.3972457076557689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP4,Metalloproteinase inhibitor 4,1741,50,1.65 [0.99-2.75],0.0548992146687807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TINAGL1,Tubulointerstitial nephritis antigen-like,1733,50,1.46 [0.52-4.09],0.4749182761344171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJAP1,Tight junction-associated protein 1,1741,50,0.89 [0.66-1.21],0.4574624556419748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJP3,Tight junction protein ZO-3,1441,37,1.25 [0.68-2.30],0.463591788189826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TK1,"Thymidine kinase, cytosolic",1483,38,1.18 [0.66-2.10],0.5822181582642825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR1,Toll-like receptor 1,1453,37,1.17 [0.40-3.39],0.7716337473328437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR2,Toll-like receptor 2,1483,38,1.07 [0.28-4.06],0.916665491293894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR3,Toll-like receptor 3,1751,50,0.96 [0.66-1.38],0.8102668699088144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR4,Toll-like receptor 4,1453,37,0.66 [0.20-2.18],0.4943743038787921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,1465,37,1.09 [0.58-2.05],0.7822622389934956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED1,Transmembrane emp24 domain-containing protein 1,1483,38,1.23 [0.76-1.98],0.4005466173148911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED10,Transmembrane emp24 domain-containing protein 10,1448,37,0.93 [0.44-1.97],0.8489697011231392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED4,Transmembrane emp24 domain-containing protein 4,1448,37,1.15 [0.75-1.77],0.5159396284260407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED8,Protein TMED8,1487,38,0.90 [0.66-1.22],0.4999428242251712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM106A,Transmembrane protein 106A,1498,38,0.81 [0.50-1.32],0.3943925536271844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM132A,Transmembrane protein 132A,1469,38,0.91 [0.56-1.48],0.6965857293069497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,1506,38,1.72 [1.04-2.85],0.035492380959228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMOD4,Tropomodulin-4,1449,38,1.13 [0.58-2.19],0.7273164603324438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11B,Transmembrane protease serine 11B,1441,37,1.13 [0.79-1.60],0.5050055110215796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11D,Transmembrane protease serine 11D,1495,37,2.06 [1.17-3.63],0.0119742939826652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,1733,49,1.32 [1.00-1.75],0.049741370248204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS5,Transmembrane protease serine 5,1710,47,1.98 [1.00-3.94],0.0498797857442794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMSB10,Thymosin beta-10,1741,50,1.38 [0.97-1.96],0.0711240041624909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNC,Tenascin,1743,49,1.25 [0.77-2.01],0.3648736856637041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNF,Tumor necrosis factor,1700,48,1.25 [0.75-2.09],0.3906850505746497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,1487,38,0.90 [0.48-1.70],0.7458963898654782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,1687,47,0.76 [0.37-1.58],0.4631877709170604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,1479,37,0.76 [0.45-1.26],0.2842822464663243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1718,47,5.16 [2.62-10.14],2.0307159629440165e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1718,47,1.53 [1.24-1.88],5.050207724671718e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,1738,50,0.81 [0.49-1.33],0.4076594629008367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1751,50,2.65 [1.68-4.17],2.795659065906033e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1726,49,1.96 [1.02-3.75],0.0425785023944609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1741,50,3.32 [2.00-5.52],3.391872905635034e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,1730,49,1.27 [0.64-2.52],0.4954135918373025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,1687,47,1.21 [0.67-2.20],0.5286525804242228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1730,49,3.52 [2.01-6.17],1.088906751613951e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,1479,37,0.73 [0.34-1.55],0.4101884948642432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1751,50,2.87 [1.76-4.68],2.429399649540302e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1741,50,3.43 [1.86-6.31],7.775303313408917e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1741,50,1.66 [1.20-2.28],0.0019585702000708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1748,49,3.32 [1.50-7.35],0.0030859344373127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1749,50,2.43 [1.50-3.94],0.0003234765974092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1718,47,2.14 [1.43-3.19],0.0002012817880162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1748,49,1.67 [1.10-2.52],0.0152790930488305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1718,47,2.70 [1.71-4.28],2.2593002165648105e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,1751,50,0.70 [0.28-1.74],0.4425368191313978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,1726,49,0.89 [0.59-1.34],0.5768453861110343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,1751,50,0.53 [0.23-1.21],0.128757747412861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1738,49,5.35 [2.47-11.56],2.0070506992801443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,1750,50,1.17 [0.51-2.66],0.7100478161202112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,1718,47,1.12 [0.71-1.78],0.6246277497973576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,1508,38,2.33 [1.13-4.83],0.0221585813970539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNIP1,TNFAIP3-interacting protein 1,1497,38,0.82 [0.56-1.19],0.2853488628646144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNN,Tenascin-N,1508,38,1.17 [0.60-2.30],0.6441056871135185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNNI3,"Troponin I, cardiac muscle",1701,48,1.14 [0.81-1.59],0.453319783819435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNPO1,Transportin-1,1483,38,0.81 [0.32-2.09],0.6691304137596374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNR,Tenascin-R,1718,47,1.68 [0.95-2.97],0.0761694112920444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNXB,Tenascin-X,1741,50,0.54 [0.23-1.28],0.1628613306037488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,1502,38,1.02 [0.68-1.51],0.93616201731421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1,DNA topoisomerase 1,1487,38,1.11 [0.84-1.47],0.4457461303933444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1MT,"DNA topoisomerase I, mitochondrial",1449,38,0.72 [0.32-1.63],0.4310829585094439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP2B,DNA topoisomerase 2-beta,1453,37,0.87 [0.57-1.32],0.5053876177169544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOR1AIP1,Torsin-1A-interacting protein 1,1469,38,1.15 [0.70-1.91],0.5766517770490861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53,Cellular tumor antigen p53,1682,45,0.79 [0.42-1.48],0.4620725022282215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53BP1,TP53-binding protein 1,1453,37,1.04 [0.72-1.52],0.8286224895472214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53I3,Quinone oxidoreductase PIG3,1438,35,1.20 [0.68-2.11],0.527624726695737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,1701,48,0.80 [0.31-2.07],0.6487701391978196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP73,Tumor protein p73,1465,37,0.80 [0.33-1.97],0.6327834698791834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPBGL,Trophoblast glycoprotein-like,1465,37,1.22 [0.68-2.20],0.4993278787929192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPD52L2,Tumor protein D54,1479,37,0.89 [0.66-1.19],0.4330443055533947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPK1,Thiamin pyrophosphokinase 1,1502,38,0.57 [0.19-1.72],0.3168165175922126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPM3,Tropomyosin alpha-3 chain,1448,37,1.09 [0.61-1.92],0.7763061214363253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPMT,Thiopurine S-methyltransferase,1682,45,0.73 [0.50-1.08],0.1138104011627017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPP1,Tripeptidyl-peptidase 1,1718,49,1.20 [0.72-2.01],0.4777288529722985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP2,Tubulin polymerization-promoting protein family member 2,1483,38,0.89 [0.60-1.32],0.5613752805066906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP3,Tubulin polymerization-promoting protein family member 3,1670,45,1.45 [1.02-2.07],0.0395571487687538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPR,Nucleoprotein TPR,1448,37,1.19 [0.73-1.93],0.4921852529062487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPRKB,EKC/KEOPS complex subunit TPRKB,1449,38,1.16 [0.75-1.77],0.5102751979390212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSAB1,Tryptase alpha/beta-1,1747,50,1.65 [0.98-2.76],0.0576338645919747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSD1,Tryptase delta,1506,38,1.19 [0.52-2.75],0.6781054622696605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSG1,Tryptase gamma,1453,37,1.38 [0.56-3.41],0.4852543761493418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPT1,Translationally-controlled tumor protein,1687,47,0.80 [0.48-1.33],0.3877747293913413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF2,TNF receptor-associated factor 2,1726,49,0.83 [0.58-1.21],0.3370835905257348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",1453,37,1.37 [0.73-2.59],0.323452958580175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,1448,37,0.83 [0.39-1.76],0.6258231912182122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,1483,38,0.85 [0.57-1.25],0.40497408707299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREH,Trehalase,1508,38,1.38 [0.89-2.12],0.1510762348302293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREM2,Triggering receptor expressed on myeloid cells 2,1726,49,1.13 [0.75-1.71],0.5474018010432715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML1,Trem-like transcript 1 protein,1511,38,1.07 [0.61-1.88],0.804914136874988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML2,Trem-like transcript 2 protein,1741,50,0.89 [0.42-1.89],0.7559100167594152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,1751,50,1.18 [0.79-1.76],0.4155339911141404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,1726,49,1.03 [0.76-1.39],0.8680692183218505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM24,Transcription intermediary factor 1-alpha,1478,38,0.75 [0.44-1.26],0.2778263338944229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,1487,38,0.86 [0.64-1.15],0.3087662786626866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM26,Tripartite motif-containing protein 26,1449,38,1.14 [0.84-1.56],0.3938498966741252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM40,E3 ubiquitin ligase TRIM40,1465,37,0.73 [0.46-1.16],0.1787655294344144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM5,Tripartite motif-containing protein 5,1726,49,0.89 [0.66-1.20],0.4403808423313924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,1498,38,0.74 [0.52-1.05],0.0922354919158978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,1448,37,0.76 [0.39-1.48],0.4179666541703892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC1,Hamartin,1453,37,0.75 [0.42-1.33],0.3248204018046489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC22D1,TSC22 domain family protein 1,1506,38,1.10 [0.71-1.71],0.6735590083545111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSHB,Thyrotropin subunit beta,1735,50,1.03 [0.78-1.38],0.8139316173590176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSLP,Thymic stromal lymphopoietin,1701,48,1.12 [0.78-1.61],0.530244555126952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSNAX,Translin-associated protein X,1448,37,0.81 [0.37-1.76],0.5915154549311776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN1,Tetraspanin-1,1701,48,1.25 [0.58-2.73],0.5663344940830519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN15,Tetraspanin-15,1448,37,1.02 [0.55-1.88],0.9563706564767755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN7,Tetraspanin-7,1441,37,1.22 [0.93-1.60],0.1458307944497259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN8,Tetraspanin-8,1487,38,1.07 [0.81-1.40],0.6342429632327413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPYL1,Testis-specific Y-encoded-like protein 1,1453,37,0.99 [0.47-2.11],0.9881068462316004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TST,Thiosulfate sulfurtransferase,1670,45,0.93 [0.65-1.34],0.7032205914937804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTF2,Transcription termination factor 2,1465,37,0.90 [0.47-1.74],0.7583456446308118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTN,Titin,1448,37,1.23 [0.84-1.79],0.2809056277022451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTR,Transthyretin,1500,37,1.13 [0.35-3.60],0.8424723076151025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TUBB3,Tubulin beta-3 chain,1441,37,0.85 [0.26-2.74],0.7817659221816174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TWF2,Twinfilin-2,1508,38,0.90 [0.62-1.30],0.5638955658213138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXK,Tyrosine-protein kinase TXK,1483,38,1.12 [0.76-1.65],0.5724352931712897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXLNA,Alpha-taxilin,1718,47,1.05 [0.78-1.41],0.7380648210666907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXN,Thioredoxin,1483,37,0.88 [0.43-1.79],0.7238922614931269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC15,Thioredoxin domain-containing protein 15,1741,50,1.18 [0.52-2.69],0.6990980374896125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC5,Thioredoxin domain-containing protein 5,1748,49,1.21 [0.84-1.74],0.3184769523350961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC9,Thioredoxin domain-containing protein 9,1497,38,0.79 [0.43-1.44],0.4349483158638113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNL1,Thioredoxin-like protein 1,1439,37,0.96 [0.69-1.34],0.8137945615057658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",1741,50,0.76 [0.45-1.29],0.3162988597483345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYMP,Thymidine phosphorylase,1721,49,0.81 [0.54-1.21],0.2947609938944047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,1735,50,0.75 [0.32-1.77],0.5150708185704866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1453,37,2.42 [1.36-4.31],0.0026184197531503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBAC1,Ubiquitin-associated domain-containing protein 1,1733,49,1.69 [0.86-3.32],0.1283808193350172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,1498,38,0.84 [0.29-2.41],0.7472590273544626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,1502,38,1.02 [0.61-1.70],0.9542013676602424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,1453,37,0.65 [0.33-1.29],0.2186627108097862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBQLN3,Ubiquilin-3,1448,37,0.85 [0.45-1.61],0.6226341318647106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBXN1,UBX domain-containing protein 1,1479,37,0.96 [0.62-1.50],0.8704931433035002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,1487,38,0.98 [0.78-1.23],0.8642291635743654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UGDH,UDP-glucose 6-dehydrogenase,1448,37,0.94 [0.66-1.35],0.7520851740244617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,1448,37,0.63 [0.19-2.05],0.4389153038260182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,1718,47,3.44 [1.98-5.97],1.0894160713255728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,1747,50,0.31 [0.22-0.44],2.8540815124170888e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC5D,Netrin receptor UNC5D,1453,37,1.14 [0.34-3.85],0.8331576736874086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC79,Protein unc-79 homolog,1449,38,0.84 [0.46-1.53],0.567427220385309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNG,Uracil-DNA glycosylase,1498,38,1.17 [0.49-2.77],0.7211374154700572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPB1,Beta-ureidopropionase,1502,38,1.15 [0.86-1.54],0.3570948828555705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3A,Uroplakin-3a,1441,37,0.65 [0.31-1.34],0.2415128643605585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3BL1,Uroplakin-3b-like protein 1,1480,37,0.72 [0.33-1.60],0.4209514537113517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROD,Uroporphyrinogen decarboxylase,1479,37,0.96 [0.61-1.51],0.8674432182749788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROS,Uroporphyrinogen-III synthase,1465,37,1.13 [0.69-1.84],0.6349544798606712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USO1,General vesicular transport factor p115,1733,49,0.98 [0.74-1.29],0.8727823441713605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,1498,38,0.90 [0.57-1.40],0.6275228388527458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,1497,38,1.54 [0.85-2.80],0.1520554255685416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,1448,37,1.02 [0.70-1.49],0.9173443631641582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,1701,48,0.99 [0.75-1.30],0.9333292098204676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UXS1,UDP-glucuronic acid decarboxylase 1,1682,45,0.95 [0.58-1.56],0.8412765350426761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP5,Vesicle-associated membrane protein 5,1701,48,0.77 [0.45-1.30],0.3281945123875863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP8,Vesicle-associated membrane protein 8,1453,37,0.85 [0.58-1.25],0.4042048027831545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,1726,49,0.89 [0.65-1.22],0.4643341535855891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASN,Vasorin,1709,47,2.13 [0.96-4.74],0.062582924955913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASP,Vasodilator-stimulated phosphoprotein,1511,38,0.74 [0.48-1.14],0.1763035290232936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,1733,49,0.39 [0.10-1.45],0.1600785165306401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAV3,Guanine nucleotide exchange factor VAV3,1441,37,0.95 [0.69-1.30],0.736725013283563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,1742,49,2.01 [0.93-4.35],0.0760858636456469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAN,Versican core protein,1748,49,1.11 [0.50-2.43],0.7994495725456296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCPKMT,Protein-lysine methyltransferase METTL21D,1449,38,1.22 [0.93-1.61],0.1478338835722545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFA,Vascular endothelial growth factor A,1747,50,1.17 [0.78-1.77],0.4440165146302995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,1453,37,3.41 [1.28-9.09],0.0140731711431357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFC,Vascular endothelial growth factor C,1741,50,0.92 [0.59-1.42],0.7016073613677626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,1749,50,2.42 [1.29-4.54],0.0059878605020683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VGF,Neurosecretory protein VGF,1506,38,1.81 [0.96-3.41],0.0686644700220443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIM,Vimentin,1701,48,1.06 [0.85-1.32],0.6189747966745555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,1469,38,0.80 [0.25-2.52],0.7047715116078231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIT,Vitrin,1502,38,0.91 [0.42-1.98],0.8195050471197607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,1733,49,1.78 [1.18-2.68],0.0056627697652736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN1,Pantetheinase,1511,38,1.49 [0.95-2.33],0.0800456879833288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN2,Vascular non-inflammatory molecule 2,1733,49,0.92 [0.52-1.61],0.7627799906070786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,1483,38,0.96 [0.61-1.53],0.8667874622395126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS37A,Vacuolar protein sorting-associated protein 37A,1733,49,0.96 [0.70-1.32],0.7866819361267817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS4B,Vacuolar protein sorting-associated protein 4B,1498,38,0.93 [0.67-1.29],0.6672093763960752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,1733,49,0.89 [0.64-1.24],0.4853725843952927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,1498,38,1.58 [0.82-3.01],0.1683234502618178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,1448,37,1.54 [0.77-3.07],0.2242573621113026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,1498,38,1.87 [1.32-2.66],0.0004397073926295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1737,48,2.34 [1.44-3.80],0.0005809144310844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,1732,50,1.01 [0.69-1.50],0.9434819343787824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSNL1,Visinin-like protein 1,1497,38,0.65 [0.32-1.34],0.2484095345782807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM1,V-set and transmembrane domain-containing protein 1,1670,45,1.39 [0.84-2.30],0.1985604301532703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,1483,38,0.82 [0.38-1.75],0.6047399569203075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,1701,48,1.11 [0.75-1.64],0.5974392737796899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,1748,49,0.89 [0.63-1.27],0.5251081804272181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,1682,45,0.49 [0.21-1.16],0.1033938864318172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,1479,37,0.77 [0.43-1.39],0.3875275091450274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA1,von Willebrand factor A domain-containing protein 1,1746,50,1.26 [0.70-2.28],0.4418623109723469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA5A,von Willebrand factor A domain-containing protein 5A,1449,38,0.98 [0.67-1.43],0.9224120332932348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,1711,47,3.34 [1.86-5.99],5.442865153012694e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,1506,38,1.30 [0.86-1.96],0.2072346822499566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWF,von Willebrand factor,1753,50,1.20 [0.86-1.66],0.2832002066017886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",1741,50,0.70 [0.37-1.33],0.2744969911629812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WAS,Wiskott-Aldrich syndrome protein,1687,47,0.69 [0.45-1.07],0.0957081726140083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,1701,48,0.83 [0.62-1.12],0.2218739680876506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,1670,45,0.92 [0.66-1.29],0.6376202466864519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASHC3,WASH complex subunit 3,1497,38,0.78 [0.50-1.22],0.2724199242222258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASL,Neural Wiskott-Aldrich syndrome protein,1453,37,1.37 [1.01-1.88],0.0460769606054696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WDR46,WD repeat-containing protein 46,1498,38,1.52 [0.85-2.70],0.1550228005488891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC1,WAP four-disulfide core domain protein 1,1466,38,1.23 [0.84-1.79],0.2829460269584328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,1749,50,1.60 [1.15-2.22],0.0050736439296828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,1652,47,2.80 [1.92-4.06],6.897629155023066e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1711,47,0.52 [0.29-0.95],0.0344690552187952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",1730,49,1.33 [0.69-2.56],0.3968531078884232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WIF1,Wnt inhibitory factor 1,1751,50,0.75 [0.37-1.51],0.4212904234695838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,1687,47,1.82 [1.12-2.96],0.0159153201005969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,1718,47,0.91 [0.56-1.47],0.6964829269058315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XCL1,Lymphotactin,1751,50,1.34 [0.94-1.91],0.1096230759291782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,1743,50,3.39 [1.99-5.76],6.890317708476241e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XIAP,E3 ubiquitin-protein ligase XIAP,1453,37,0.83 [0.47-1.47],0.5209425315728269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XPNPEP2,Xaa-Pro aminopeptidase 2,1741,50,0.91 [0.70-1.18],0.4700654093892114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XRCC4,DNA repair protein XRCC4,1670,45,0.65 [0.30-1.42],0.2809789788663437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,1497,38,3.15 [1.31-7.55],0.0103094458765158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",1487,38,0.93 [0.75-1.15],0.5219924245837546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YES1,Tyrosine-protein kinase Yes,1733,49,0.98 [0.79-1.21],0.8239095281430269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YJU2,Splicing factor YJU2,1498,38,1.23 [0.47-3.24],0.6766999429917702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YOD1,Ubiquitin thioesterase OTU1,1448,37,1.13 [0.71-1.80],0.6038972871882642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YTHDF3,YTH domain-containing family protein 3,1687,47,0.95 [0.70-1.28],0.739519211918001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YWHAQ,14-3-3 protein theta,1479,37,0.87 [0.57-1.33],0.531963569121433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YY1,Transcriptional repressor protein YY1,1453,37,0.64 [0.19-2.22],0.485847108534738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBP1,Z-DNA-binding protein 1,1453,37,1.36 [0.65-2.85],0.4146150470712567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,1682,45,0.84 [0.57-1.26],0.4050676645874964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,1701,48,1.12 [0.63-2.02],0.6939893727209803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,1448,37,0.94 [0.54-1.63],0.8127333990730218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZFYVE19,Abscission/NoCut checkpoint regulator,1487,38,0.94 [0.66-1.33],0.7160828444294816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZHX2,Zinc fingers and homeoboxes protein 2,1497,38,1.27 [0.65-2.46],0.4876519993596847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF174,Zinc finger protein 174,1453,37,1.45 [0.72-2.92],0.2946592322020221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF75D,Zinc finger protein 75D,1483,38,0.83 [0.49-1.42],0.5026340410215386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF830,Zinc finger protein 830,1498,38,0.99 [0.67-1.46],0.9493646036468608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRD2,Protein ZNRD2,1487,38,0.94 [0.61-1.44],0.7801544495522322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,1498,38,0.84 [0.47-1.50],0.5581642110558567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP3,Zona pellucida sperm-binding protein 3,1469,38,1.15 [1.01-1.31],0.0397213677370909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP4,Zona pellucida sperm-binding protein 4,1449,38,0.99 [0.41-2.35],0.9740130400728446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZPR1,Zinc finger protein ZPR1,1441,37,1.11 [0.86-1.44],0.4187106478594914
